5-Amino-1MQDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- 5-Amino-1-methylquinolinium, 5-amino-1-methylquinoline, 5A1MQ
Sources - PubMed PMID 29155147 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| 5-Amino-1-methylquinolinium, 5-amino-1-methylquinoline, 5A1MQ | Small molecule, not a peptide | Status not recorded | PubMed PMID 29155147 |
AbaloparatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2017
- INN stem
- -tide
- All names
- Abaloparatida, BA-058, BA058, BIM-44058, Bim44058, Eladynos, Tymlos
Sources - ChEMBL CHEMBL3301581 (read 2026-10-02)
| Abaloparatida, BA-058, BA058 | Peptide | Approved (2017) | ChEMBL CHEMBL3301581 |
AbarelixDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2003
- INN stem
- -relix
- All names
- PPI-149, Plenaxis, R-382, R-3827, R382, R3827
Sources - ChEMBL CHEMBL1252 (read 2026-10-02)
| PPI-149, Plenaxis, R-382 | Peptide | Approved (2003) | ChEMBL CHEMBL1252 |
ACE-031Details- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- ActRIIB-Fc, Activin type IIB receptor-Fc fusion, Ramatercept
Sources - PubMed PMID 23169607 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| ActRIIB-Fc, Activin type IIB receptor-Fc fusion, Ramatercept | Protein, not a peptide | Status not recorded | PubMed PMID 23169607 |
Acetyl Decapeptide-3Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 91936932 (read 2026-10-02): PubChem title: Acetyl decapeptide-3
| — | Peptide | Status not recorded | PubChem CID 91936932 |
Acetyl Dipeptide-1 Cetyl EsterDetails- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 11685829 (read 2026-10-02): PubChem title: Acetyl dipeptide-1 cetyl ester
| — | Peptide | Status not recorded | PubChem CID 11685829 |
Acetyl Hexapeptide-30Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Acetyl Hexapeptide-25 (former INCI), Inyline
Sources - PubMed PMID 33195061 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Acetyl Hexapeptide-25 (former INCI), Inyline | Peptide | Status not recorded | PubMed PMID 33195061 |
Acetyl Hexapeptide-37Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Ac-SPAGGP-NH2, Ac-Ser-Pro-Ala-Gly-Gly-Pro-NH2, Diffuporine
Sources - PubMed PMID 18548108 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Ac-SPAGGP-NH2, Ac-Ser-Pro-Ala-Gly-Gly-Pro-NH2, Diffuporine | Peptide | Status not recorded | PubMed PMID 18548108 |
Acetyl Octapeptide-3Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Acetyl glutamyl heptapeptide-1, SNAP-8, Super Argireline
Sources - PubMed PMID 18498523 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Acetyl glutamyl heptapeptide-1, SNAP-8, Super Argireline | Peptide | Status not recorded | PubMed PMID 18498523 |
Acetyl Tetrapeptide-11Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 91936941 (read 2026-10-02): PubChem title: Acetyl tetrapeptide-11
| — | Peptide | Status not recorded | PubChem CID 91936941 |
Acetyl Tetrapeptide-3Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 11752568 (read 2026-10-02): PubChem title: Acetyl tetrapeptide-3
| — | Peptide | Status not recorded | PubChem CID 11752568 |
Acetyl Tetrapeptide-5Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Ac-bAla-His-Ser-His, Ac-βAla-His-Ser-His, Eyeseryl
Sources - PubMed PMID 33195061 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Ac-bAla-His-Ser-His, Ac-βAla-His-Ser-His, Eyeseryl | Peptide | Status not recorded | PubMed PMID 33195061 |
Acetyl Tetrapeptide-9Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 11606295 (read 2026-10-02): PubChem title: Acetyl tetrapeptide-9
| — | Peptide | Status not recorded | PubChem CID 11606295 |
acetyl-SH-heptapeptide-1Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 122190547 (read 2026-10-02): PubChem title: Acetyl sh-Heptapeptide-1
| — | Peptide | Status not recorded | PubChem CID 122190547 |
AclerastideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Aclerastida, Asp-arg-nle-tyr-ile-his-pro, DSC127, Dsc-127, Dsc127, Norleu3-a(1-7), Norleu3-angiotensin(1-7), USB-001, USB-005, USB005
Sources - ChEMBL CHEMBL4297940 (read 2026-10-02)
| Aclerastida, Asp-arg-nle-tyr-ile-his-pro, DSC127 | Peptide | Phase 3 | ChEMBL CHEMBL4297940 |
Act-1 PeptideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Acti peptide, Granexin, Granexin peptide, Peptide 328967
Sources - ChEMBL CHEMBL4297964 (read 2026-10-02)
| Acti peptide, Granexin, Granexin peptide | Peptide | Phase 3 | ChEMBL CHEMBL4297964 |
AdamaxDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Ac-MEHFPGP-AG-NH2, Adamax peptide, N-acetyl Semax with adamantyl P21 modification
Sources - PubMed PMID 16996037 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Ac-MEHFPGP-AG-NH2, Adamax peptide, N-acetyl Semax with adamantyl P21 modification | Peptide | Status not recorded | PubMed PMID 16996037 |
AdipotideDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- FTPP, Fat-Targeted Proapoptotic Peptide, Prohibitin-TP01
Sources - PubMed PMID 22072637 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FTPP, Fat-Targeted Proapoptotic Peptide, Prohibitin-TP01 | Peptide | Status not recorded | PubMed PMID 22072637 |
AdrenomedullinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P35318 (read 2026-10-02): mature peptide 95-146 of Pro-adrenomedullin
| — | Peptide | Made by the body | UniProt P35318 |
Adrenomedullin-2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q7Z4H4 (read 2026-10-02): mature peptide 101-147 of Protein ADM2
| — | Peptide | Made by the body | UniProt Q7Z4H4 |
AfamelanotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2014
- INN stem
- -tide
- All names
- (nle4,d-phe7)-.alpha.-msh, A-melanotropin, 4(nle)-7(d-phe), Afamelanotida, CUV-1647, CUV-1647 ACETATE, CUV1647, CUV1647 ACETATE, Melanotan, Melanotan i, Melanotan-1, Ndp-alpha-msh, Scenesse
Sources - ChEMBL CHEMBL441738 (read 2026-10-02)
- ChEMBL CHEMBL4297213 (read 2026-10-02): salt form, folded into this row
| (nle4,d-phe7)-.alpha.-msh, A-melanotropin, 4(nle)-7(d-phe), Afamelanotida | Peptide | Approved (2014) | ChEMBL CHEMBL441738; ChEMBL CHEMBL4297213 |
AHK-CuDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AHK copper peptide, Ala-His-Lys-copper
Sources - PubMed PMID 17703734 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AHK copper peptide, Ala-His-Lys-copper | Peptide | Status not recorded | PubMed PMID 17703734 |
AICARDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- AICA Ribotide
Sources - PubChem CID 65110 (read 2026-10-02): PubChem title: AICA Ribotide
| AICA Ribotide | Small molecule, not a peptide | Status not recorded | PubChem CID 65110 |
AlbiglutideDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- First approval
- 2014
- INN stem
- -tide
- All names
- Albiglutida, Albiglutide (genetical recombination), Eperzan, GSK-716155, GSK716155, Tanzeum
Sources - ChEMBL CHEMBL2107841 (read 2026-10-02)
| Albiglutida, Albiglutide (genetical recombination), Eperzan | Protein, not a peptide | Approved (2014) | ChEMBL CHEMBL2107841 |
AlbuvirtideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide; -vir-
- All names
- FB-006M, Labuvirtide
Sources - ChEMBL CHEMBL4297257 (read 2026-10-02)
| FB-006M, Labuvirtide | Peptide | Phase 3 | ChEMBL CHEMBL4297257 |
Alizulatide VixocianineDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Alizulatida vixocianina
Sources - ChEMBL CHEMBL6068041 (read 2026-10-02)
| Alizulatida vixocianina | Peptide | Phase 2 | ChEMBL CHEMBL6068041 |
AlmurtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Almurtida, CGP-11637, Desmethylmuramoyldipeptide, NORMDP, Nor-mdp, Normuramyldipeptide
Sources - ChEMBL CHEMBL3989787 (read 2026-10-02)
| Almurtida, CGP-11637, Desmethylmuramoyldipeptide | Peptide | Phase 2 | ChEMBL CHEMBL3989787 |
Alpha-MSHDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Alpha-Melanocyte Stimulating Hormone, α-MSH, α-Melanotropin
Sources - PubMed PMID 16763547 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Alpha-Melanocyte Stimulating Hormone, α-MSH, α-Melanotropin | Peptide | Status not recorded | PubMed PMID 16763547 |
Alpha-neoendorphinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 175-184 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
AlprostadilDetails- Status
- Approved
- Class
- Small molecule, not a peptide
- Highest phase
- 4.0
- All names
- Caverject, Edex, MUSE, PGE1, Prostaglandin E1, Prostin VR
Sources - PubMed PMID 8596569 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Caverject, Edex, MUSE | Small molecule, not a peptide | Approved | PubMed PMID 8596569 |
AlsactideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Alsactida, HOE-433, Synchrodyn
Sources - ChEMBL CHEMBL3989434 (read 2026-10-02)
| Alsactida, HOE-433, Synchrodyn | Peptide | Phase 2 | ChEMBL CHEMBL3989434 |
AmilomotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Amilomotida, CAD-106, CAD106, Cad106
Sources - ChEMBL CHEMBL2108328 (read 2026-10-02)
| Amilomotida, CAD-106, CAD106 | Peptide | Phase 2 | ChEMBL CHEMBL2108328 |
AmycretinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- NNC0487-0111
Sources - PubMed PMID 40550231 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NNC0487-0111 | Peptide | Status not recorded | PubMed PMID 40550231 |
AmylinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AC-001, AC001, Amlintida, Amylin, Amylin human, Amylin human amylin, Islet amyloid polypeptide (human)
Sources - ChEMBL CHEMBL2109025 (read 2026-10-02)
- UniProt P10997 (read 2026-10-02): mature peptide 34-70 of Islet amyloid polypeptide
| AC-001, AC001, Amlintida | Peptide | Phase 2 | ChEMBL CHEMBL2109025; UniProt P10997 |
AnamorelinDetails- Status
- Phase 3
- Class
- Small molecule, not a peptide
- Highest phase
- 3.0
- INN stem
- -relin
- All names
- Anamorelin hcl, Anamorelina, Anamoreline, Ono-7643, RC-1291, RC-1291 HCl, ST-1291
Sources - ChEMBL CHEMBL2110579 (read 2026-10-02)
- ChEMBL CHEMBL2103794 (read 2026-10-02): salt form, folded into this row
| Anamorelin hcl, Anamorelina, Anamoreline | Small molecule, not a peptide | Phase 3 | ChEMBL CHEMBL2110579; ChEMBL CHEMBL2103794 |
AnfibatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Agkisacucetin
Sources - ChEMBL CHEMBL4297694 (read 2026-10-02)
| Agkisacucetin | Peptide | Phase 2 | ChEMBL CHEMBL4297694 |
Angiotensin IIDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- AT-II, Ang II, Giapreza, LJPC-501, synthetic human angiotensin II
Sources - PubMed PMID 28528561 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AT-II, Ang II, Giapreza | Peptide | Approved | PubMed PMID 28528561 |
AnidulafunginDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2006
- All names
- Eraxis
Sources - openFDA NDA021632 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Eraxis | Peptide | Approved (2006) | openFDA NDA021632 |
ANPDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Anaritida, WY-47,663, WY-47,663 ACETATE, WY-47663 ACETATE
Sources - ChEMBL CHEMBL2108934 (read 2026-10-02)
| Anaritida, WY-47,663, WY-47,663 ACETATE | Peptide | Phase 2 | ChEMBL CHEMBL2108934 |
AOD-9604Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Frag 176-191, HGH Frag 176-191, Lipolytic fragment of GH, hGH fragment 176-191
Sources - PubMed PMID 11146367 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Frag 176-191, HGH Frag 176-191, Lipolytic fragment of GH | Peptide | Status not recorded | PubMed PMID 11146367 |
ApelinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9ULZ1 (read 2026-10-02): mature peptide 65-77 of Apelin
| — | Peptide | Made by the body | UniProt Q9ULZ1 |
Apelin-28Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9ULZ1 (read 2026-10-02): mature peptide 50-77 of Apelin
| — | Peptide | Made by the body | UniProt Q9ULZ1 |
Apelin-31Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9ULZ1 (read 2026-10-02): mature peptide 47-77 of Apelin
| — | Peptide | Made by the body | UniProt Q9ULZ1 |
ApitegromabDetails- Status
- Approved
- Class
- Antibody, not a peptide
- Highest phase
- 4.0
- All names
- SRK-015
Sources - PubMed PMID 40818473 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| SRK-015 | Antibody, not a peptide | Approved | PubMed PMID 40818473 |
ApraglutideDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- FE 203799
Sources - PubMed PMID 39461299 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FE 203799 | Peptide | Status not recorded | PubMed PMID 39461299 |
ARA-290Details- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ARA 290, ARA-290, ARA290, Ara 290, Ara290, Cibinetida, Ph-bsp, Phbsp
Sources - ChEMBL CHEMBL3545305 (read 2026-10-02)
| ARA 290, ARA-290, ARA290 | Peptide | Phase 2 | ChEMBL CHEMBL3545305 |
Arg-vasopressinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01185 (read 2026-10-02): mature peptide 20-28 of Vasopressin-neurophysin 2-copeptin
| — | Peptide | Made by the body | UniProt P01185 |
Argipressin TannateDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -pressin
- All names
- Argipresina, Argipressin, Argipressine, CI-107
Sources - ChEMBL CHEMBL2108986 (read 2026-10-02)
| Argipresina, Argipressin, Argipressine | Peptide | Phase 2 | ChEMBL CHEMBL2108986 |
ArgiprestocinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tocin
- All names
- 8-arginineoxytocin, Arginine vasotocin, Argiprestocina, Argiprestocine
Sources - ChEMBL CHEMBL2370156 (read 2026-10-02)
| 8-arginineoxytocin, Arginine vasotocin, Argiprestocina | Peptide | Phase 2 | ChEMBL CHEMBL2370156 |
ArgirelineDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AH-8, Acetyl Hexapeptide-3, Acetyl Hexapeptide-8
Sources - PubMed PMID 18498523 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AH-8, Acetyl Hexapeptide-3, Acetyl Hexapeptide-8 | Peptide | Status not recorded | PubMed PMID 18498523 |
AspartocinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tocin
- All names
- A 8999, A-8999, Aspartocina, Aspartocine, Oxytocin, 4-l-asparagine-
Sources - ChEMBL CHEMBL2104384 (read 2026-10-02)
| A 8999, A-8999, Aspartocina | Peptide | Phase 2 | ChEMBL CHEMBL2104384 |
AtosibanDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Antocin, Tractocile
Sources - PubMed PMID 10819855 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Antocin, Tractocile | Peptide | Status not recorded | PubMed PMID 10819855 |
Atriopeptin-1Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 128-148 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
Atriopeptin-2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 128-150 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
Atriopeptin-3Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 128-151 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
Auriculin-ADetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 127-150 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
Auriculin-BDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 127-151 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
Auriculin-CDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 119-151 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
Auriculin-DDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 121-145 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
AvexitideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Avexitida, Exendin (9-39), Exendin (9-39) amide, Exendin (9-39) amide acetate, Exendin 9-39, Exendin 9-39 Acetate, Exendin(9-39)amide, Exendin-(9-39) acetate, Exendin-3 (9-39) amide
Sources - ChEMBL CHEMBL4297949 (read 2026-10-02)
- ChEMBL CHEMBL4298175 (read 2026-10-02): separate ChEMBL record of the same molecule
| Avexitida, Exendin (9-39), Exendin (9-39) amide | Peptide | Phase 3 | ChEMBL CHEMBL4297949; ChEMBL CHEMBL4298175 |
AvorelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Avorelina, Avoreline, EP-23904, MF-6001, Meterelin
Sources - ChEMBL CHEMBL2103984 (read 2026-10-02)
| Avorelina, Avoreline, EP-23904 | Peptide | Phase 2 | ChEMBL CHEMBL2103984 |
Azagly-nafarelinDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -relin
- All names
- Gonazon
Sources - ChEMBL CHEMBL6068344 (read 2026-10-02)
| Gonazon | Peptide | Status not recorded | ChEMBL CHEMBL6068344 |
AZD6234Details- Status
- Status not recorded
- Class
- Peptide
Sources - ClinicalTrials.gov NCT06132841 (read 2026-10-02): trial registration cited on the encyclopedia entry
| — | Peptide | Status not recorded | ClinicalTrials.gov NCT06132841 |
AzetirelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Azetirelina, Azetireline
Sources - ChEMBL CHEMBL2104559 (read 2026-10-02)
| Azetirelina, Azetireline | Peptide | Phase 2 | ChEMBL CHEMBL2104559 |
BacitracinDetails- Status
- Approved
- Class
- Blend or mixture
- Highest phase
- 4.0
- First approval
- 1995
- All names
- Bacitracin Zinc And Polymyxin B Sulfate, Neomycin And Polymyxin B Sulfates And Bacitracin Zinc, Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone
Sources - openFDA ANDA064046 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Bacitracin Zinc And Polymyxin B Sulfate, Neomycin And Polymyxin B Sulfates And Bacitracin Zinc, Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone | Blend or mixture | Approved (1995) | openFDA ANDA064046 |
BalixafortideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Balixafortida, POL-6326, POL6326, Pol6326
Sources - ChEMBL CHEMBL4802129 (read 2026-10-02)
| Balixafortida, POL-6326, POL6326 | Peptide | Phase 3 | ChEMBL CHEMBL4802129 |
BaloramotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Baloramotida, Lage-2, recombinant, Recombinant ny-eso-1 protein
Sources - ChEMBL CHEMBL4298083 (read 2026-10-02)
| Baloramotida, Lage-2, recombinant, Recombinant ny-eso-1 protein | Peptide | Phase 2 | ChEMBL CHEMBL4298083 |
BeinaglutideDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -tide
- All names
- Glp-1 (7-36), Glucagon like peptide-i (7-36), Glucagon-like-peptide-1 (7-36)
Sources - ChEMBL CHEMBL5095267 (read 2026-10-02)
- UniProt P01275 (read 2026-10-02): mature peptide 98-127 of Pro-glucagon
| Glp-1 (7-36), Glucagon like peptide-i (7-36), Glucagon-like-peptide-1 (7-36) | Peptide | Status not recorded | ChEMBL CHEMBL5095267; UniProt P01275 |
Beta-EndorphinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 237-267 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
Beta-neoendorphinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 175-183 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
BetiatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Betiatida, MP-600, S-benzoylmercaptoacetyltriglycine
Sources - ChEMBL CHEMBL2109104 (read 2026-10-02)
| Betiatida, MP-600, S-benzoylmercaptoacetyltriglycine | Peptide | Phase 2 | ChEMBL CHEMBL2109104 |
BevemipretideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Bevemipretida, SBT-272
Sources - ChEMBL CHEMBL5314506 (read 2026-10-02)
| Bevemipretida, SBT-272 | Peptide | Phase 2 | ChEMBL CHEMBL5314506 |
BibapcitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Bibapcitida, P-280, P280, Technetium tc 99m apcitide dimer
Sources - ChEMBL CHEMBL2106413 (read 2026-10-02)
| Bibapcitida, P-280, P280 | Peptide | Phase 2 | ChEMBL CHEMBL2106413 |
Big gastrinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01350 (read 2026-10-02): mature peptide 59-92 of Gastrin
| — | Peptide | Made by the body | UniProt P01350 |
Big LENDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 245-260 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
Big PEN-LENDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 221-260 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
Big SAASDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 34-59 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
BimagrumabDetails- Status
- Status not recorded
- Class
- Antibody, not a peptide
- All names
- ActRII antibody, BYM338
Sources - PubMed PMID 41772149 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| ActRII antibody, BYM338 | Antibody, not a peptide | Status not recorded | PubMed PMID 41772149 |
Bioactive Food PeptidesDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Casein Peptides, Dietary Bioactive Peptides, Food-Derived Peptides, Whey Peptides
Sources - PubMed PMID 20811398 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Casein Peptides, Dietary Bioactive Peptides, Food-Derived Peptides | Peptide | Status not recorded | PubMed PMID 20811398 |
Biotinoyl Tripeptide-1Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Biotinyl-GHK, Procapil component
Sources - PubMed PMID 39609969 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Biotinyl-GHK, Procapil component | Peptide | Status not recorded | PubMed PMID 39609969 |
BivalirudinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2000
- All names
- Angiomax, Angiomax Rtu
Sources - openFDA NDA020873 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Angiomax, Angiomax Rtu | Peptide | Approved (2000) | openFDA NDA020873 |
BNPDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 27-102 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(1-28)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 103-130 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(1-29)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 103-131 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(1-30)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 103-132 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(2-31)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 104-133 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(3-29)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 105-131 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(3-30)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 105-132 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(3-32)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 105-134 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(4-27)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 106-129 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(4-29)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 106-131 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(4-30)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 106-132 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(4-31)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 106-133 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(5-29)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 107-131 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(5-31)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 107-133 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BNP(5-32)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 107-134 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BofanglutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Bofanglutida
Sources - ChEMBL CHEMBL6068096 (read 2026-10-02)
| Bofanglutida | Peptide | Phase 2 | ChEMBL CHEMBL6068096 |
Botulinum ToxinDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- BoNT, Botox, Dysport, Jeuveau, Myobloc, Xeomin, abobotulinumtoxinA, incobotulinumtoxinA, onabotulinumtoxinA, prabotulinumtoxinA, rimabotulinumtoxinB
Sources - PubMed PMID 33040610 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| BoNT, Botox, Dysport | Protein, not a peptide | Approved | PubMed PMID 33040610 |
BPC-157Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Body Protective Compound 157, PL 14736, Pentadecapeptide BPC 157
Sources - PubMed PMID 30690000 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Body Protective Compound 157, PL 14736, Pentadecapeptide BPC 157 | Peptide | Status not recorded | PubMed PMID 30690000 |
BradykininDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- BK, Kallidin, Kinin-9
Sources - PubMed PMID 8227859 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| BK, Kallidin, Kinin-9 | Peptide | Status not recorded | PubMed PMID 8227859 |
Brain natriuretic peptide 29Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 106-134 of Natriuretic peptides B
| — | Peptide | Made by the body | UniProt P16860 |
BrimapitideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Brimapitida, Xg-102
Sources - ChEMBL CHEMBL4297650 (read 2026-10-02)
| Brimapitida, Xg-102 | Peptide | Phase 3 | ChEMBL CHEMBL4297650 |
BRN2 (POU3F2) Research PeptideDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- N-Oct3 fragment, POU3F2-derived peptide
Sources - PubMed PMID 11859196 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| N-Oct3 fragment, POU3F2-derived peptide | Peptide | Status not recorded | PubMed PMID 11859196 |
BronchogenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AEDL, Ala-Glu-Asp-Leu
Sources - PubMed PMID 23734519 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AEDL, Ala-Glu-Asp-Leu | Peptide | Status not recorded | PubMed PMID 23734519 |
BulevirtideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2020
- INN stem
- -tide; -vir-
- All names
- 915207G, Bulevirtida, Hepcludex, Hepcludextm, Myrcludex
Sources - ChEMBL CHEMBL4297711 (read 2026-10-02)
- ChEMBL CHEMBL5315080 (read 2026-10-02): salt form, folded into this row
| 915207G, Bulevirtida, Hepcludex | Peptide | Approved (2020) | ChEMBL CHEMBL4297711; ChEMBL CHEMBL5315080 |
BuserelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- INN stem
- -relin
- All names
- Buserelin monoacetate, Buserelina, Busereline, Conceptal, HOE 766, HOE-766, NSC-725176, Suprefact
Sources - ChEMBL CHEMBL2110824 (read 2026-10-02)
- ChEMBL CHEMBL2106198 (read 2026-10-02): salt form, folded into this row
| Buserelin monoacetate, Buserelina, Busereline | Peptide | Approved | ChEMBL CHEMBL2110824; ChEMBL CHEMBL2106198 |
C-flanking peptide of NPYDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01303 (read 2026-10-02): mature peptide 68-97 of Pro-neuropeptide Y
| — | Peptide | Made by the body | UniProt P01303 |
C-terminal peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P05408 (read 2026-10-02): mature peptide 200-212 of Neuroendocrine protein 7B2
| — | Peptide | Made by the body | UniProt P05408 |
C-terminal-flanking peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20366 (read 2026-10-02): mature peptide 111-126 of Protachykinin-1
| — | Peptide | Made by the body | UniProt P20366 |
CagrilintideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Cagrilintide component of cagrisema, NNC0174-0833
Sources - ChEMBL CHEMBL4802169 (read 2026-10-02)
| Cagrilintide component of cagrisema, NNC0174-0833 | Peptide | Phase 3 | ChEMBL CHEMBL4802169 |
CagriSemaDetails- Status
- Status not recorded
- Class
- Blend or mixture
- All names
- NN9838, cagrilintide/semaglutide 2.4/2.4
Sources - PubMed PMID 40544433 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NN9838, cagrilintide/semaglutide 2.4/2.4 | Blend or mixture | Status not recorded | PubMed PMID 40544433 |
CalcitoninDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1986
- All names
- Miacalcin
Sources - openFDA NDA017808 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Miacalcin | Peptide | Approved (1986) | openFDA NDA017808 |
Calcitonin (human)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01258 (read 2026-10-02): mature peptide 85-116 of Calcitonin
| — | Peptide | Made by the body | UniProt P01258 |
Calcitonin gene-related peptide 2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P10092 (read 2026-10-02): mature peptide 82-118 of Calcitonin gene-related peptide 2
| — | Peptide | Made by the body | UniProt P10092 |
CanvuparatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Canvuparatida
Sources - ChEMBL CHEMBL6068219 (read 2026-10-02)
| Canvuparatida | Peptide | Phase 2 | ChEMBL CHEMBL6068219 |
CapreomycinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1971
- All names
- Capastat, Capostatin, Capreomicin, Capreomicina, Capreomycine, Capromycin
Sources - ChEMBL CHEMBL2221250 (read 2026-10-02)
| Capastat, Capostatin, Capreomicin | Peptide | Approved (1971) | ChEMBL CHEMBL2221250 |
Capromab PendetideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1996
- INN stem
- -mab; -tide
- All names
- CYT-356, Oncoscint prostate, Prostascint
Sources - ChEMBL CHEMBL1201579 (read 2026-10-02)
| CYT-356, Oncoscint prostate, Prostascint | Peptide | Approved (1996) | ChEMBL CHEMBL1201579 |
CapromorelinDetails- Status
- Phase 2
- Class
- Small molecule, not a peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- CP-424,391, CP-424,391-18, CP-424391-18, Capimorelin, Capimorelin tartrate, Capromorelina, Capromoreline, Cp-424,391, Cp-424391, Eluracat
Sources - ChEMBL CHEMBL113313 (read 2026-10-02)
- ChEMBL CHEMBL6068501 (read 2026-10-02): salt form, folded into this row
| CP-424,391, CP-424,391-18, CP-424391-18 | Small molecule, not a peptide | Phase 2 | ChEMBL CHEMBL113313; ChEMBL CHEMBL6068501 |
CarbetocinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- INN stem
- -tocin
- All names
- Carbetocina, Carbetocine, Duratocin, Duratocin long acting, FE 992097, FE-992097, LV-101, Pabal
Sources - ChEMBL CHEMBL3301668 (read 2026-10-02)
| Carbetocina, Carbetocine, Duratocin | Peptide | Approved | ChEMBL CHEMBL3301668 |
CardiogenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AEDR, Ala-Glu-Asp-Arg
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AEDR, Ala-Glu-Asp-Arg | Peptide | Status not recorded | PubMed PMID 19830585 |
CargutocinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tocin
- All names
- Cargutocina, Cargutocine, Statocin, Y-5350
Sources - ChEMBL CHEMBL2218869 (read 2026-10-02)
| Cargutocina, Cargutocine, Statocin | Peptide | Phase 2 | ChEMBL CHEMBL2218869 |
CarnosineDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Beta-alanyl-L-histidine, L-Carnosine
Sources - PubMed PMID 42308284 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Beta-alanyl-L-histidine, L-Carnosine | Peptide | Status not recorded | PubMed PMID 42308284 |
CarperitideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Atrial natriuretic peptide, Atrial natriuretic peptide carperitide, Carperitida, Hanp, SUN 4936, SUN-4936
Sources - ChEMBL CHEMBL2104386 (read 2026-10-02)
- UniProt P01160 (read 2026-10-02): mature peptide 124-151 of Natriuretic peptides A
| Atrial natriuretic peptide, Atrial natriuretic peptide carperitide, Carperitida | Peptide | Phase 3 | ChEMBL CHEMBL2104386; UniProt P01160 |
CART(1-39)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q16568 (read 2026-10-02): mature peptide 28-66 of Cocaine- and amphetamine-regulated transcript protein, 2 copies
| — | Peptide | Made by the body | UniProt Q16568 |
CART(42-89)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q16568 (read 2026-10-02): mature peptide 69-116 of Cocaine- and amphetamine-regulated transcript protein, 2 copies
| — | Peptide | Made by the body | UniProt Q16568 |
CartalaxDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AED tripeptide, Ala-Glu-Asp
Sources - PubMed PMID 23734519 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AED tripeptide, Ala-Glu-Asp | Peptide | Status not recorded | PubMed PMID 23734519 |
CaspofunginDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2001
- All names
- Cancidas
Sources - openFDA NDA021227 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Cancidas | Peptide | Approved (2001) | openFDA NDA021227 |
CathelicidinDetails- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- CAMP, Cathelicidin Antimicrobial Peptide, hCAP-18
Sources - PubMed PMID 35849644 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CAMP, Cathelicidin Antimicrobial Peptide, hCAP-18 | Protein, not a peptide | Status not recorded | PubMed PMID 35849644 |
CecropinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Cecropin A, Cecropin B, Cecropin P1
Sources - PubMed PMID 7019715 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Cecropin A, Cecropin B, Cecropin P1 | Peptide | Status not recorded | PubMed PMID 7019715 |
CenderetideDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL2108582 (read 2026-10-02)
| — | Peptide | Status not recorded | ChEMBL CHEMBL2108582 |
CenderitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- CD-NP, Cenderitida
Sources - ChEMBL CHEMBL2108721 (read 2026-10-02)
| CD-NP, Cenderitida | Peptide | Phase 2 | ChEMBL CHEMBL2108721 |
CerebrolysinDetails- Status
- Status not recorded
- Class
- Blend or mixture
- All names
- FPF-1070, porcine brain peptide preparation
Sources - PubMed PMID 22282884 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FPF-1070, porcine brain peptide preparation | Blend or mixture | Status not recorded | PubMed PMID 22282884 |
CerlutenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Lung cytomedine, Lung peptide bioregulator (Khavinson)
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Lung cytomedine, Lung peptide bioregulator (Khavinson) | Peptide | Status not recorded | PubMed PMID 19830585 |
CertepetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- CEND-1, Certepetida, LSTA-1, LSTA1, Lsta1
Sources - ChEMBL CHEMBL5315026 (read 2026-10-02)
| CEND-1, Certepetida, LSTA-1 | Peptide | Phase 2 | ChEMBL CHEMBL5315026 |
CeruletideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1982
- INN stem
- -tide
- All names
- CERULETIDE DIETHYLAMINE, Caerulein, Caerulein diethylamine, Ceosunin, Cerulein, Ceruletida, Ceruletide diethylamine, Ceruletide diethylamine salt, Takus, Tymtran
Sources - ChEMBL CHEMBL1201355 (read 2026-10-02)
- ChEMBL CHEMBL1200755 (read 2026-10-02): salt form, folded into this row
| CERULETIDE DIETHYLAMINE, Caerulein, Caerulein diethylamine | Peptide | Approved (1982) | ChEMBL CHEMBL1201355; ChEMBL CHEMBL1200755 |
CetrorelixDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1999
- INN stem
- -relix
- All names
- Cetrorelix (as acetate), Cetrotide, Cetrotide acetate, D-20761, NS-75A, SB-075 ACETATE
Sources - ChEMBL CHEMBL1200490 (read 2026-10-02)
- ChEMBL CHEMBL2103735 (read 2026-10-02): salt form, folded into this row
| Cetrorelix (as acetate), Cetrotide, Cetrotide acetate | Peptide | Approved (1999) | ChEMBL CHEMBL1200490; ChEMBL CHEMBL2103735 |
CGRPDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06881 (read 2026-10-02): mature peptide 83-119 of Calcitonin gene-related peptide 1
| — | Peptide | Made by the body | UniProt P06881 |
CholecystokininDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1976
- All names
- Cck c-terminal octapeptide, Cck-8, Cck-8s, Cholecystokinin c-terminal octapeptide, Kinevac, SQ 19844, SQ-19844, Sincalida, Sincalide
Sources - openFDA NDA017697 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
- UniProt P06307 (read 2026-10-02): mature peptide 96-103 of Cholecystokinin
- ChEMBL CHEMBL1121 (read 2026-10-02)
| Cck c-terminal octapeptide, Cck-8, Cck-8s | Peptide | Approved (1976) | openFDA NDA017697; UniProt P06307; ChEMBL CHEMBL1121 |
Cholecystokinin-12Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 92-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-18Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 86-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-25Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 79-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-33Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 71-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-39Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 65-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-5Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 99-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-58Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 46-103 of Cholecystokinin
| — | Protein, not a peptide | Made by the body | UniProt P06307 |
Cholecystokinin-58 desnonopeptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 46-94 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
Cholecystokinin-7Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P06307 (read 2026-10-02): mature peptide 97-103 of Cholecystokinin
| — | Peptide | Made by the body | UniProt P06307 |
ChonlutenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- EDG tripeptide, Glu-Asp-Gly
Sources - PubMed PMID 24003726 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| EDG tripeptide, Glu-Asp-Gly | Peptide | Status not recorded | PubMed PMID 24003726 |
CilengitideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Cilengitida, EMD 121974, EMD-12192, EMD-121974
Sources - ChEMBL CHEMBL429876 (read 2026-10-02)
| Cilengitida, EMD 121974, EMD-12192 | Peptide | Phase 3 | ChEMBL CHEMBL429876 |
CJC-1295Details- Status
- Status not recorded
- Class
- Peptide
- All names
- CJC-1295 DAC, CJC-1295 with DAC, DAC:GRF, Drug Affinity Complex:GRF
Sources - PubMed PMID 16352683 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CJC-1295 DAC, CJC-1295 with DAC, DAC:GRF | Peptide | Status not recorded | PubMed PMID 16352683 |
CNPDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P23582 (read 2026-10-02): mature peptide 105-126 of C-type natriuretic peptide
| — | Peptide | Made by the body | UniProt P23582 |
CNP-29Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P23582 (read 2026-10-02): mature peptide 98-126 of C-type natriuretic peptide
| — | Peptide | Made by the body | UniProt P23582 |
CNP-53Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P23582 (read 2026-10-02): mature peptide 74-126 of C-type natriuretic peptide
| — | Protein, not a peptide | Made by the body | UniProt P23582 |
CodactideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- BA-41795, Codactida
Sources - ChEMBL CHEMBL2104378 (read 2026-10-02)
| BA-41795, Codactida | Peptide | Phase 2 | ChEMBL CHEMBL2104378 |
ColistinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1970
- All names
- Coly-Mycin M
Sources - openFDA NDA050108 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Coly-Mycin M | Peptide | Approved (1970) | openFDA NDA050108 |
Collagen PeptidesDetails- Status
- Status not recorded
- Class
- Blend or mixture
- All names
- Collagen Hydrolysate, Collagen Protein, Hydrolyzed Collagen
Sources - PubMed PMID 33742704 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Collagen Hydrolysate, Collagen Protein, Hydrolyzed Collagen | Blend or mixture | Status not recorded | PubMed PMID 33742704 |
ColostrininDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- CLN, PRP, Proline-Rich Polypeptide Complex
Sources - PubMed PMID 10608295 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CLN, PRP, Proline-Rich Polypeptide Complex | Peptide | Status not recorded | PubMed PMID 10608295 |
ColulintideDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- LY-3541105, LY3541105, Ly3541105
Sources - ChEMBL CHEMBL6068472 (read 2026-10-02)
| LY-3541105, LY3541105, Ly3541105 | Peptide | Phase 1 | ChEMBL CHEMBL6068472 |
CopeptinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01185 (read 2026-10-02): mature peptide 126-164 of Vasopressin-neurophysin 2-copeptin
| — | Peptide | Made by the body | UniProt P01185 |
Copper (64cu) Adarulatide TetraxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- Cobre (64cu) adarulatida tetraxetan, Cuivre (64cu) adarulatide tetraxetan
Sources - ChEMBL CHEMBL6068105 (read 2026-10-02)
| Cobre (64cu) adarulatida tetraxetan, Cuivre (64cu) adarulatide tetraxetan | Peptide | Phase 2 | ChEMBL CHEMBL6068105 |
Copper Cu 64 dotatateDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2020
- INN stem
- -tide
- All names
- 64cu-dotatate, COPPER OXODOTREOTIDE CU-64, Copper (64cu) dotatate, Copper 64-dota-tate, Copper cu-64 dotatate, Copper dotatate cu-64, Copper oxodotreotide cu-64, Detectnet
Sources - ChEMBL CHEMBL4302413 (read 2026-10-02)
- ChEMBL CHEMBL4297339 (read 2026-10-02): salt form, folded into this row
| 64cu-dotatate, COPPER OXODOTREOTIDE CU-64, Copper (64cu) dotatate | Peptide conjugate | Approved (2020) | ChEMBL CHEMBL4302413; ChEMBL CHEMBL4297339 |
Corifollitropin alfaDetails- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- Elonva, FSH-CTP
Sources - PubMed PMID 26003273 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Elonva, FSH-CTP | Protein, not a peptide | Status not recorded | PubMed PMID 26003273 |
CortagenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AEDP, Ala-Glu-Asp-Pro, Cortexin peptide
Sources - PubMed PMID 12374906 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AEDP, Ala-Glu-Asp-Pro, Cortexin peptide | Peptide | Status not recorded | PubMed PMID 12374906 |
CorticorelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1996
- INN stem
- -relin; -vin-
- All names
- Acthrel, Corticoliberin human, Corticorelin (human), Corticorelin acetate human, Corticorelin human, Corticorelina, Corticoreline, Corticotropin-releasing factor, Corticotropin-releasing hormone, Crf, Human corticoliberin, NEU 3002, NEU-3002, NEU-3002 ACETATE, Xerecept
Sources - ChEMBL CHEMBL1201591 (read 2026-10-02)
- ChEMBL CHEMBL2107324 (read 2026-10-02): separate ChEMBL record of the same molecule
- ChEMBL CHEMBL2108182 (read 2026-10-02): separate ChEMBL record of the same molecule
- UniProt P06850 (read 2026-10-02): mature peptide 154-194 of Corticotropin-releasing hormone
| Acthrel, Corticoliberin human, Corticorelin (human) | Peptide | Approved (1996) | ChEMBL CHEMBL1201591; ChEMBL CHEMBL2107324; ChEMBL CHEMBL2108182 |
CorticotropinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1952
- All names
- Acthar Gel, Acthar Gel (Autoinjector), Purified Cortrophin Gel
Sources - openFDA NDA008372 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Acthar Gel, Acthar Gel (Autoinjector), Purified Cortrophin Gel | Peptide | Approved (1952) | openFDA NDA008372 |
Corticotropin (human)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 138-176 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
Corticotropin-like intermediary peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 156-176 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
Cortistatin-14Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O00230 (read 2026-10-02): mature peptide 92-105 of Cortistatin
| — | Peptide | Made by the body | UniProt O00230 |
Cortistatin-17Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O00230 (read 2026-10-02): mature peptide 89-105 of Cortistatin
| — | Peptide | Made by the body | UniProt O00230 |
Cortistatin-29Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O00230 (read 2026-10-02): mature peptide 77-105 of Cortistatin
| — | Peptide | Made by the body | UniProt O00230 |
CotadutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Cotadutida, MEDI-0382, MEDI0382, Medi 0382, Medi0382
Sources - ChEMBL CHEMBL4297630 (read 2026-10-02)
| Cotadutida, MEDI-0382, MEDI0382 | Peptide | Phase 2 | ChEMBL CHEMBL4297630 |
CyclosporineDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1983
- All names
- Cequa, Neoral, Restasis, Restasis Multidose, Sandimmune, Verkazia, Vevye
Sources - openFDA NDA050573 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Cequa, Neoral, Restasis | Peptide | Approved (1983) | openFDA NDA050573 |
DalazatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Dalazatida, SHK-186, SHK186
Sources - ChEMBL CHEMBL4297738 (read 2026-10-02)
| Dalazatida, SHK-186, SHK186 | Peptide | Phase 2 | ChEMBL CHEMBL4297738 |
DalbavancinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2014
- All names
- Dalvance
Sources - openFDA NDA021883 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Dalvance | Peptide | Approved (2014) | openFDA NDA021883 |
DanegaptideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Danegaptida, GAP-134, ZP-1609, ZP1609
Sources - ChEMBL CHEMBL560592 (read 2026-10-02)
| Danegaptida, GAP-134, ZP-1609 | Peptide | Phase 3 | ChEMBL CHEMBL560592 |
DanuglipronDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- PF-06882961
Sources - ClinicalTrials.gov NCT04707313 (read 2026-10-02): trial registration cited on the encyclopedia entry
| PF-06882961 | Small molecule, not a peptide | Status not recorded | ClinicalTrials.gov NCT04707313 |
DapiglutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL5314980 (read 2026-10-02)
| — | Peptide | Phase 2 | ChEMBL CHEMBL5314980 |
DaptomycinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2017
Sources - openFDA NDA208385 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| — | Peptide | Approved (2017) | openFDA NDA208385 |
DasiglucagonDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2021
- All names
- ZP-4207, ZP-GA-1, ZP4207, Zegalogue, Zegalogue (Autoinjector)
Sources - openFDA NDA214231 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
- ChEMBL CHEMBL4297741 (read 2026-10-02)
| ZP-4207, ZP-GA-1, ZP4207 | Peptide | Approved (2021) | openFDA NDA214231; ChEMBL CHEMBL4297741 |
DavalintideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AC-2307, AC2307, Ac2307, Davalintida
Sources - ChEMBL CHEMBL2105635 (read 2026-10-02)
- ChEMBL CHEMBL2105636 (read 2026-10-02): salt form, folded into this row
| AC-2307, AC2307, Ac2307 | Peptide | Phase 2 | ChEMBL CHEMBL2105635; ChEMBL CHEMBL2105636 |
DavunetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AL-108, AL-208, Davunetida
Sources - ChEMBL CHEMBL2103826 (read 2026-10-02)
| AL-108, AL-208, Davunetida | Peptide | Phase 2 | ChEMBL CHEMBL2103826 |
DazdotuftideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Dazdotuftida, TRS-01, TRS01
Sources - ChEMBL CHEMBL5095261 (read 2026-10-02)
| Dazdotuftida, TRS-01, TRS01 | Peptide | Phase 3 | ChEMBL CHEMBL5095261 |
DecorinylDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Decorin-mimetic peptide, Lys-Asp-Ile-Cit-NH2, T10-C, Tripeptide-10 Citrulline
Sources - PubMed PMID 18377618 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Decorin-mimetic peptide, Lys-Asp-Ile-Cit-NH2, T10-C | Peptide | Status not recorded | PubMed PMID 18377618 |
DegarelixDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2008
- INN stem
- -relix
- All names
- Degarelix (as acetate), Degarelix accord, FE-200486, FE200486, FE200486 (AS ACETATE SALT), FE200486 (FREE BASE), Firmagon
Sources - ChEMBL CHEMBL415606 (read 2026-10-02)
- ChEMBL CHEMBL2028987 (read 2026-10-02): salt form, folded into this row
| Degarelix (as acetate), Degarelix accord, FE-200486 | Peptide | Approved (2008) | ChEMBL CHEMBL415606; ChEMBL CHEMBL2028987 |
DelmitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Delmitida, RSP-58, RSP58
Sources - ChEMBL CHEMBL2108587 (read 2026-10-02)
- ChEMBL CHEMBL2108588 (read 2026-10-02): separate ChEMBL record of the same molecule
| Delmitida, RSP-58, RSP58 | Peptide | Phase 2 | ChEMBL CHEMBL2108587; ChEMBL CHEMBL2108588 |
DemoxytocinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tocin
- All names
- 1-deaminooxytocin, Deaminooxytocin, Demoxitocina, Demoxytocine, Desaminooxytocin, ODA 914, ODA-914, Oxytocin, deamino-, Sandopart
Sources - ChEMBL CHEMBL435716 (read 2026-10-02)
| 1-deaminooxytocin, Deaminooxytocin, Demoxitocina | Peptide | Phase 2 | ChEMBL CHEMBL435716 |
DepreotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2000
- INN stem
- -tide
- All names
- Depreotida, Neospect, P-829, P829
Sources - ChEMBL CHEMBL1908335 (read 2026-10-02)
- ChEMBL CHEMBL5315079 (read 2026-10-02): separate ChEMBL record of the same molecule
| Depreotida, Neospect, P-829 | Peptide | Approved (2000) | ChEMBL CHEMBL1908335; ChEMBL CHEMBL5315079 |
DermcidinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- DCD, DCD-1L, Sweat antimicrobial peptide
Sources - PubMed PMID 11694882 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DCD, DCD-1L, Sweat antimicrobial peptide | Peptide | Status not recorded | PubMed PMID 11694882 |
DermorphinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Phyllomedusa opioid peptide, [D-Ala2]-dermorphin
Sources - PubMed PMID 2544892 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Phyllomedusa opioid peptide, [D-Ala2]-dermorphin | Peptide | Status not recorded | PubMed PMID 2544892 |
DeslorelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- D-TRP LHRH-PEA, D-TRP-LHRH-PEA, Deslorelina, Desloreline, Suprelorin
Sources - ChEMBL CHEMBL2365665 (read 2026-10-02)
- ChEMBL CHEMBL2357192 (read 2026-10-02): salt form, folded into this row
| D-TRP LHRH-PEA, D-TRP-LHRH-PEA, Deslorelina | Peptide | Phase 2 | ChEMBL CHEMBL2365665; ChEMBL CHEMBL2357192 |
DesmopressinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1978
- INN stem
- -pressin
- All names
- Anhydrous desmopressin acetate, Concentraid, Ddavp, Ddavp (needs no refrigeration), Desmomelt, Desmopresina, Desmopressin acetate (needs no refrigeration), Desmopressin acetate anhydrous, Desmopressin acetate preservative free, Desmopressine, Desmospray, Desmotabs, H01BA02, Minirin, Nocdurna, Noctiva, Nocutil, Noqdirna, Octim, Octostim, Presinex, Ser-120, Ser120, Stimate, Stimate (needs no refrigeration)
Sources - ChEMBL CHEMBL1429 (read 2026-10-02)
- ChEMBL CHEMBL1200556 (read 2026-10-02): salt form, folded into this row
| Anhydrous desmopressin acetate, Concentraid, Ddavp | Peptide | Approved (1978) | ChEMBL CHEMBL1429; ChEMBL CHEMBL1200556 |
DetirelixDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relix
- All names
- RS-68439
Sources - ChEMBL CHEMBL2106408 (read 2026-10-02)
| RS-68439 | Peptide | Phase 2 | ChEMBL CHEMBL2106408 |
DiamfenetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- COMPOUND 68-198, COMPOUND-68-198, Diamfenetida, NSC-291838
Sources - ChEMBL CHEMBL2104259 (read 2026-10-02)
| COMPOUND 68-198, COMPOUND-68-198, Diamfenetida | Peptide | Phase 2 | ChEMBL CHEMBL2104259 |
DiclometideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Diclometida
Sources - ChEMBL CHEMBL2106106 (read 2026-10-02)
| Diclometida | Peptide | Phase 2 | ChEMBL CHEMBL2106106 |
DifelikefalinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2021
- All names
- Korsuva
Sources - openFDA NDA214916 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Korsuva | Peptide | Approved (2021) | openFDA NDA214916 |
DihexaDetails- Status
- Status not recorded
- Class
- Peptidomimetic
- All names
- N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, PNB-0408
Sources - PubMed PMID 34827486 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, PNB-0408 | Peptidomimetic | Status not recorded | PubMed PMID 34827486 |
Dipeptide-2Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Valyltryptophan
Sources - PubChem CID 168182 (read 2026-10-02): PubChem title: Valyltryptophan
| Valyltryptophan | Peptide | Status not recorded | PubChem CID 168182 |
DirucotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Dirucotida, MBP-8298, MBP8298, MBP8298 PEPTIDE, SF-328, SF328
Sources - ChEMBL CHEMBL2105639 (read 2026-10-02)
- ChEMBL CHEMBL2105640 (read 2026-10-02): salt form, folded into this row
| Dirucotida, MBP-8298, MBP8298 | Peptide | Phase 3 | ChEMBL CHEMBL2105639; ChEMBL CHEMBL2105640 |
Disaccharide Tripeptide Glycerol DipalmitoylDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Dtp-gdp, Immther
Sources - ChEMBL CHEMBL4297391 (read 2026-10-02)
| Dtp-gdp, Immther | Peptide | Phase 2 | ChEMBL CHEMBL4297391 |
DisitertideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Disitertida, P-144, P144, Peptide 144 tgf beta-1-inhibitor
Sources - ChEMBL CHEMBL2108346 (read 2026-10-02)
| Disitertida, P-144, P144 | Peptide | Phase 2 | ChEMBL CHEMBL2108346 |
DisomotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Disomotida, Gp-100:209-217(210m) peptide, Gp100:209-217(210m) peptide, MPS-22
Sources - ChEMBL CHEMBL263429 (read 2026-10-02)
| Disomotida, Gp-100:209-217(210m) peptide, Gp100:209-217(210m) peptide | Peptide | Phase 2 | ChEMBL CHEMBL263429 |
DolcanatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Dolcanatida, SP-333
Sources - ChEMBL CHEMBL3545122 (read 2026-10-02)
| Dolcanatida, SP-333 | Peptide | Phase 2 | ChEMBL CHEMBL3545122 |
DoreptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Doreptida
Sources - ChEMBL CHEMBL2109123 (read 2026-10-02)
| Doreptida | Peptide | Phase 2 | ChEMBL CHEMBL2109123 |
DSIPDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Delta sleep inducing peptide, Delta sleep-inducing peptide, Dsip, Emideltida, Trp-ala-gly-gly-asp-ala-ser-gly-glu
Sources - ChEMBL CHEMBL2104403 (read 2026-10-02)
| Delta sleep inducing peptide, Delta sleep-inducing peptide, Dsip | Peptide | Phase 2 | ChEMBL CHEMBL2104403 |
DulaglutideDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- First approval
- 2014
- INN stem
- -tide
- All names
- Dulaglutida, Dulaglutide component of trulicity, LY-2189265, LY2189265, Trulicity
Sources - ChEMBL CHEMBL2108027 (read 2026-10-02)
| Dulaglutida, Dulaglutide component of trulicity, LY-2189265 | Protein, not a peptide | Approved (2014) | ChEMBL CHEMBL2108027 |
DumorelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Dumorelina, Dumoreline
Sources - ChEMBL CHEMBL2108374 (read 2026-10-02)
| Dumorelina, Dumoreline | Peptide | Phase 2 | ChEMBL CHEMBL2108374 |
DusquetideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Arg-ile-val-pro-ala-nh2, Dusquetida, IMX-942, SGX-94, SGX-942, SGX94, SGX942, Sgx942
Sources - ChEMBL CHEMBL3545314 (read 2026-10-02)
| Arg-ile-val-pro-ala-nh2, Dusquetida, IMX-942 | Peptide | Phase 3 | ChEMBL CHEMBL3545314 |
DynorphinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 207-238 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
Dynorphin A(1-13)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 207-219 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
Dynorphin A(1-8)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 207-214 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
Early placenta insulin-like peptide A chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q14641 (read 2026-10-02): mature peptide 115-139 of Early placenta insulin-like peptide
| — | Peptide | Made by the body | UniProt Q14641 |
Early placenta insulin-like peptide B chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q14641 (read 2026-10-02): mature peptide 26-58 of Early placenta insulin-like peptide
| — | Peptide | Made by the body | UniProt Q14641 |
EbiratideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Ebiratida
Sources - ChEMBL CHEMBL2106396 (read 2026-10-02)
| Ebiratida | Peptide | Phase 2 | ChEMBL CHEMBL2106396 |
EcallantideDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- First approval
- 2009
- INN stem
- -tide
- All names
- DX-88, Ecalantida, Escallantide
Sources - ChEMBL CHEMBL1201837 (read 2026-10-02)
| DX-88, Ecalantida, Escallantide | Protein, not a peptide | Approved (2009) | ChEMBL CHEMBL1201837 |
ECC5004Details- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- AZD5004, elecoglipron
Sources - PubMed PMID 39495140 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AZD5004, elecoglipron | Small molecule, not a peptide | Status not recorded | PubMed PMID 39495140 |
EcnoglutideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Ecnoglutida, Ecnoglutide component of xw-004, Ecnoglutide component of xw004 xw003, XW-003, Xw003
Sources - ChEMBL CHEMBL5095115 (read 2026-10-02)
| Ecnoglutida, Ecnoglutide component of xw-004, Ecnoglutide component of xw004 xw003 | Peptide | Phase 3 | ChEMBL CHEMBL5095115 |
EderimotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Ederimotida, Wt-1 a1, Wt1-a1
Sources - ChEMBL CHEMBL5314734 (read 2026-10-02)
| Ederimotida, Wt-1 a1, Wt1-a1 | Peptide | Phase 2 | ChEMBL CHEMBL5314734 |
EdotreotideDetails- Status
- Phase 3
- Class
- Peptide conjugate
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Dotatoc, Edotreotida, SMT 487, SMT-487, SMT487
Sources - ChEMBL CHEMBL408350 (read 2026-10-02)
| Dotatoc, Edotreotida, SMT 487 | Peptide conjugate | Phase 3 | ChEMBL CHEMBL408350 |
Edotreotide YttriumDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- 90Y-SMT-487, 90y-dota-tyr3-octreotide, 90y-dotatoc, 90ydotatoc, Dotatoc yttrium y-90, EDOTREOTIDE YTTRIUM Y-90, Edotreotide 90y chelate, Edotreotide yttrium y-90, SMT-487 Y-90, Y-90 dota-tyr(3)-octreotide, Yttrium (90 y) dotatoc, Yttrium (90y) edotreotide, Yttrium y 90-dota-tyr3-octreotide, Yttrium y 90-edotreotide
Sources - ChEMBL CHEMBL386768 (read 2026-10-02)
- ChEMBL CHEMBL4297342 (read 2026-10-02): salt form, folded into this row
| 90Y-SMT-487, 90y-dota-tyr3-octreotide, 90y-dotatoc | Peptide | Phase 2 | ChEMBL CHEMBL386768; ChEMBL CHEMBL4297342 |
EdratideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Edratida, TV-4710
Sources - ChEMBL CHEMBL2107743 (read 2026-10-02)
| Edratida, TV-4710 | Peptide | Phase 2 | ChEMBL CHEMBL2107743 |
EfinopegdutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- ef-; -peg-; -tide
- All names
- Efinopegdutida, HM-12525A, HM12525A, JNJ-64565111, Jnj-64565111
Sources - ChEMBL CHEMBL4297576 (read 2026-10-02)
| Efinopegdutida, HM-12525A, HM12525A | Peptide | Phase 2 | ChEMBL CHEMBL4297576 |
Efmedaglutide AlfaDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- ef-; -tide
- All names
- Efmedaglutida alfa
Sources - ChEMBL CHEMBL6068240 (read 2026-10-02)
| Efmedaglutida alfa | Peptide | Phase 2 | ChEMBL CHEMBL6068240 |
EfocipegtrutideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- ef-; -peg-; -tide
- All names
- Efocipegtrutida
Sources - ChEMBL CHEMBL5095149 (read 2026-10-02)
| Efocipegtrutida | Peptide conjugate | Phase 2 | ChEMBL CHEMBL5095149 |
EfpeglenatideDetails- Status
- Phase 3
- Class
- Peptide conjugate
- Highest phase
- 3.0
- INN stem
- ef-; -peg-; -tide
- All names
- HM-11260C, HM11260C, Hm11260c, Langlenatide, SAR-439977, SAR439977
Sources - ChEMBL CHEMBL4650470 (read 2026-10-02)
| HM-11260C, HM11260C, Hm11260c | Peptide conjugate | Phase 3 | ChEMBL CHEMBL4650470 |
Efsubaglutide AlfaDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- ef-; -tide
- All names
- Efsubaglutida alfa
Sources - ChEMBL CHEMBL6068241 (read 2026-10-02)
| Efsubaglutida alfa | Peptide | Phase 2 | ChEMBL CHEMBL6068241 |
ElagolixDetails- Status
- Approved
- Class
- Small molecule, not a peptide
- Highest phase
- 4.0
- All names
- NBI-56418, Orilissa
Sources - PubMed PMID 28525302 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NBI-56418, Orilissa | Small molecule, not a peptide | Approved | PubMed PMID 28525302 |
ElcatoninDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- All names
- Elcatonina, Elcatonine
Sources - ChEMBL CHEMBL2104402 (read 2026-10-02)
| Elcatonina, Elcatonine | Peptide | Phase 2 | ChEMBL CHEMBL2104402 |
EloralintideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AMY-1176, AMY1176, Eloralintida, LY-3841136, LY3841136, Ly3841136
Sources - ChEMBL CHEMBL6068462 (read 2026-10-02)
| AMY-1176, AMY1176, Eloralintida | Peptide | Phase 2 | ChEMBL CHEMBL6068462 |
ElpamotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Elpamotida, VEGFR2-169, Vegfr2-169 peptide vaccine
Sources - ChEMBL CHEMBL2108295 (read 2026-10-02)
| Elpamotida, VEGFR2-169, Vegfr2-169 peptide vaccine | Peptide | Phase 2 | ChEMBL CHEMBL2108295 |
ElsiglutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Elsiglutida, ZP-1846, ZP1846, Zp1846
Sources - ChEMBL CHEMBL2108318 (read 2026-10-02)
| Elsiglutida, ZP-1846, ZP1846 | Peptide | Phase 2 | ChEMBL CHEMBL2108318 |
EnavermotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Enavermotida
Sources - ChEMBL CHEMBL5314828 (read 2026-10-02)
| Enavermotida | Peptide | Phase 2 | ChEMBL CHEMBL5314828 |
EndolutenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- A-8 (pineal peptide preparation), Pineal peptide bioregulator
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| A-8 (pineal peptide preparation), Pineal peptide bioregulator | Peptide | Status not recorded | PubMed PMID 19830585 |
Endomorphin-1Details- Status
- Preclinical
- Class
- Peptide
Sources - ChEMBL CHEMBL316446 (read 2026-10-02)
| — | Peptide | Preclinical | ChEMBL CHEMBL316446 |
Endothelin-1Details- Status
- Status not recorded
- Class
- Peptide
- All names
- ET-1, Endothelin
Sources - PubMed PMID 9279213 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| ET-1, Endothelin | Peptide | Status not recorded | PubMed PMID 9279213 |
EneboparatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AZP-3601, AZP3601, Eneboparatida
Sources - ChEMBL CHEMBL5095311 (read 2026-10-02)
| AZP-3601, AZP3601, Eneboparatida | Peptide | Phase 2 | ChEMBL CHEMBL5095311 |
EnfuvirtideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2003
- INN stem
- -tide; -vir-
- All names
- DP-178, DP178, Enfuvirtida, Fuzeon, Fuzeon t-20, Pentafuside (trivial name), T-20, T20
Sources - ChEMBL CHEMBL525076 (read 2026-10-02)
| DP-178, DP178, Enfuvirtida | Peptide | Approved (2003) | ChEMBL CHEMBL525076 |
EnkephalinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 230-234 of Proenkephalin-A, 4 copies
| — | Peptide | Made by the body | UniProt P01210 |
EnlicitideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Chlorure d'enlicitide, Chloruro de enlicitida, ENLICITIDE DECANOATE, Enlicitide decanoate, MK-0616, Mk-0616
Sources - ChEMBL CHEMBL6068773 (read 2026-10-02)
- ChEMBL CHEMBL6067978 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL6068420 (read 2026-10-02): salt form, folded into this row
| Chlorure d'enlicitide, Chloruro de enlicitida, ENLICITIDE DECANOATE | Peptide | Phase 3 | ChEMBL CHEMBL6068773; ChEMBL CHEMBL6067978; ChEMBL CHEMBL6068420 |
EnsereptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- PXL-01, PXL01
Sources - ChEMBL CHEMBL5095372 (read 2026-10-02)
| PXL-01, PXL01 | Peptide | Phase 2 | ChEMBL CHEMBL5095372 |
EpithalonDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- AEDG, Epitalon, Epithalamin
Sources - PubMed PMID 12937682 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AEDG, Epitalon, Epithalamin | Peptide | Status not recorded | PubMed PMID 12937682 |
EptifibatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1998
- INN stem
- -tide
- All names
- Eptifibatida, Eptifibatide accord, Integrelin, Integrilin
Sources - ChEMBL CHEMBL1174 (read 2026-10-02)
| Eptifibatida, Eptifibatide accord, Integrelin | Peptide | Approved (1998) | ChEMBL CHEMBL1174 |
Erythropoietin (EPO)Details- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Aranesp, Darbepoetin alfa, EPO, Epoetin alfa, Epoetin beta, Epogen, Procrit, rHuEPO, rhEpo
Sources - PubMed PMID 24273483 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Aranesp, Darbepoetin alfa, EPO | Protein, not a peptide | Approved | PubMed PMID 24273483 |
EtarfolatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- EC-20
Sources - ChEMBL CHEMBL4297280 (read 2026-10-02)
| EC-20 | Peptide | Phase 2 | ChEMBL CHEMBL4297280 |
EtelcalcetideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2016
- INN stem
- -tide
- All names
- AMG 416, Etelcalcetida, KAI-4169, KAI-4169 HCl, KAI-4169 HYDROCHLORIDE, ONO-5163, Parsabiv, Telcalcetide, Telcalcetide hydrochloride, Velcalcetide, Velcalcetide hydrochloride
Sources - ChEMBL CHEMBL3545184 (read 2026-10-02)
- ChEMBL CHEMBL3545183 (read 2026-10-02): salt form, folded into this row
| AMG 416, Etelcalcetida, KAI-4169 | Peptide | Approved (2016) | ChEMBL CHEMBL3545184; ChEMBL CHEMBL3545183 |
EtimumotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Etimumotida
Sources - ChEMBL CHEMBL5314741 (read 2026-10-02)
| Etimumotida | Peptide | Phase 2 | ChEMBL CHEMBL5314741 |
ExenatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2005
- INN stem
- -tide
- All names
- AC 2993, AC-002993, AC-2993, AC-2993A, AC-2993LAR, AC002993, AC2993, AC2993A, Bydureon, Bydureon bcise, Bydureon pen, Byetta, DA-3091, EXENDIN-4, Exenatida, Exenatide synthetic, Exendin 4, ITCA-650, LY-2148568, LY2148568
Sources - ChEMBL CHEMBL414357 (read 2026-10-02)
| AC 2993, AC-002993, AC-2993 | Peptide | Approved (2005) | ChEMBL CHEMBL414357 |
FelypressinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -pressin
- All names
- Felipresina, Felypressine, PLV-2
Sources - ChEMBL CHEMBL3185126 (read 2026-10-02)
| Felipresina, Felypressine, PLV-2 | Peptide | Phase 2 | ChEMBL CHEMBL3185126 |
FequesetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Fequesetida
Sources - ChEMBL CHEMBL5314679 (read 2026-10-02)
| Fequesetida | Peptide | Phase 2 | ChEMBL CHEMBL5314679 |
FertirelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Conceral, Fertirelina, Fertireline, Ovalyse, TAP 031, TAP 031 (AS THE BASE), TAP 031 ACETATE, TAP-031, TAP-031 ACETATE, U-69689E
Sources - ChEMBL CHEMBL3272563 (read 2026-10-02)
- ChEMBL CHEMBL3989593 (read 2026-10-02): salt form, folded into this row
| Conceral, Fertirelina, Fertireline | Peptide | Phase 2 | ChEMBL CHEMBL3272563; ChEMBL CHEMBL3989593 |
FexapotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- FEXAPOTIDE TRIFLUTATE, Fexapotida, Fexapotide triflutate, NX-1207, NX-1207 TRIFLUOROACETATE, NYM-4805, NYM4805
Sources - ChEMBL CHEMBL3545061 (read 2026-10-02)
- ChEMBL CHEMBL3707309 (read 2026-10-02): salt form, folded into this row
| FEXAPOTIDE TRIFLUTATE, Fexapotida, Fexapotide triflutate | Peptide | Phase 3 | ChEMBL CHEMBL3545061; ChEMBL CHEMBL3707309 |
FGL PeptideDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- EVYVVAENQQGKSKA, FGL, NCAM-derived FGL peptide
Sources - PubMed PMID 15525346 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| EVYVVAENQQGKSKA, FGL, NCAM-derived FGL peptide | Peptide | Status not recorded | PubMed PMID 15525346 |
FK-13Details- Status
- Status not recorded
- Class
- Peptide
- All names
- FKRIVQRIKDFLR, LL-37 central fragment, LL-37(17-29)
Sources - PubMed PMID 16637646 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FKRIVQRIKDFLR, LL-37 central fragment, LL-37(17-29) | Peptide | Status not recorded | PubMed PMID 16637646 |
Flavin Adenin DinucleotideDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -tide
- All names
- Adenine-riboflavin dinucleotide, Fad, Flavin adenine dinucleotide, Flavin-adenine dinucleotide, Flavine adenine dinucleotide, Flavine adenosine diphosphate, Flavine-adenine dinucleotide, NSC-112207
Sources - ChEMBL CHEMBL1232653 (read 2026-10-02)
| Adenine-riboflavin dinucleotide, Fad, Flavin adenine dinucleotide | Peptide | Status not recorded | ChEMBL CHEMBL1232653 |
FluciclatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- (18F)AH-111585, (18F)AH111585, AH-111585, AH-111585 (18F), AH-111585 F-18, FLUCICLATIDE F 18, Fluciclatida (18f), Fluciclatide (18f), Fluciclatide (f-18), Fluciclatide f 18, Fluciclatide f-18, [18F]AH111585
Sources - ChEMBL CHEMBL3990277 (read 2026-10-02)
- ChEMBL CHEMBL3989518 (read 2026-10-02): salt form, folded into this row
| (18F)AH-111585, (18F)AH111585, AH-111585 | Peptide | Phase 2 | ChEMBL CHEMBL3990277; ChEMBL CHEMBL3989518 |
Follistatin-315Details- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- FS-315
Sources - PubMed PMID 8340384 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FS-315 | Protein, not a peptide | Status not recorded | PubMed PMID 8340384 |
Follistatin-344Details- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- FS-344
Sources - PubMed PMID 25322757 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FS-344 | Protein, not a peptide | Status not recorded | PubMed PMID 25322757 |
Follitropin alfaDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Gonal-F RFF, Gonal-F RFF Redi-ject, Gonal-f, rFSH alfa
Sources - PubMed PMID 8822421 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Gonal-F RFF, Gonal-F RFF Redi-ject, Gonal-f | Protein, not a peptide | Approved | PubMed PMID 8822421 |
Follitropin betaDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Follistim, Follistim AQ, Puregon, rFSH beta
Sources - PubMed PMID 8567765 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Follistim, Follistim AQ, Puregon | Protein, not a peptide | Approved | PubMed PMID 8567765 |
Follitropin deltaDetails- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- FE 999049, Rekovelle
Sources - PubMed PMID 34179971 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FE 999049, Rekovelle | Protein, not a peptide | Status not recorded | PubMed PMID 34179971 |
FOXO4-DRIDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- FOXO4-p53 interfering peptide
Sources - PubMed PMID 28340339 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FOXO4-p53 interfering peptide | Peptide | Status not recorded | PubMed PMID 28340339 |
FroniglutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Glymera, PB-1023, PB1023, PF-1801, PF1801
Sources - ChEMBL CHEMBL5314983 (read 2026-10-02)
| Glymera, PB-1023, PB1023 | Peptide | Phase 2 | ChEMBL CHEMBL5314983 |
FulipiftideDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- BR21001
Sources - ChEMBL CHEMBL6068486 (read 2026-10-02)
| BR21001 | Peptide | Phase 1 | ChEMBL CHEMBL6068486 |
GalaninDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P22466 (read 2026-10-02): mature peptide 33-62 of Galanin peptides
| — | Peptide | Made by the body | UniProt P22466 |
Galanin message-associated peptideDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P22466 (read 2026-10-02): mature peptide 65-123 of Galanin peptides
| — | Protein, not a peptide | Made by the body | UniProt P22466 |
Gallium Ga 68 dotatateDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2016
- INN stem
- -tide
- All names
- (68ga)gallium dotatate, 68ga-dota-tyr3-octreotide, 68ga-dotatate, 68ga-dotatoc, Dota-octreotate gallium ga-68, Dota-toc gallium ga-68, Dotatate gallium ga-68, EDOTREOTIDE GALLIUM GA-68, Edotreotide gallium ga 68, Edotreotide gallium ga-68, Ga 68 dotatoc, Ga-68 dota-tyr3-octreotide, Ga-68-dotatoc, Galiomedix, Gallium (68ga) dota-tate, Gallium (68ga) dotatate, Gallium (68ga) edotreotide, Gallium (ga68) dotatate, Gallium 68 dotatate, Gallium dotatate ga-68, Gallium dotatate, ga-68, Gallium dotatoc ga 68, Gallium dotatoc ga-68, Gallium edotreotide ga-68, Gallium ga 68 dotatate, Gallium ga 68 edotreotide, Gallium ga 68-dotatoc, Gallium ga 68-edotreotide, Gallium ga-68 edotreotide, Gallium oxodotreotide ga-68, Gallium-dota-octreotate ga-68, Gallium-dota-octreotate, ga-68, Gatate, Netspot, Somakit toc
Sources - ChEMBL CHEMBL262135 (read 2026-10-02)
- ChEMBL CHEMBL4297340 (read 2026-10-02): salt form, folded into this row
| (68ga)gallium dotatate, 68ga-dota-tyr3-octreotide, 68ga-dotatate | Peptide conjugate | Approved (2016) | ChEMBL CHEMBL262135; ChEMBL CHEMBL4297340 |
Gallium RofapitidexetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- GALLIUM (68GA) ROFAPITIDE TETRAXETAN, Galio (68ga) rofapitida tetraxetan, Gallium (68ga) rofapitide tetraxetan
Sources - ChEMBL CHEMBL5316152 (read 2026-10-02)
- ChEMBL CHEMBL5314464 (read 2026-10-02): salt form, folded into this row
| GALLIUM (68GA) ROFAPITIDE TETRAXETAN, Galio (68ga) rofapitida tetraxetan, Gallium (68ga) rofapitide tetraxetan | Peptide | Phase 2 | ChEMBL CHEMBL5316152; ChEMBL CHEMBL5314464 |
GanipatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL5314835 (read 2026-10-02)
| — | Peptide | Phase 2 | ChEMBL CHEMBL5314835 |
GanirelixDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1999
- INN stem
- -relix
- All names
- Ganirelix acetate injection, Ganirelix gedeon richter, Ganirest, Orgalutran, RS-26306, RS-26306-298
Sources - ChEMBL CHEMBL1251 (read 2026-10-02)
- ChEMBL CHEMBL5314377 (read 2026-10-02): salt form, folded into this row
| Ganirelix acetate injection, Ganirelix gedeon richter, Ganirest | Peptide | Approved (1999) | ChEMBL CHEMBL1251; ChEMBL CHEMBL5314377 |
GaretosmabDetails- Status
- Approved
- Class
- Antibody, not a peptide
- Highest phase
- 4.0
- All names
- REGN2477
Sources - PubMed PMID 37770652 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| REGN2477 | Antibody, not a peptide | Approved | PubMed PMID 37770652 |
GastrinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01350 (read 2026-10-02): mature peptide 76-92 of Gastrin
| — | Peptide | Made by the body | UniProt P01350 |
Gastrin-14Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01350 (read 2026-10-02): mature peptide 79-92 of Gastrin
| — | Peptide | Made by the body | UniProt P01350 |
Gastrin-52Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01350 (read 2026-10-02): mature peptide 41-92 of Gastrin
| — | Protein, not a peptide | Made by the body | UniProt P01350 |
Gastrin-6Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01350 (read 2026-10-02): mature peptide 87-92 of Gastrin
| — | Peptide | Made by the body | UniProt P01350 |
Gastrin-71Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01350 (read 2026-10-02): mature peptide 22-92 of Gastrin
| — | Protein, not a peptide | Made by the body | UniProt P01350 |
GDF11Details- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- BMP-11, Growth differentiation factor 11
Sources - PubMed PMID 23663781 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| BMP-11, Growth differentiation factor 11 | Protein, not a peptide | Status not recorded | PubMed PMID 23663781 |
GDF15Details- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- Growth differentiation factor 15, MIC-1, NAG-1, PLAB, PTGFB
Sources - PubMed PMID 39282907 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Growth differentiation factor 15, MIC-1, NAG-1 | Protein, not a peptide | Status not recorded | PubMed PMID 39282907 |
GersizangitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AXT-107, AXT107, Gersizangitida, Gersizangtide
Sources - ChEMBL CHEMBL5095123 (read 2026-10-02)
| AXT-107, AXT107, Gersizangitida | Peptide | Phase 2 | ChEMBL CHEMBL5095123 |
GHK-CuDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- glycyl-L-histidyl-L-lysine
Sources - PubChem CID 73587 (read 2026-10-02): PubChem title: glycyl-L-histidyl-L-lysine
| glycyl-L-histidyl-L-lysine | Peptide | Status not recorded | PubChem CID 73587 |
GhrelinDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -relin
- All names
- Human ghrelin, Lenomorelin, Lenomorelina, Lenomoreline
Sources - ChEMBL CHEMBL2108303 (read 2026-10-02)
- UniProt Q9UBU3 (read 2026-10-02): mature peptide 24-51 of Appetite-regulating hormone
- ChEMBL CHEMBL500468 (read 2026-10-02): separate ChEMBL record of the same molecule
| Human ghrelin, Lenomorelin, Lenomorelina | Peptide | Phase 3 | ChEMBL CHEMBL2108303; UniProt Q9UBU3; ChEMBL CHEMBL500468 |
Ghrelin-27Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UBU3 (read 2026-10-02): mature peptide 24-50 of Appetite-regulating hormone
| — | Peptide | Made by the body | UniProt Q9UBU3 |
GHRP-1Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 8049717 (read 2026-10-02): earliest PubMed record naming GHRP-1 in its title (1994): Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells
| — | Peptide | Status not recorded | PubMed PMID 8049717 |
GHRP-2Details- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Ghrp, Ghrp-2, KP-102, Pralmorelina, Pralmoreline, WAY-GPA-748
Sources - ChEMBL CHEMBL106593 (read 2026-10-02)
- ChEMBL CHEMBL2105772 (read 2026-10-02): salt form, folded into this row
| Ghrp, Ghrp-2, KP-102 | Peptide | Phase 2 | ChEMBL CHEMBL106593; ChEMBL CHEMBL2105772 |
GHRP-6Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Growth Hormone Releasing Peptide 6, SKF-110679
Sources - PubMed PMID 7617137 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Growth Hormone Releasing Peptide 6, SKF-110679 | Peptide | Status not recorded | PubMed PMID 7617137 |
Gi HeptapeptideDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL4297759 (read 2026-10-02)
| — | Peptide | Phase 1 | ChEMBL CHEMBL4297759 |
GIPDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P09681 (read 2026-10-02): mature peptide 52-93 of Gastric inhibitory polypeptide
| — | Peptide | Made by the body | UniProt P09681 |
GiractideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Giractida
Sources - ChEMBL CHEMBL2370090 (read 2026-10-02)
| Giractida | Peptide | Phase 2 | ChEMBL CHEMBL2370090 |
Glatiramer AcetateDetails- Status
- Approved
- Class
- Not a peptide
- Highest phase
- 4.0
- All names
- Copaxone, Copolymer 1, Glatopa
Sources - PubMed PMID 7617181 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Copaxone, Copolymer 1, Glatopa | Not a peptide | Approved | PubMed PMID 7617181 |
GlepaglutideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Glepaglutida, ZP-1848, ZP1848, Zp1848
Sources - ChEMBL CHEMBL4297761 (read 2026-10-02)
| Glepaglutida, ZP-1848, ZP1848 | Peptide | Phase 3 | ChEMBL CHEMBL4297761 |
GlicentinDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01275 (read 2026-10-02): mature peptide 21-89 of Pro-glucagon
| — | Protein, not a peptide | Made by the body | UniProt P01275 |
Glicentin-related polypeptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01275 (read 2026-10-02): mature peptide 21-50 of Pro-glucagon
| — | Peptide | Made by the body | UniProt P01275 |
GlisentideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- gli-; -tide
- All names
- Glisentida, SU-661, SU661, Staticum, UR-661, UR661
Sources - ChEMBL CHEMBL2105089 (read 2026-10-02)
| Glisentida, SU-661, SU661 | Peptide | Phase 2 | ChEMBL CHEMBL2105089 |
GLP-2Details- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- 1-33-glucagon-like peptide ii, Glp-2, Glp-2 (1-33), Glp-2 (human), Glucagon-like peptide 2
Sources - ChEMBL CHEMBL4297958 (read 2026-10-02)
- UniProt P01275 (read 2026-10-02): mature peptide 146-178 of Pro-glucagon
| 1-33-glucagon-like peptide ii, Glp-2, Glp-2 (1-33) | Peptide | Phase 3 | ChEMBL CHEMBL4297958; UniProt P01275 |
GlucagonDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2015
- All names
- Baqsimi, Gvoke Hypopen, Gvoke Kit, Gvoke Pfs, Gvoke Vialdx
Sources - openFDA NDA201849 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
- UniProt P01275 (read 2026-10-02): mature peptide 53-81 of Pro-glucagon
| Baqsimi, Gvoke Hypopen, Gvoke Kit | Peptide | Approved (2015) | openFDA NDA201849; UniProt P01275 |
Glucagon-like Peptide 1Details- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- Glp-1
Sources - ChEMBL CHEMBL4594475 (read 2026-10-02)
- UniProt P01275 (read 2026-10-02): mature peptide 92-128 of Pro-glucagon
| Glp-1 | Peptide | Phase 1 | ChEMBL CHEMBL4594475; UniProt P01275 |
Glucagon-like peptide 1(7-37)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01275 (read 2026-10-02): mature peptide 98-128 of Pro-glucagon
| — | Peptide | Made by the body | UniProt P01275 |
GlutathioneDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- GSH, L-glutathione, gamma-glutamylcysteinylglycine, reduced glutathione, γ-L-glutamyl-L-cysteinylglycine
Sources - PubMed PMID 37035339 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| GSH, L-glutathione, gamma-glutamylcysteinylglycine | Peptide | Status not recorded | PubMed PMID 37035339 |
GnRH-associated peptide 1Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01148 (read 2026-10-02): mature peptide 37-92 of Progonadoliberin-1
| — | Protein, not a peptide | Made by the body | UniProt P01148 |
GnRH-associated peptide 2Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt O43555 (read 2026-10-02): mature peptide 37-120 of Progonadoliberin-2
| — | Protein, not a peptide | Made by the body | UniProt O43555 |
Gonadoliberin-1Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01148 (read 2026-10-02): mature peptide 24-33 of Progonadoliberin-1
| — | Peptide | Made by the body | UniProt P01148 |
Gonadoliberin-2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O43555 (read 2026-10-02): mature peptide 24-33 of Progonadoliberin-2
| — | Peptide | Made by the body | UniProt O43555 |
GonadorelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1982
- INN stem
- -relin
- All names
- ABBOTT-41070, AY-24,031, AY-24031, Factrel, Fertagyl, Fertiral lh-rh, Gnrh, Gonadorelin acetate anhydrous, Gonadorelin acetate mixture, Gonadorelin decapeptide, Gonadorelin hcl, Gonadorelina, Gonadoreline, Gonadotropin releasing hormone, Gonadotropin-releasing hormone, Hypocrine, Lh releasing factor, Luteinizing, Luteinizing hormone-releasing factor diacetate tetrahydrate, Luteinizing hormone-releasing factor dihydrochloride, Lutrelef, Lutrepulse kit, Relefact lh-rh
Sources - ChEMBL CHEMBL1007 (read 2026-10-02)
- ChEMBL CHEMBL1200511 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL1200516 (read 2026-10-02): salt form, folded into this row
| ABBOTT-41070, AY-24,031, AY-24031 | Peptide | Approved (1982) | ChEMBL CHEMBL1007; ChEMBL CHEMBL1200511; ChEMBL CHEMBL1200516 |
GoralatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Ac-SDKP, Ac-ser-asp-lys-pro, Goralatida, Seraspenide
Sources - ChEMBL CHEMBL420741 (read 2026-10-02)
- PubChem CID 65938 (read 2026-10-02): PubChem title: Goralatide
| Ac-SDKP, Ac-ser-asp-lys-pro, Goralatida | Peptide | Phase 2 | ChEMBL CHEMBL420741; PubChem CID 65938 |
GoserelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1989
- INN stem
- -relin
- All names
- Fertilan, Goserelina, Gosereline, ICI 118,630, ICI-118630, Novgos, Zoladex, Zoladex la
Sources - ChEMBL CHEMBL1201247 (read 2026-10-02)
- ChEMBL CHEMBL1200501 (read 2026-10-02): salt form, folded into this row
| Fertilan, Goserelina, Gosereline | Peptide | Approved (1989) | ChEMBL CHEMBL1201247; ChEMBL CHEMBL1200501 |
GozetotideDetails- Status
- Approved
- Class
- Peptidomimetic
- Highest phase
- 4.0
- First approval
- 2020
- INN stem
- -tide
- All names
- (68ga)hbed-psma, (68ga)psma-hbed-cc, (al18f)psma-hbed, 18f-psma, 18f-psma-11, 68Ga-PSMA-11, 68ga-psma-11, 68ga-psma-hbed-cc, Al(18f)psma-11, DKFZ-PSMA-11 GA-68, GALLIUM GA 68 GOZETOTIDE, GOZETOTIDE ALF-18, Ga-68 psma-11, Ga-68-labeled psma-11, Ga-psma-hbed-cc ga-68, Gallium (68ga) gozetotide, Gallium ga 68 gozetotide, Gallium ga 68 psma-11, Gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc, Gallium ga-68 gozetotide, Gallium ga-68 psma-11, Gallium gozetotide ga-68, Glu-urea-lys(ahx)-hbed-cc ga-68, Gozetotide alf-18, Illuccix, Locametz, Prostamedix, Psma-11, Psma-11 ga 68, Psma-11 ga-68, Psma-hbed-cc, Psma-hbed-cc alf-18, Psma-hbed-cc ga-68
Sources - ChEMBL CHEMBL3578202 (read 2026-10-02)
- ChEMBL CHEMBL4650355 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL5095039 (read 2026-10-02): salt form, folded into this row
| (68ga)hbed-psma, (68ga)psma-hbed-cc, (al18f)psma-hbed | Peptidomimetic | Approved (2020) | ChEMBL CHEMBL3578202; ChEMBL CHEMBL4650355; ChEMBL CHEMBL5095039 |
GramicidinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1996
- All names
- Neomycin And Polymyxin B Sulfates And Gramicidin
Sources - openFDA ANDA064047 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Neomycin And Polymyxin B Sulfates And Gramicidin | Peptide | Approved (1996) | openFDA ANDA064047 |
Guanylate cyclase C-activating peptide 2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q16661 (read 2026-10-02): mature peptide 89-112 of Guanylate cyclase activator 2B
| — | Peptide | Made by the body | UniProt Q16661 |
GuanylinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q02747 (read 2026-10-02): mature peptide 101-115 of Guanylin
| — | Peptide | Made by the body | UniProt Q02747 |
hBD-1Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DEFB1, defensin β1, human β-defensin 1
Sources - PubMed PMID 7628632 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DEFB1, defensin β1, human β-defensin 1 | Peptide | Status not recorded | PubMed PMID 7628632 |
hBD-2Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DEFB4, DEFB4A, SAP1 — skin-antimicrobial peptide 1, defensin β2, human β-defensin 2
Sources - PubMed PMID 9202117 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DEFB4, DEFB4A, SAP1 — skin-antimicrobial peptide 1 | Peptide | Status not recorded | PubMed PMID 9202117 |
hBD-3Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DEFB103, DEFB103A, defensin β3, human β-defensin 3
Sources - PubMed PMID 11085990 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DEFB103, DEFB103A, defensin β3 | Peptide | Status not recorded | PubMed PMID 11085990 |
HCGDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Novarel, Ovidrel, Pregnyl, choriogonadotropin alfa, human chorionic gonadotropin
Sources - PubMed PMID 15713727 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Novarel, Ovidrel, Pregnyl | Protein, not a peptide | Approved | PubMed PMID 15713727 |
HD5Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DEFA5, defensin α5, enteric α-defensin 5, human α-defensin 5
Sources - PubMed PMID 27636409 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DEFA5, defensin α5, enteric α-defensin 5 | Peptide | Status not recorded | PubMed PMID 27636409 |
HD6Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DEFA6, defensin α6, enteric α-defensin 6, human α-defensin 6
Sources - PubMed PMID 22722251 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DEFA6, defensin α6, enteric α-defensin 6 | Peptide | Status not recorded | PubMed PMID 22722251 |
HepalatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- L47
Sources - ChEMBL CHEMBL4650398 (read 2026-10-02)
| L47 | Peptide | Phase 2 | ChEMBL CHEMBL4650398 |
Hepcidin-20Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P81172 (read 2026-10-02): mature peptide 65-84 of Hepcidin, 2 copies
| — | Peptide | Made by the body | UniProt P81172 |
Hepcidin-25Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P81172 (read 2026-10-02): mature peptide 60-84 of Hepcidin, 2 copies
| — | Peptide | Made by the body | UniProt P81172 |
Hexapeptide-11Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 24998056 (read 2026-10-02): PubChem title: Hexapeptide-11
| — | Peptide | Status not recorded | PubChem CID 24998056 |
Hexapeptide-9Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 16129319 (read 2026-10-02): PubChem title: Hexapeptide-9
| — | Peptide | Status not recorded | PubChem CID 16129319 |
HexarelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- EP-23905, Examorelina, Examoreline, Hexarelin, MF-6003
Sources - ChEMBL CHEMBL108335 (read 2026-10-02)
| EP-23905, Examorelina, Examoreline | Peptide | Phase 2 | ChEMBL CHEMBL108335 |
HistatinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Histatin-1, Histatin-3, Histatin-5, Salivary histatins
Sources - PubMed PMID 12492903 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Histatin-1, Histatin-3, Histatin-5 | Peptide | Status not recorded | PubMed PMID 12492903 |
HistrelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1991
- INN stem
- -relin
- All names
- Histrelina, Histreline, ORF 17070, ORF 17070RWJ 17070, ORF-17070, RWJ 17070, RWJ-17070, Supprelin, Supprelin la, Vantas
Sources - ChEMBL CHEMBL1201255 (read 2026-10-02)
- ChEMBL CHEMBL1200509 (read 2026-10-02): salt form, folded into this row
| Histrelina, Histreline, ORF 17070 | Peptide | Approved (1991) | ChEMBL CHEMBL1201255; ChEMBL CHEMBL1200509 |
HM15136Details- Status
- Status not recorded
- Class
- Peptide conjugate
- All names
- Efpegerglucagon
Sources - PubMed PMID 34726329 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Efpegerglucagon | Peptide conjugate | Status not recorded | PubMed PMID 34726329 |
HM15275Details- Status
- Status not recorded
- Class
- Peptide
Sources - ClinicalTrials.gov NCT06481098 (read 2026-10-02): trial registration cited on the encyclopedia entry
| — | Peptide | Status not recorded | ClinicalTrials.gov NCT06481098 |
HNP-1Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DEFA1, defensin α1, human neutrophil peptide 1, human α-defensin 1, myeloid-related sequence peptide 30a
Sources - PubMed PMID 2997278 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DEFA1, defensin α1, human neutrophil peptide 1 | Peptide | Status not recorded | PubMed PMID 2997278 |
HRS-9531Details- Status
- Status not recorded
- Class
- Peptide
- All names
- KAI-9531, ribupatide
Sources - PubMed PMID 42764407 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KAI-9531, ribupatide | Peptide | Status not recorded | PubMed PMID 42764407 |
Human C-peptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- C-peptide, Human proinsulin c-peptide, Insulin c-peptide, Nmij-crm 6901a, Proinsulin c-peptide, Proinsulin c-peptide (human)
Sources - ChEMBL CHEMBL4594409 (read 2026-10-02)
| C-peptide, Human proinsulin c-peptide, Insulin c-peptide | Peptide | Phase 2 | ChEMBL CHEMBL4594409 |
Human Neuropeptide YDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL438945 (read 2026-10-02)
| — | Peptide | Phase 1 | ChEMBL CHEMBL438945 |
HumaninDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- HN, MTRNR2, S14G-Humanin (HNG)
Sources - PubMed PMID 15655255 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| HN, MTRNR2, S14G-Humanin (HNG) | Peptide | Status not recorded | PubMed PMID 15655255 |
Hyaluronic AcidDetails- Status
- Approved
- Class
- Not a peptide
- Highest phase
- 4.0
- All names
- Euflexxa, HA, Hyaluronan, Juvéderm, Restylane, Sodium hyaluronate, Synvisc
Sources - PubMed PMID 17309996 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Euflexxa, HA, Hyaluronan | Not a peptide | Approved | PubMed PMID 17309996 |
IcatibantDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- Firazyr, HOE 140
Sources - PubMed PMID 20818888 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Firazyr, HOE 140 | Peptide | Approved | PubMed PMID 20818888 |
IcotrokinraDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2026
- All names
- Icotyde
Sources - openFDA NDA220149 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Icotyde | Peptide | Approved (2026) | openFDA NDA220149 |
IcrocaptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ITF-1697, ITF1697, Icrocaptida
Sources - ChEMBL CHEMBL2107753 (read 2026-10-02)
| ITF-1697, ITF1697, Icrocaptida | Peptide | Phase 2 | ChEMBL CHEMBL2107753 |
IGF-1Details- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- IGF-I, Insulin-like Growth Factor 1, Somatomedin C
Sources - PubMed PMID 17192294 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| IGF-I, Insulin-like Growth Factor 1, Somatomedin C | Peptide | Approved | PubMed PMID 17192294 |
IGF-1 DES(1-3)Details- Status
- Status not recorded
- Class
- Peptide
- All names
- DES IGF-1, DES(1-3) IGF-1, des1-3 IGF-1
Sources - PubMed PMID 8930132 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| DES IGF-1, DES(1-3) IGF-1, des1-3 IGF-1 | Peptide | Status not recorded | PubMed PMID 8930132 |
IGF-1 LR3Details- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- LR3 IGF-1, Long Arg3 IGF-1, Long R3 IGF-1
Sources - PubMed PMID 7561636 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| LR3 IGF-1, Long Arg3 IGF-1, Long R3 IGF-1 | Protein, not a peptide | Status not recorded | PubMed PMID 7561636 |
IlatreotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Ilatreotida, SDZ CO 611, SDZ-CO-611
Sources - ChEMBL CHEMBL2104390 (read 2026-10-02)
| Ilatreotida, SDZ CO 611, SDZ-CO-611 | Peptide | Phase 2 | ChEMBL CHEMBL2104390 |
ImsamotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Imsamotida
Sources - ChEMBL CHEMBL5314745 (read 2026-10-02)
| Imsamotida | Peptide | Phase 2 | ChEMBL CHEMBL5314745 |
Indium In 111 Capromab PendetideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- INN stem
- -mab; -tide
- All names
- (sup 111)in-capromab pendetide, CYT-351, Capromab pendetide, Indium (111in) capromab pendetide, Indium in-111 prostascint, Prostascint indium in-111
Sources - ChEMBL CHEMBL2108800 (read 2026-10-02)
| (sup 111)in-capromab pendetide, CYT-351, Capromab pendetide | Peptide | Approved | ChEMBL CHEMBL2108800 |
Indium In 111 pentetreotideDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 1994
- INN stem
- -tide
- All names
- (sup 111)indium pentetreotide, 111indium pentetreotide, INDIUM IN 111 PENTETREOTIDE, Indium (111 in) pentetreotide, Indium (111in) pentetreotide, Indium in 111 pentetreotide, Indium in-111 pentetreotide, Indium in-111 pentetreotide kit, Indium-111 pentetreotide, MP-1727, Octreoscan, Pentetreotide 111in chelate
Sources - ChEMBL CHEMBL2110556 (read 2026-10-02)
- ChEMBL CHEMBL1200642 (read 2026-10-02): salt form, folded into this row
| (sup 111)indium pentetreotide, 111indium pentetreotide, INDIUM IN 111 PENTETREOTIDE | Peptide conjugate | Approved (1994) | ChEMBL CHEMBL2110556; ChEMBL CHEMBL1200642 |
Indium In 111 Satumomab PendetideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1991
- INN stem
- -mab; -tide
- All names
- B72.3, CYT-099, CYT-103, CYT-103 (111IN), CYT-103 111 IN, IN-111 CYT-103, Indium (111in) satumomab pendetide, Indium in 111 cyt-103, Monab b72.3-gyk-dtpa-111in, Oncoscint, Satumomab, Satumomab pendetide, Satumomab pendetide 111in, Satumomab pendetide indium in-111
Sources - ChEMBL CHEMBL1743091 (read 2026-10-02)
| B72.3, CYT-099, CYT-103 | Peptide | Approved (1991) | ChEMBL CHEMBL1743091 |
Insulin A chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01308 (read 2026-10-02): mature peptide 90-110 of Insulin
| — | Peptide | Made by the body | UniProt P01308 |
Insulin aspartDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Fiasp, Kirsty, NovoLog, NovoRapid
Sources - PubMed PMID 10353301 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Fiasp, Kirsty, NovoLog | Protein, not a peptide | Approved | PubMed PMID 10353301 |
Insulin B chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01308 (read 2026-10-02): mature peptide 25-54 of Insulin
| — | Peptide | Made by the body | UniProt P01308 |
Insulin degludecDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- NN1250, Tresiba, Xultophy (combo)
Sources - PubMed PMID 28605603 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NN1250, Tresiba, Xultophy (combo) | Peptide | Approved | PubMed PMID 28605603 |
Insulin degludec / liraglutide (IDegLira)Details- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- IDegLira, Xultophy, Xultophy 100/3.6
Sources - PubMed PMID 25190523 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| IDegLira, Xultophy, Xultophy 100/3.6 | Peptide | Approved | PubMed PMID 25190523 |
Insulin detemirDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Levemir, NN304
Sources - PubMed PMID 19565569 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Levemir, NN304 | Peptide | Status not recorded | PubMed PMID 19565569 |
Insulin efsitora alfaDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- LY3209590, basal insulin Fc, efsitora, efsitora alfa
Sources - PubMed PMID 40548694 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| LY3209590, basal insulin Fc, efsitora | Protein, not a peptide | Approved | PubMed PMID 40548694 |
Insulin glargineDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- Basaglar, Lantus, Rezvoglar, Semglee, Toujeo
Sources - PubMed PMID 11315821 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Basaglar, Lantus, Rezvoglar | Peptide | Approved | PubMed PMID 11315821 |
Insulin glargine / lixisenatide (iGlarLixi)Details- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- Soliqua, Soliqua 100/33, Suliqua, iGlarLixi
Sources - PubMed PMID 27284114 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Soliqua, Soliqua 100/33, Suliqua | Peptide | Approved | PubMed PMID 27284114 |
Insulin glulisineDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Apidra, HMR1964
Sources - PubMed PMID 21291333 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Apidra, HMR1964 | Protein, not a peptide | Approved | PubMed PMID 21291333 |
Insulin icodecDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Awiqli, NN1436
Sources - PubMed PMID 37356066 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Awiqli, NN1436 | Protein, not a peptide | Approved | PubMed PMID 37356066 |
Insulin lisproDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Admelog, Humalog, LY275585, Lyumjev
Sources - PubMed PMID 37786396 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Admelog, Humalog, LY275585 | Protein, not a peptide | Approved | PubMed PMID 37786396 |
Insulin-like 3 A chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P51460 (read 2026-10-02): mature peptide 106-131 of Insulin-like 3
| — | Peptide | Made by the body | UniProt P51460 |
Insulin-like 3 B chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P51460 (read 2026-10-02): mature peptide 21-55 of Insulin-like 3
| — | Peptide | Made by the body | UniProt P51460 |
Insulin-like peptide INSL5 A chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9Y5Q6 (read 2026-10-02): mature peptide 115-135 of Insulin-like peptide INSL5
| — | Peptide | Made by the body | UniProt Q9Y5Q6 |
Insulin-like peptide INSL5 B chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9Y5Q6 (read 2026-10-02): mature peptide 23-46 of Insulin-like peptide INSL5
| — | Peptide | Made by the body | UniProt Q9Y5Q6 |
Insulin-like peptide INSL6 A chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9Y581 (read 2026-10-02): mature peptide 173-198 of Insulin-like peptide INSL6
| — | Peptide | Made by the body | UniProt Q9Y581 |
Insulin-like peptide INSL6 B chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9Y581 (read 2026-10-02): mature peptide 21-53 of Insulin-like peptide INSL6
| — | Peptide | Made by the body | UniProt Q9Y581 |
Intermedin-shortDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q7Z4H4 (read 2026-10-02): mature peptide 108-147 of Protein ADM2
| — | Peptide | Made by the body | UniProt Q7Z4H4 |
Intestinal peptide PHM-27Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01282 (read 2026-10-02): mature peptide 81-107 of VIP peptides
| — | Peptide | Made by the body | UniProt P01282 |
Intestinal peptide PHV-42Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01282 (read 2026-10-02): mature peptide 81-122 of VIP peptides
| — | Peptide | Made by the body | UniProt P01282 |
InvopressinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -pressin
- All names
- Invopressina, Invopressine, Oce-205
Sources - ChEMBL CHEMBL5314925 (read 2026-10-02)
| Invopressina, Invopressine, Oce-205 | Peptide | Phase 2 | ChEMBL CHEMBL5314925 |
Iodine i124 EvuzamitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- io-; -tide
- All names
- 124I-p5+14, 124i-at-01, APi1832, AT-01, Evuzamitide iodine i-124, Iodine (124i) evuzamitide
Sources - ChEMBL CHEMBL5314633 (read 2026-10-02)
| 124I-p5+14, 124i-at-01, APi1832 | Peptide | Phase 2 | ChEMBL CHEMBL5314633 |
IpamorelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Aib-his-d-2-nal-d-phe-lys-nh2, Ipamorelina, Ipamoreline, NNC 26-0161, NNC-26-0161, NNC-260161
Sources - ChEMBL CHEMBL58547 (read 2026-10-02)
| Aib-his-d-2-nal-d-phe-lys-nh2, Ipamorelina, Ipamoreline | Peptide | Phase 2 | ChEMBL CHEMBL58547 |
IrucalantideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Irucalantida
Sources - ChEMBL CHEMBL5314840 (read 2026-10-02)
| Irucalantida | Peptide | Phase 2 | ChEMBL CHEMBL5314840 |
IturelixDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relix
- All names
- Antide, Nal-lys anatagonist, ORF-32541
Sources - ChEMBL CHEMBL3989438 (read 2026-10-02)
| Antide, Nal-lys anatagonist, ORF-32541 | Peptide | Phase 2 | ChEMBL CHEMBL3989438 |
Kaliuretic peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 104-123 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
KatacalcinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01258 (read 2026-10-02): mature peptide 121-141 of Calcitonin
| — | Peptide | Made by the body | UniProt P01258 |
KEPDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 34-40 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
Kisspeptin-10Details- Status
- Status not recorded
- Class
- Peptide
- All names
- KISS1(68-77), Kp-10, metastin 45-54
Sources - PubMed PMID 21632807 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KISS1(68-77), Kp-10, metastin 45-54 | Peptide | Status not recorded | PubMed PMID 21632807 |
Kisspeptin-54Details- Status
- Status not recorded
- Class
- Peptide
- All names
- KISS1(68-121), Kp-54, metastin
Sources - PubMed PMID 26192876 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KISS1(68-121), Kp-54, metastin | Peptide | Status not recorded | PubMed PMID 26192876 |
Klotho PeptideDetails- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- KL-VS, S-Klotho, Soluble Klotho, α-Klotho
Sources - PubMed PMID 35053218 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KL-VS, S-Klotho, Soluble Klotho | Protein, not a peptide | Status not recorded | PubMed PMID 35053218 |
KN056Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 40328758 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| — | Peptide | Status not recorded | PubMed PMID 40328758 |
KPVDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Lys-Pro-Val, lysine-proline-valine, tripeptide KPV, α-MSH(11-13)
Sources - PubMed PMID 6333677 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Lys-Pro-Val, lysine-proline-valine, tripeptide KPV | Peptide | Status not recorded | PubMed PMID 6333677 |
KR-12Details- Status
- Status not recorded
- Class
- Peptide
- All names
- KRIVQRIKDFLR, LL-37(18-29), minimal LL-37 antimicrobial fragment
Sources - PubMed PMID 18818205 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KRIVQRIKDFLR, LL-37(18-29), minimal LL-37 antimicrobial fragment | Peptide | Status not recorded | PubMed PMID 18818205 |
L-carnitineDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- (-)-Carnitine
Sources - PubChem CID 10917 (read 2026-10-02): PubChem title: (-)-Carnitine
| (-)-Carnitine | Small molecule, not a peptide | Status not recorded | PubChem CID 10917 |
LactoferricinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Lactoferricin B, Lactoferricin H, LfcinB
Sources - PubMed PMID 16261252 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Lactoferricin B, Lactoferricin H, LfcinB | Peptide | Status not recorded | PubMed PMID 16261252 |
LagatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- BN-52080, BN52080, Lagatida
Sources - ChEMBL CHEMBL2218863 (read 2026-10-02)
| BN-52080, BN52080, Lagatida | Peptide | Phase 2 | ChEMBL CHEMBL2218863 |
LancovutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Duramycin, Lancovutida, Leucopeptin, MOLI-1901, MOLI1901, Moli1901
Sources - ChEMBL CHEMBL2108327 (read 2026-10-02)
| Duramycin, Lancovutida, Leucopeptin | Peptide | Phase 2 | ChEMBL CHEMBL2108327 |
LanreotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2007
- INN stem
- -tide
- All names
- Angiopeptin, BIM-23014C, Lanreotida, Somatuline, Somatuline autogel, Somatuline depot, Somatuline la, Somatuline lp
Sources - ChEMBL CHEMBL1201185 (read 2026-10-02)
- ChEMBL CHEMBL1201184 (read 2026-10-02): salt form, folded into this row
| Angiopeptin, BIM-23014C, Lanreotida | Peptide | Approved (2007) | ChEMBL CHEMBL1201185; ChEMBL CHEMBL1201184 |
LarazotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- AT-1001, AT-1001 (LARAZOTIDE ACETATE), AT-2347, Larazotida
Sources - ChEMBL CHEMBL2105646 (read 2026-10-02)
- ChEMBL CHEMBL2103815 (read 2026-10-02): salt form, folded into this row
| AT-1001, AT-1001 (LARAZOTIDE ACETATE), AT-2347 | Peptide | Phase 3 | ChEMBL CHEMBL2105646; ChEMBL CHEMBL2103815 |
Lead Bamzireotide NavoxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- LEAD (212PB) BAMZIREOTIDE NAVOXETAN, Lead (212pb) bamzireotide navoxetan, Plomb (212pb) bamzireotide navoxetan, Plomo (212pb) bamzireotida navoxetan
Sources - ChEMBL CHEMBL6068769 (read 2026-10-02)
- ChEMBL CHEMBL6068067 (read 2026-10-02): salt form, folded into this row
| LEAD (212PB) BAMZIREOTIDE NAVOXETAN, Lead (212pb) bamzireotide navoxetan, Plomb (212pb) bamzireotide navoxetan | Peptide | Phase 2 | ChEMBL CHEMBL6068769; ChEMBL CHEMBL6068067 |
Lead Lapemelanotide ZapixetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- LEAD (212PB) LAPEMELANOTIDE ZAPIXETAN, Lead (212pb) lapemelanotide zapixetan, Plomb (212pb) lapemelanotide zapixetan, Plomo (212pb) lapemelanotide zapixetan
Sources - ChEMBL CHEMBL6068770 (read 2026-10-02)
- ChEMBL CHEMBL6068068 (read 2026-10-02): salt form, folded into this row
| LEAD (212PB) LAPEMELANOTIDE ZAPIXETAN, Lead (212pb) lapemelanotide zapixetan, Plomb (212pb) lapemelanotide zapixetan | Peptide | Phase 2 | ChEMBL CHEMBL6068770; ChEMBL CHEMBL6068068 |
LeconotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Leconotida, Omega-conopeptide mviia
Sources - ChEMBL CHEMBL2108419 (read 2026-10-02)
| Leconotida, Omega-conopeptide mviia | Peptide | Phase 2 | ChEMBL CHEMBL2108419 |
LeumorphinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 226-254 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
LeuphasylDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Pentapeptide-18, Tyr-D-Ala-Gly-Phe-Leu
Sources - PubMed PMID 41722287 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Pentapeptide-18, Tyr-D-Ala-Gly-Phe-Leu | Peptide | Status not recorded | PubMed PMID 41722287 |
LeuprolideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- Camcevi, Eligard, Fensolvi, Lupron, Lupron Depot, leuprorelin
Sources - PubMed PMID 2108883 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Camcevi, Eligard, Fensolvi | Peptide | Approved | PubMed PMID 2108883 |
LinaclotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2012
- INN stem
- -tide
- All names
- ASP-0456, ASP0456, Constella, Linaclotida, Linzess, MD-1100, MD-1100 ACETATE, MD-7246 (DELAYED RELEASE FORMULATION), MM-416775
Sources - ChEMBL CHEMBL3301675 (read 2026-10-02)
- ChEMBL CHEMBL3301676 (read 2026-10-02): salt form, folded into this row
| ASP-0456, ASP0456, Constella | Peptide | Approved (2012) | ChEMBL CHEMBL3301675; ChEMBL CHEMBL3301676 |
Lipotropin betaDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 179-267 of Pro-opiomelanocortin
| — | Protein, not a peptide | Made by the body | UniProt P01189 |
Lipotropin gammaDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 179-234 of Pro-opiomelanocortin
| — | Protein, not a peptide | Made by the body | UniProt P01189 |
LiraglutideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2009
- INN stem
- -tide
- All names
- Liraglutida, Liraglutide (rdna origin), Liraglutide component of xultophy 100/3.6, Liraglutide recombinant, NN-2211, NN-9924, NN2211, NN9924, NNC 90-1170, NNC-90-1170, Saxenda, Victoza
Sources - ChEMBL CHEMBL4084119 (read 2026-10-02)
| Liraglutida, Liraglutide (rdna origin), Liraglutide component of xultophy 100/3.6 | Peptide | Approved (2009) | ChEMBL CHEMBL4084119 |
Little LENDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 245-254 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
Little SAASDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 42-59 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
LivagenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- KEDA, Lys-Glu-Asp-Ala
Sources - PubMed PMID 32362099 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KEDA, Lys-Glu-Asp-Ala | Peptide | Status not recorded | PubMed PMID 32362099 |
LivoletideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AZP 531, AZP-531, AZP531, Azp-531, Livoletida
Sources - ChEMBL CHEMBL2029605 (read 2026-10-02)
| AZP 531, AZP-531, AZP531 | Peptide | Phase 2 | ChEMBL CHEMBL2029605 |
LixisenatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2013
- INN stem
- -tide
- All names
- AVE 010, AVE-0010, AVE-010, AVE0010, Lixisenatida, Lixisenatide component of soliqua 100/33, Lyxumia, ZP 10, ZP-10
Sources - ChEMBL CHEMBL2108336 (read 2026-10-02)
| AVE 010, AVE-0010, AVE-010 | Peptide | Approved (2013) | ChEMBL CHEMBL2108336 |
LixivaptanDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- Jinarc Alternative, VPA-985
Sources - PubMed PMID 22932119 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Jinarc Alternative, VPA-985 | Small molecule, not a peptide | Status not recorded | PubMed PMID 22932119 |
LL-37Details- Status
- Status not recorded
- Class
- Peptide
- All names
- CAMP, Cathelicidin LL-37, human cationic antimicrobial protein 18 (hCAP18)
Sources - PubMed PMID 25041740 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CAMP, Cathelicidin LL-37, human cationic antimicrobial protein 18 (hCAP18) | Peptide | Status not recorded | PubMed PMID 25041740 |
LonapegsomatropinDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- ACP-011, Skytrofa, TransCon growth hormone, TransCon hGH, lonapegsomatropin-tcgd
Sources - PubMed PMID 34272849 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| ACP-011, Skytrofa, TransCon growth hormone | Protein, not a peptide | Approved | PubMed PMID 34272849 |
Long-acting natriuretic peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 26-55 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
LorutengitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Lorutengitida
Sources - ChEMBL CHEMBL6068133 (read 2026-10-02)
| Lorutengitida | Peptide | Phase 2 | ChEMBL CHEMBL6068133 |
Lsalt PeptideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -sal-; -tide
- All names
- Metablok
Sources - ChEMBL CHEMBL5314991 (read 2026-10-02)
| Metablok | Peptide | Phase 3 | ChEMBL CHEMBL5314991 |
LucicebtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Lucicebtida, ST-101 (D-AMINO ACID PEPTIDE), ST101 (peptide)
Sources - ChEMBL CHEMBL5314846 (read 2026-10-02)
| Lucicebtida, ST-101 (D-AMINO ACID PEPTIDE), ST101 (peptide) | Peptide | Phase 2 | ChEMBL CHEMBL5314846 |
LunasinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Lunasine
Sources - PubChem CID 20054959 (read 2026-10-02): PubChem title: Lunasine
| Lunasine | Peptide | Status not recorded | PubChem CID 20054959 |
LusupultideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- B-9420-001, B9420-001, Lusupultida, Rsp-c surfactant
Sources - ChEMBL CHEMBL2218909 (read 2026-10-02)
| B-9420-001, B9420-001, Lusupultida | Peptide | Phase 2 | ChEMBL CHEMBL2218909 |
Lutetium Lu 177 Zadavotide GuraxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- 177lu-pnt2002, Pnt2002 lu-177, Zadavotide guraxetan lutetium lu-177
Sources - ChEMBL CHEMBL5314936 (read 2026-10-02)
| 177lu-pnt2002, Pnt2002 lu-177, Zadavotide guraxetan lutetium lu-177 | Peptide | Phase 2 | ChEMBL CHEMBL5314936 |
Lutetium Lu177 EdotreotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- (177ludota)-toc, 177lu-dotatoc, Dotatoc lu-177, Edotreotide lutetium lu-177, Lutecio lu177 edotreotida, Lutecium lu177 edotreotide, Lutetium (177lu) edotreotide
Sources - ChEMBL CHEMBL5095425 (read 2026-10-02)
| (177ludota)-toc, 177lu-dotatoc, Dotatoc lu-177 | Peptide | Phase 2 | ChEMBL CHEMBL5095425 |
Lutetium RofapitidexetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- LUTETIUM (LU177) ROFAPITIDE TETRAXETAN, Lutecio (lu177) rofapitida tetraxetan, Lutecium (lu177) rofapitide tetraxetan, Lutetium (lu177) rofapitide tetraxetan
Sources - ChEMBL CHEMBL5316153 (read 2026-10-02)
- ChEMBL CHEMBL5314468 (read 2026-10-02): salt form, folded into this row
| LUTETIUM (LU177) ROFAPITIDE TETRAXETAN, Lutecio (lu177) rofapitida tetraxetan, Lutecium (lu177) rofapitide tetraxetan | Peptide | Phase 2 | ChEMBL CHEMBL5316153; ChEMBL CHEMBL5314468 |
Lutetium TezuvotidexetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- 177lu-rhpsma-10.1, LUTETIUM (177LU) TEZUVOTIDE TETRAXETAN, Luteci0 (177lu) tezuvotida tetraxetan, Lutecium (177lu) tezuvotide tetraxetan, Lutetium (177lu) rhpsma-10.1, Lutetium (177lu) tezuvotide tetraxetan, Rhpsma-10.1 lutetium lu-177
Sources - ChEMBL CHEMBL6068768 (read 2026-10-02)
- ChEMBL CHEMBL6068058 (read 2026-10-02): salt form, folded into this row
| 177lu-rhpsma-10.1, LUTETIUM (177LU) TEZUVOTIDE TETRAXETAN, Luteci0 (177lu) tezuvotida tetraxetan | Peptide | Phase 2 | ChEMBL CHEMBL6068768; ChEMBL CHEMBL6068058 |
Lutetium-177 DOTATATEDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2017
- INN stem
- -tide
- All names
- (177)lu-dotatate, 177lu-dota-tyr3-octreotate, 177lu-dotatate, Dota-octreotate lutetium lu-177, Dotatate lutenium lu-177, Dotatate lutetium lu-177, LUTETIUM OXODOTREOTIDE LU-177, Lutathera, Lutecio (177lu) oxodotreotida, Lutecium (177lu) oxodotreotide, Lutetium (177lu) dotatate, Lutetium (177lu) oxodotreotide, Lutetium dotatate lu-177, Lutetium dotatate, lu-177, Lutetium lu 177 dotatate, Lutetium lu-177 dotatate, Lutetium oxodotreotide lu-177, Oxodotreotide lutetium lu-177, Oxodotreotide lutetium, lu-177
Sources - ChEMBL CHEMBL4302409 (read 2026-10-02)
- ChEMBL CHEMBL4297545 (read 2026-10-02): salt form, folded into this row
| (177)lu-dotatate, 177lu-dota-tyr3-octreotate, 177lu-dotatate | Peptide conjugate | Approved (2017) | ChEMBL CHEMBL4302409; ChEMBL CHEMBL4297545 |
LutrelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Lutrelina, Lutreline, WY-40,972, WY-40972, WY40,972
Sources - ChEMBL CHEMBL2370578 (read 2026-10-02)
- ChEMBL CHEMBL3989436 (read 2026-10-02): salt form, folded into this row
| Lutrelina, Lutreline, WY-40,972 | Peptide | Phase 2 | ChEMBL CHEMBL2370578; ChEMBL CHEMBL3989436 |
Lutropin alfaDetails- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- Luveris, rLH
Sources - PubMed PMID 28137754 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Luveris, rLH | Protein, not a peptide | Status not recorded | PubMed PMID 28137754 |
LypressinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1982
- INN stem
- -pressin
- All names
- 8-l-lysinevasopressin, Diapid, L-8, Lipresina, Lypressine, Lysine vasopressin, Vasopressin pig, Vasopressin, 8-l-lysine
Sources - ChEMBL CHEMBL1200690 (read 2026-10-02)
| 8-l-lysinevasopressin, Diapid, L-8 | Peptide | Approved (1982) | ChEMBL CHEMBL1200690 |
MacimorelinDetails- Status
- Approved
- Class
- Small molecule, not a peptide
- Highest phase
- 4.0
- First approval
- 2017
- INN stem
- -relin
- All names
- AEZS-130, ARD 07, ARD-07, ARD-07 ACETATE, ARD07, Ard-07, D-87575, D-87575 ACETATE, EP 1572, EP-01572, EP-1572, EP-1572 ACETATE, EP01572, EP1572, Ghryvelin (previously macimorelin aeterna zentaris), JMV 1843, JMV-1843, Macimorelina, Macimoreline, Macrilen, Solorel
Sources - ChEMBL CHEMBL278623 (read 2026-10-02)
- ChEMBL CHEMBL2364617 (read 2026-10-02): salt form, folded into this row
| AEZS-130, ARD 07, ARD-07 | Small molecule, not a peptide | Approved (2017) | ChEMBL CHEMBL278623; ChEMBL CHEMBL2364617 |
MacupatideDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- LY3532226
Sources - ChEMBL CHEMBL6068487 (read 2026-10-02)
| LY3532226 | Peptide | Phase 1 | ChEMBL CHEMBL6068487 |
MagaininDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- MSI-78, Magainin 2, Pexiganan
Sources - PubMed PMID 18990064 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| MSI-78, Magainin 2, Pexiganan | Peptide | Status not recorded | PubMed PMID 18990064 |
MaraciclatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Maraciclatida, NC 100692, NC-100692, NC100692
Sources - ChEMBL CHEMBL3989765 (read 2026-10-02)
| Maraciclatida, NC 100692, NC-100692 | Peptide | Phase 2 | ChEMBL CHEMBL3989765 |
Maridebart cafraglutideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- -bart; -tide
- All names
- Maridebart cafraglutida
Sources - ChEMBL CHEMBL5314751 (read 2026-10-02)
| Maridebart cafraglutida | Peptide conjugate | Phase 2 | ChEMBL CHEMBL5314751 |
MarlumotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Marlumotida, Wt-1 122 long, Wt1-122a1 long
Sources - ChEMBL CHEMBL5314752 (read 2026-10-02)
| Marlumotida, Wt-1 122 long, Wt1-122a1 long | Peptide | Phase 2 | ChEMBL CHEMBL5314752 |
MatrixylDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Matrixyl 3000, Pal-KTTKS, Palmitoyl Pentapeptide-3, Palmitoyl Pentapeptide-4
Sources - PubMed PMID 18492182 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Matrixyl 3000, Pal-KTTKS, Palmitoyl Pentapeptide-3 | Peptide | Status not recorded | PubMed PMID 18492182 |
MazdutideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Ibi-362, Ibi362, LY-3305677, LY3305677, Mazdutida
Sources - ChEMBL CHEMBL5095358 (read 2026-10-02)
| Ibi-362, Ibi362, LY-3305677 | Peptide | Phase 3 | ChEMBL CHEMBL5095358 |
MecaserminDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- Increlex, recombinant IGF-1, rhIGF-1, somatomedin C
Sources - PubMed PMID 40626687 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Increlex, recombinant IGF-1, rhIGF-1 | Peptide | Approved | PubMed PMID 40626687 |
Mecasermin rinfabateDetails- Status
- Status not recorded
- Class
- Protein, not a peptide
- All names
- IGF-1/IGFBP-3 complex, iPlex, rhIGF-1/rhIGFBP-3
Sources - PubMed PMID 28934640 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| IGF-1/IGFBP-3 complex, iPlex, rhIGF-1/rhIGFBP-3 | Protein, not a peptide | Status not recorded | PubMed PMID 28934640 |
Melanin-concentrating hormoneDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20382 (read 2026-10-02): mature peptide 147-165 of Pro-MCH
| — | Peptide | Made by the body | UniProt P20382 |
Melanocyte-stimulating hormone alphaDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 138-150 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
Melanocyte-stimulating hormone betaDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 217-234 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
Melanotan IIDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Barbie drug, MT-2, MT-II, MT2, melanotan 2
Sources - PubMed PMID 8637402 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Barbie drug, MT-2, MT-II | Peptide | Status not recorded | PubMed PMID 8637402 |
Melanotropin gammaDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 77-87 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
MelatoninDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- 5-methoxy-N-acetyltryptamine, Circadin, MT, N-acetyl-5-methoxytryptamine
Sources - PubMed PMID 17875243 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| 5-methoxy-N-acetyltryptamine, Circadin, MT | Small molecule, not a peptide | Status not recorded | PubMed PMID 17875243 |
MelittinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Apis mellifera peptide, Bee venom peptide
Sources - PubMed PMID 4113805 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Apis mellifera peptide, Bee venom peptide | Peptide | Status not recorded | PubMed PMID 4113805 |
MenotropinDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Humegon, Menopur, Repronex, hMG, highly purified hMG, human menopausal gonadotropin
Sources - PubMed PMID 22244781 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Humegon, Menopur, Repronex | Protein, not a peptide | Approved | PubMed PMID 22244781 |
MertiatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Mercaptoacetylglycylglycylglycine, Mercaptoacetyltriglycine, Mertiatida
Sources - ChEMBL CHEMBL1615778 (read 2026-10-02)
| Mercaptoacetylglycylglycylglycine, Mercaptoacetyltriglycine, Mertiatida | Peptide | Phase 2 | ChEMBL CHEMBL1615778 |
Met-enkephalin-Arg-Gly-LeuDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 186-193 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
Met-enkephalin-Arg-PheDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 261-267 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
Methylene BlueDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
Sources - PubChem CID 6099 (read 2026-10-02): PubChem title: Methylene Blue
| — | Small molecule, not a peptide | Status not recorded | PubChem CID 6099 |
MGFDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- IGF-1 Ec variant, IGF-1Ec, Mechano Growth Factor
Sources - PubMed PMID 32772171 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| IGF-1 Ec variant, IGF-1Ec, Mechano Growth Factor | Peptide | Status not recorded | PubMed PMID 32772171 |
MibenratideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- JNJ-54452840, Jnj-54452840, Mibenratida
Sources - ChEMBL CHEMBL4297617 (read 2026-10-02)
| JNJ-54452840, Jnj-54452840, Mibenratida | Peptide | Phase 2 | ChEMBL CHEMBL4297617 |
MicafunginDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2023
- All names
- Micafungin In Sodium Chloride 0.9%
Sources - openFDA NDA216142 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Micafungin In Sodium Chloride 0.9% | Peptide | Approved (2023) | openFDA NDA216142 |
MifamurtideDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2009
- INN stem
- -tide
- All names
- CGP-19835, L-MTP-PE, MIFAMURTIDE, Mepact, Mifamurtida, Mifamurtide, Mifamurtide free acid anhydrous, Mifamurtide sodium hydrate, Mifamurtide sodium salt monohydrate, Sodium mifamurtide
Sources - ChEMBL CHEMBL2111100 (read 2026-10-02)
- ChEMBL CHEMBL2107354 (read 2026-10-02): salt form, folded into this row
| CGP-19835, L-MTP-PE, MIFAMURTIDE | Peptide conjugate | Approved (2009) | ChEMBL CHEMBL2111100; ChEMBL CHEMBL2107354 |
MifomelatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Mifomelatida
Sources - ChEMBL CHEMBL6068142 (read 2026-10-02)
| Mifomelatida | Peptide | Phase 2 | ChEMBL CHEMBL6068142 |
MilpocitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL5314692 (read 2026-10-02)
| — | Peptide | Phase 2 | ChEMBL CHEMBL5314692 |
MK-677Details- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- Ibutamoren, Ibutamoren mesylate, LUM-201, MK-0677, MK0677, Nutrobal
Sources - PubMed PMID 8940347 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Ibutamoren, Ibutamoren mesylate, LUM-201 | Small molecule, not a peptide | Status not recorded | PubMed PMID 8940347 |
Mod GRF 1-29Details- Status
- Status not recorded
- Class
- Peptide
- All names
- CJC-1295 no DAC, CJC-1295 without DAC, Modified GRF(1-29), Sermorelin analog
Sources - PubMed PMID 16822960 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CJC-1295 no DAC, CJC-1295 without DAC, Modified GRF(1-29) | Peptide | Status not recorded | PubMed PMID 16822960 |
ModimelanotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ABT-719, Ap-214, Ap214, Modimelanotida, ZP-1480, ZP1480
Sources - ChEMBL CHEMBL3545104 (read 2026-10-02)
| ABT-719, Ap-214, Ap214 | Peptide | Phase 2 | ChEMBL CHEMBL3545104 |
MontirelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- CG-3703, CNK-602A, Montirelina, Montireline, NS-3
Sources - ChEMBL CHEMBL2304039 (read 2026-10-02)
| CG-3703, CNK-602A, Montirelina | Peptide | Phase 2 | ChEMBL CHEMBL2304039 |
MotilinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P12872 (read 2026-10-02): mature peptide 26-47 of Promotilin
| — | Peptide | Made by the body | UniProt P12872 |
Motilin-associated peptideDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P12872 (read 2026-10-02): mature peptide 50-115 of Promotilin
| — | Protein, not a peptide | Made by the body | UniProt P12872 |
MotixafortideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2023
- INN stem
- -tide
- All names
- 4F-BENZOYL-TN-14003, 4F-benzoyl-TN14003, Aphexda, BKT-140, BKT140, BL-8040, BL-8040 acetate, Bkt140, Bl 8040, Motixafortida, T140, TF 14016, TF-14016, TF-14016 ACETATE, TF14016
Sources - ChEMBL CHEMBL5095030 (read 2026-10-02)
- ChEMBL CHEMBL5095449 (read 2026-10-02): separate ChEMBL record of the same molecule
| 4F-BENZOYL-TN-14003, 4F-benzoyl-TN14003, Aphexda | Peptide | Approved (2023) | ChEMBL CHEMBL5095030; ChEMBL CHEMBL5095449 |
MOTS-cDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Mitochondrial ORF of 12S rRNA-c
Sources - PubMed PMID 25738459 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Mitochondrial ORF of 12S rRNA-c | Peptide | Status not recorded | PubMed PMID 25738459 |
MurabutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Murabutida
Sources - ChEMBL CHEMBL1908312 (read 2026-10-02)
| Murabutida | Peptide | Phase 2 | ChEMBL CHEMBL1908312 |
Muramyl DipeptideDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- Acetylmuramyl-alanyl-isoglutamine, Mdp (adjuvant), N-acetylmuramyl dipeptide
Sources - ChEMBL CHEMBL1779325 (read 2026-10-02)
| Acetylmuramyl-alanyl-isoglutamine, Mdp (adjuvant), N-acetylmuramyl dipeptide | Peptide | Phase 1 | ChEMBL CHEMBL1779325 |
Myristoyl Hexapeptide-16Details- Status
- Status not recorded
- Class
- Peptide conjugate
Sources - PubChem CID 163285863 (read 2026-10-02): PubChem title: Myristoyl Hexapeptide-16
| — | Peptide conjugate | Status not recorded | PubChem CID 163285863 |
Myristoyl Pentapeptide-17Details- Status
- Status not recorded
- Class
- Peptide conjugate
Sources - PubChem CID 127264611 (read 2026-10-02): PubChem title: Myristoyl Pentapeptide-17
| — | Peptide conjugate | Status not recorded | PubChem CID 127264611 |
N-acetyl SemaxDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- N-acetyl semax amidate
Sources - PubChem CID 172638603 (read 2026-10-02): PubChem title: N-acetyl semax amidate
| N-acetyl semax amidate | Peptide | Status not recorded | PubChem CID 172638603 |
NacartocinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tocin
- All names
- Nacartocina, Nacartocine
Sources - ChEMBL CHEMBL2218901 (read 2026-10-02)
| Nacartocina, Nacartocine | Peptide | Phase 2 | ChEMBL CHEMBL2218901 |
NAD+Details- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- NAD plus, Nicotinamide Adenine Dinucleotide, β-nicotinamide adenine dinucleotide
Sources - PubMed PMID 29514064 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NAD plus, Nicotinamide Adenine Dinucleotide, β-nicotinamide adenine dinucleotide | Small molecule, not a peptide | Status not recorded | PubMed PMID 29514064 |
NafarelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1990
- INN stem
- -relin
- All names
- Lhrh, 6(d-nal(2)), Nafarelin acetate anhydrous, Nafarelina, Nafareline, Nasanyl, RS-94991, RS-94991-298, Synarel
Sources - ChEMBL CHEMBL1201309 (read 2026-10-02)
- ChEMBL CHEMBL1200671 (read 2026-10-02): salt form, folded into this row
| Lhrh, 6(d-nal(2)), Nafarelin acetate anhydrous, Nafarelina | Peptide | Approved (1990) | ChEMBL CHEMBL1201309; ChEMBL CHEMBL1200671 |
NangibotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- LR-12, LR12, Motrem, Nangibotida
Sources - ChEMBL CHEMBL4297793 (read 2026-10-02)
| LR-12, LR12, Motrem | Peptide | Phase 2 | ChEMBL CHEMBL4297793 |
NavepegritideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- -peg-; -tide
- All names
- Navepegritida, Transcon cnp, Transcon cnp-38
Sources - ChEMBL CHEMBL4594507 (read 2026-10-02)
| Navepegritida, Transcon cnp, Transcon cnp-38 | Peptide conjugate | Phase 2 | ChEMBL CHEMBL4594507 |
Nendratareotide UzatansineDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tansine; -tide
- All names
- Pen-221
Sources - ChEMBL CHEMBL4650335 (read 2026-10-02)
| Pen-221 | Peptide | Phase 1 | ChEMBL CHEMBL4650335 |
NerinetideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- FN-023, FN023, NA-1, NA-1 acetate, NA-1 hydrochloride, Nerinetida, TAT-NR2B9C HYDROCHLORIDE, Tat-nr2b9c
Sources - ChEMBL CHEMBL502630 (read 2026-10-02)
- ChEMBL CHEMBL4594282 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL4594283 (read 2026-10-02): salt form, folded into this row
| FN-023, FN023, NA-1 | Peptide | Phase 3 | ChEMBL CHEMBL502630; ChEMBL CHEMBL4594282; ChEMBL CHEMBL4594283 |
NesiritideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2001
- INN stem
- -tide
- All names
- Bnp-32, Brain natriuretic peptide 32, C01DX19, Natrecor, Nesiritida, Nesiritide recombinant
Sources - ChEMBL CHEMBL1201668 (read 2026-10-02)
- UniProt P16860 (read 2026-10-02): mature peptide 103-134 of Natriuretic peptides B
- ChEMBL CHEMBL2109183 (read 2026-10-02): separate ChEMBL record of the same molecule
| Bnp-32, Brain natriuretic peptide 32, C01DX19 | Peptide | Approved (2001) | ChEMBL CHEMBL1201668; UniProt P16860; ChEMBL CHEMBL2109183 |
Neurokinin ADetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20366 (read 2026-10-02): mature peptide 98-107 of Protachykinin-1
| — | Peptide | Made by the body | UniProt P20366 |
Neurokinin-BDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHF0 (read 2026-10-02): mature peptide 81-90 of Tachykinin-3
| — | Peptide | Made by the body | UniProt Q9UHF0 |
Neuromedin precursor-related peptide 33Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P48645 (read 2026-10-02): mature peptide 104-136 of Neuromedin-U, 2 copies
| — | Peptide | Made by the body | UniProt P48645 |
Neuromedin precursor-related peptide 36Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P48645 (read 2026-10-02): mature peptide 104-139 of Neuromedin-U, 2 copies
| — | Peptide | Made by the body | UniProt P48645 |
Neuromedin-BDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P08949 (read 2026-10-02): mature peptide 47-56 of Neuromedin-B
| — | Peptide | Made by the body | UniProt P08949 |
Neuromedin-B-32Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P08949 (read 2026-10-02): mature peptide 25-56 of Neuromedin-B
| — | Peptide | Made by the body | UniProt P08949 |
Neuromedin-SDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q5H8A3 (read 2026-10-02): mature peptide 109-141 of Neuromedin-S
| — | Peptide | Made by the body | UniProt Q5H8A3 |
Neuromedin-U-25Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P48645 (read 2026-10-02): mature peptide 142-166 of Neuromedin-U, 2 copies
| — | Peptide | Made by the body | UniProt P48645 |
NeuronostatinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P61278 (read 2026-10-02): mature peptide 31-43 of Somatostatin
| — | Peptide | Made by the body | UniProt P61278 |
Neuropeptide AFDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O15130 (read 2026-10-02): mature peptide 93-110 of Pro-FMRFamide-related neuropeptide FF
| — | Peptide | Made by the body | UniProt O15130 |
Neuropeptide B-23Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8NG41 (read 2026-10-02): mature peptide 25-48 of Neuropeptide B
| — | Peptide | Made by the body | UniProt Q8NG41 |
Neuropeptide B-29Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8NG41 (read 2026-10-02): mature peptide 25-53 of Neuropeptide B
| — | Peptide | Made by the body | UniProt Q8NG41 |
Neuropeptide BAM20Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 210-229 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
Neuropeptide BAM22Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 210-231 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
Neuropeptide BAM8-22Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 217-231 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
Neuropeptide FFDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O15130 (read 2026-10-02): mature peptide 69-76 of Pro-FMRFamide-related neuropeptide FF
| — | Peptide | Made by the body | UniProt O15130 |
Neuropeptide gamma, 1st partDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20366 (read 2026-10-02): mature peptide 72-73 of Protachykinin-1
| — | Peptide | Made by the body | UniProt P20366 |
Neuropeptide gamma, 2nd partDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20366 (read 2026-10-02): mature peptide 89-107 of Protachykinin-1
| — | Peptide | Made by the body | UniProt P20366 |
Neuropeptide KDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20366 (read 2026-10-02): mature peptide 72-107 of Protachykinin-1
| — | Peptide | Made by the body | UniProt P20366 |
Neuropeptide NPSFDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9HCQ7 (read 2026-10-02): mature peptide 56-92 of Pro-FMRFamide-related neuropeptide VF
| — | Peptide | Made by the body | UniProt Q9HCQ7 |
Neuropeptide NPVFDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9HCQ7 (read 2026-10-02): mature peptide 124-131 of Pro-FMRFamide-related neuropeptide VF
| — | Peptide | Made by the body | UniProt Q9HCQ7 |
Neuropeptide RFRP-1Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9HCQ7 (read 2026-10-02): mature peptide 81-92 of Pro-FMRFamide-related neuropeptide VF
| — | Peptide | Made by the body | UniProt Q9HCQ7 |
Neuropeptide RFRP-2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9HCQ7 (read 2026-10-02): mature peptide 101-112 of Pro-FMRFamide-related neuropeptide VF
| — | Peptide | Made by the body | UniProt Q9HCQ7 |
Neuropeptide SDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P0C0P6 (read 2026-10-02): mature peptide 70-89 of Neuropeptide S
| — | Peptide | Made by the body | UniProt P0C0P6 |
Neuropeptide SFDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O15130 (read 2026-10-02): mature peptide 66-76 of Pro-FMRFamide-related neuropeptide FF
| — | Peptide | Made by the body | UniProt O15130 |
Neuropeptide W-23Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8N729 (read 2026-10-02): mature peptide 33-55 of Neuropeptide W
| — | Peptide | Made by the body | UniProt Q8N729 |
Neuropeptide W-30Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8N729 (read 2026-10-02): mature peptide 33-62 of Neuropeptide W
| — | Peptide | Made by the body | UniProt Q8N729 |
Neuropeptide YDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01303 (read 2026-10-02): mature peptide 29-64 of Pro-neuropeptide Y
| — | Peptide | Made by the body | UniProt P01303 |
Neuropeptide-glutamic acid-isoleucineDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20382 (read 2026-10-02): mature peptide 131-143 of Pro-MCH
| — | Peptide | Made by the body | UniProt P20382 |
Neuropeptide-glycine-glutamic acidDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20382 (read 2026-10-02): mature peptide 110-128 of Pro-MCH
| — | Peptide | Made by the body | UniProt P20382 |
NeurotensinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- NT, NTS
Sources - PubMed PMID 6132085 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NT, NTS | Peptide | Status not recorded | PubMed PMID 6132085 |
Nicotinamide MononucleotideDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
Sources - PubChem CID 14180 (read 2026-10-02): PubChem title: Nicotinamide Mononucleotide
| — | Small molecule, not a peptide | Status not recorded | PubChem CID 14180 |
NisinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Nisaplin, Nisin A
Sources - PubMed PMID 18689718 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Nisaplin, Nisin A | Peptide | Status not recorded | PubMed PMID 18689718 |
NisotirostideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- LY-3457263, LY3457263, Ly3457263, Nisostirotide, Nisotirostida
Sources - ChEMBL CHEMBL5315028 (read 2026-10-02)
| LY-3457263, LY3457263, Ly3457263 | Peptide | Phase 2 | ChEMBL CHEMBL5315028 |
NociceptinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q13519 (read 2026-10-02): mature peptide 130-146 of Prepronociceptin
| — | Peptide | Made by the body | UniProt Q13519 |
NocistatinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q13519 (read 2026-10-02): mature peptide 98-127 of Prepronociceptin
| — | Peptide | Made by the body | UniProt Q13519 |
Nonapeptide-1Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 10418849 (read 2026-10-02): PubChem title: Nonapeptide-1
| — | Peptide | Status not recorded | PubChem CID 10418849 |
NoopeptDetails- Status
- Status not recorded
- Class
- Peptidomimetic
- All names
- GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester, Omberacetam
Sources - PubMed PMID 22500312 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester, Omberacetam | Peptidomimetic | Status not recorded | PubMed PMID 22500312 |
NoraramtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- BHV-1100, KP-1237, KP1237, Noraramtida
Sources - ChEMBL CHEMBL6068397 (read 2026-10-02)
| BHV-1100, KP-1237, KP1237 | Peptide | Phase 2 | ChEMBL CHEMBL6068397 |
NorleusactideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- DW 75, DW-75, Norleusactida
Sources - ChEMBL CHEMBL2103941 (read 2026-10-02)
| DW 75, DW-75, Norleusactida | Peptide | Phase 2 | ChEMBL CHEMBL2103941 |
NosiheptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- NSC-307240, Nosiheptida, RP 9671, RP-9671
Sources - ChEMBL CHEMBL2103750 (read 2026-10-02)
| NSC-307240, Nosiheptida, RP 9671 | Peptide | Phase 2 | ChEMBL CHEMBL2103750 |
NPAS3 Research PeptideDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Neuronal PAS domain protein 3 fragment
Sources - PubMed PMID 12746393 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Neuronal PAS domain protein 3 fragment | Peptide | Status not recorded | PubMed PMID 12746393 |
NPH insulin (isophane)Details- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Humulin N, NPH, Novolin N, isophane insulin
Sources - PubMed PMID 1516500 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Humulin N, NPH, Novolin N | Protein, not a peptide | Approved | PubMed PMID 1516500 |
NPPDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 27-102 of Pro-opiomelanocortin
| — | Protein, not a peptide | Made by the body | UniProt P01189 |
ObestatinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UBU3 (read 2026-10-02): mature peptide 76-98 of Appetite-regulating hormone
| — | Peptide | Made by the body | UniProt Q9UBU3 |
ObinepitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Obinepitida, TM-30338, TM30338
Sources - ChEMBL CHEMBL2108338 (read 2026-10-02)
| Obinepitida, TM-30338, TM30338 | Peptide | Phase 2 | ChEMBL CHEMBL2108338 |
OciltideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Ociltida
Sources - ChEMBL CHEMBL4297081 (read 2026-10-02)
| Ociltida | Peptide | Phase 2 | ChEMBL CHEMBL4297081 |
Octapeptide-2Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 16657324 (read 2026-10-02): PubChem title: Octapeptide-2
| — | Peptide | Status not recorded | PubChem CID 16657324 |
OctreotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1988
- INN stem
- -tide
- All names
- Bynfezia pen, CAM-2029, CAM2029, Mycapssa, Octreolin, Octreotida, Octreotide (as acetate), Octreotide acetate (preservative free), Octreotide acetate preservative free, Octreotide hydrochloride, (-)-, SMS 201-995, SMS 201-995 AC, SMS 201-995 PA, SMS PA, SMS-201-995, SMS-201-995 AC, SMS-201-995 PA, SMS-201995-AC, SMS-995, SMS-995-AAA, SMS-PA, SMS995, SMS995-AAA, Sandostatin, Sandostatin lar
Sources - ChEMBL CHEMBL1680 (read 2026-10-02)
- ChEMBL CHEMBL1200480 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL2105834 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL3545066 (read 2026-10-02): salt form, folded into this row
| Bynfezia pen, CAM-2029, CAM2029 | Peptide | Approved (1988) | ChEMBL CHEMBL1680; ChEMBL CHEMBL1200480; ChEMBL CHEMBL2105834 |
OlatorepatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Olatorepatida
Sources - ChEMBL CHEMBL6068153 (read 2026-10-02)
| Olatorepatida | Peptide | Phase 2 | ChEMBL CHEMBL6068153 |
Oligopeptide-68Details- Status
- Status not recorded
- Class
- Peptide
- All names
- H-Gly-Arg-Gly-Asp-Tyr-Ile-Trp-Ser-Leu-Asp-Thr-Gln-OH
Sources - PubChem CID 163285842 (read 2026-10-02): PubChem title: H-Gly-Arg-Gly-Asp-Tyr-Ile-Trp-Ser-Leu-Asp-Thr-Gln-OH
| H-Gly-Arg-Gly-Asp-Tyr-Ile-Trp-Ser-Leu-Asp-Thr-Gln-OH | Peptide | Status not recorded | PubChem CID 163285842 |
OmigananDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- CLS001, MBI-226, MX-594AN, Omiganan pentahydrochloride, Omigard
Sources - PubMed PMID 33010325 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CLS001, MBI-226, MX-594AN | Peptide | Status not recorded | PubMed PMID 33010325 |
OmramotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Omramotida
Sources - ChEMBL CHEMBL5314855 (read 2026-10-02)
| Omramotida | Peptide | Phase 2 | ChEMBL CHEMBL5314855 |
Onvitrelin UcalontideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin; -tide
- All names
- EP-100, EP-100 (PEPTIDE), EP100, Ep 100, Ep-100, Onvitrelina ucalontida, Onvitreline ucalontide, Ucalolictide
Sources - ChEMBL CHEMBL4297748 (read 2026-10-02)
| EP-100, EP-100 (PEPTIDE), EP100 | Peptide | Phase 2 | ChEMBL CHEMBL4297748 |
Orexin-ADetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O43612 (read 2026-10-02): mature peptide 34-66 of Hypocretin neuropeptide precursor
| — | Peptide | Made by the body | UniProt O43612 |
Orexin-BDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O43612 (read 2026-10-02): mature peptide 70-97 of Hypocretin neuropeptide precursor
| — | Peptide | Made by the body | UniProt O43612 |
OrforglipronDetails- Status
- Approved
- Class
- Small molecule, not a peptide
- Highest phase
- 4.0
- All names
- LY3502970, OWL833
Sources - PubMed PMID 40960239 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| LY3502970, OWL833 | Small molecule, not a peptide | Approved | PubMed PMID 40960239 |
OritavancinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2021
- All names
- Kimyrsa
Sources - openFDA NDA214155 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Kimyrsa | Peptide | Approved (2021) | openFDA NDA214155 |
OrnipressinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -pressin
- All names
- 8-l-ornithinevasopressin, 8-ornithinevasopressin, Orn(8)-vasopressin, Ornipresina, Ornipressine, POR 8, POR-8, Por 8 sandoz
Sources - ChEMBL CHEMBL1819440 (read 2026-10-02)
| 8-l-ornithinevasopressin, 8-ornithinevasopressin, Orn(8)-vasopressin | Peptide | Phase 2 | ChEMBL CHEMBL1819440 |
OrotirelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Cg-3509, Cg3509, Orotirelina, Orotireline
Sources - ChEMBL CHEMBL2105278 (read 2026-10-02)
| Cg-3509, Cg3509, Orotirelina | Peptide | Phase 2 | ChEMBL CHEMBL2105278 |
Orphanin FQ2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q13519 (read 2026-10-02): mature peptide 149-165 of Prepronociceptin
| — | Peptide | Made by the body | UniProt Q13519 |
OsteostatinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P12272 (read 2026-10-02): mature peptide 143-175 of Parathyroid hormone-related protein
| — | Peptide | Made by the body | UniProt P12272 |
OvagenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- EDL tripeptide, Glu-Asp-Leu
Sources - PubMed PMID 23734519 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| EDL tripeptide, Glu-Asp-Leu | Peptide | Status not recorded | PubMed PMID 23734519 |
OvemotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- (leu27)-melan-a, mart 1 (26-35), Elagigiltv, Gp100:280-288(288v) peptide, MPS-21, Mart-1:26-35(27l) peptide, Melan-a(aa26-35*a27l)), Ovemotida
Sources - ChEMBL CHEMBL263441 (read 2026-10-02)
| (leu27)-melan-a, mart 1 (26-35), Elagigiltv, Gp100:280-288(288v) peptide | Peptide | Phase 2 | ChEMBL CHEMBL263441 |
OximbomotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Oximbomotida
Sources - ChEMBL CHEMBL5314861 (read 2026-10-02)
| Oximbomotida | Peptide | Phase 2 | ChEMBL CHEMBL5314861 |
OxyntomodulinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01275 (read 2026-10-02): mature peptide 53-89 of Pro-glucagon
| — | Peptide | Made by the body | UniProt P01275 |
OxytocinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1980
- INN stem
- -tocin
- All names
- Alpha-hypophamine, Endopituitrina, Intertocine s, Orasthin, Oxitocina, Oxytocine, Oxytocinum, Pitocin, Syntocinon, Syntometrine, TNX-1900, TNX1900, TTA-121
Sources - ChEMBL CHEMBL395429 (read 2026-10-02)
- openFDA NDA018248 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
- UniProt P01178 (read 2026-10-02): mature peptide 20-28 of Oxytocin-neurophysin 1 proprotein
| Alpha-hypophamine, Endopituitrina, Intertocine s | Peptide | Approved (1980) | ChEMBL CHEMBL395429; openFDA NDA018248; UniProt P01178 |
OzarelixDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -relix
- All names
- D-63153, D63153
Sources - ChEMBL CHEMBL2108312 (read 2026-10-02)
| D-63153, D63153 | Peptide | Phase 3 | ChEMBL CHEMBL2108312 |
P21Details- Status
- Status not recorded
- Class
- Peptidomimetic
- All names
- Cerebrolysin-derived peptide 21, Cognitive enhancer peptide-21
Sources - PubMed PMID 22083255 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Cerebrolysin-derived peptide 21, Cognitive enhancer peptide-21 | Peptidomimetic | Status not recorded | PubMed PMID 22083255 |
PACAPDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- PACAP-27, PACAP-38, PACAP38, Pituitary adenylate cyclase-activating polypeptide
Sources - PubMed PMID 40229719 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| PACAP-27, PACAP-38, PACAP38 | Peptide | Status not recorded | PubMed PMID 40229719 |
PACAP-related peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P18509 (read 2026-10-02): mature peptide 82-129 of Pituitary adenylate cyclase-activating polypeptide, 2 copies
| — | Peptide | Made by the body | UniProt P18509 |
Pal-GHKDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Pal-Gly-His-Lys, Palmitoyl Oligopeptide, Palmitoyl Tripeptide-1
Sources - PubMed PMID 20729942 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Pal-Gly-His-Lys, Palmitoyl Oligopeptide, Palmitoyl Tripeptide-1 | Peptide | Status not recorded | PubMed PMID 20729942 |
Palmitoyl Dipeptide-5 Diaminobutyroyl HydroxythreonineDetails- Status
- Status not recorded
- Class
- Peptide conjugate
- All names
- Palmitoyllysylvalyldiaminobutyroylthreonine
Sources - PubChem CID 72941935 (read 2026-10-02): PubChem title: Palmitoyllysylvalyldiaminobutyroylthreonine
| Palmitoyllysylvalyldiaminobutyroylthreonine | Peptide conjugate | Status not recorded | PubChem CID 72941935 |
Palmitoyl Hexapeptide-12Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Biopeptide EL, Elastin spring-fragment peptide, Pal-VGVAPG, Pal-Val-Gly-Val-Ala-Pro-Gly
Sources - PubMed PMID 6903189 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Biopeptide EL, Elastin spring-fragment peptide, Pal-VGVAPG | Peptide | Status not recorded | PubMed PMID 6903189 |
Palmitoyl Pentapeptide-4Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Matrixyl, Pal-KTTKS
Sources - PubMed PMID 18492182 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Matrixyl, Pal-KTTKS | Peptide | Status not recorded | PubMed PMID 18492182 |
Palmitoyl Tetrapeptide-10Details- Status
- Status not recorded
- Class
- Peptide conjugate
Sources - PubChem CID 24967468 (read 2026-10-02): PubChem title: Palmitoyl tetrapeptide-10
| — | Peptide conjugate | Status not recorded | PubChem CID 24967468 |
Palmitoyl Tetrapeptide-7Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Pal-GQPR, Pal-Gly-Gln-Pro-Arg, Palmitoyl Tetrapeptide-3, Rigin, Rigin Palmitoyl
Sources - PubMed PMID 7309346 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Pal-GQPR, Pal-Gly-Gln-Pro-Arg, Palmitoyl Tetrapeptide-3 | Peptide | Status not recorded | PubMed PMID 7309346 |
Palmitoyl Tripeptide-38Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Matrixyl S6, Matrixyl Synthe'6, Pal-KMO2K, Pal-Lys-Met(O2)-Lys
Sources - PubMed PMID 33195061 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Matrixyl S6, Matrixyl Synthe'6, Pal-KMO2K | Peptide | Status not recorded | PubMed PMID 33195061 |
Palmitoyl Tripeptide-5Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Pal-KVK, Pal-Lys-Val-Lys, SYN-COLL, Syn-Coll
Sources - PubMed PMID 10708953 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Pal-KVK, Pal-Lys-Val-Lys, SYN-COLL | Peptide | Status not recorded | PubMed PMID 10708953 |
PalopegteriparatideDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2023
- INN stem
- -peg-; -tide
- All names
- ACP-014, Mpeg 40000-teriparatide, TransCon PTH, Transcon pth (1-34), Yorvipath
Sources - ChEMBL CHEMBL5095475 (read 2026-10-02)
| ACP-014, Mpeg 40000-teriparatide, TransCon PTH | Peptide conjugate | Approved (2023) | ChEMBL CHEMBL5095475 |
PaluratideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Paluratida
Sources - ChEMBL CHEMBL6068161 (read 2026-10-02)
| Paluratida | Peptide | Phase 2 | ChEMBL CHEMBL6068161 |
PancragenDetails- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 18642713 (read 2026-10-02): earliest PubMed record naming Pancragen in its title (2007): Effect of pancragen on blood glucose level, capillary permeability and adhesion in rats with experimental diabetes melli
| — | Peptide | Status not recorded | PubMed PMID 18642713 |
Pancreatic icosapeptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01298 (read 2026-10-02): mature peptide 69-88 of Pancreatic polypeptide prohormone
| — | Peptide | Made by the body | UniProt P01298 |
Pancreatic PolypeptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Human pancreatic polypeptide, Pancreatic hormone iii, Pancreatic polypeptide (human), Pancreatic polypeptide human
Sources - ChEMBL CHEMBL4540843 (read 2026-10-02)
- UniProt P01298 (read 2026-10-02): mature peptide 30-65 of Pancreatic polypeptide prohormone
| Human pancreatic polypeptide, Pancreatic hormone iii, Pancreatic polypeptide (human) | Peptide | Phase 2 | ChEMBL CHEMBL4540843; UniProt P01298 |
PareptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AY-24,856, AY-24856, Pareptida
Sources - ChEMBL CHEMBL2111011 (read 2026-10-02)
- ChEMBL CHEMBL2107041 (read 2026-10-02): salt form, folded into this row
| AY-24,856, AY-24856, Pareptida | Peptide | Phase 2 | ChEMBL CHEMBL2111011; ChEMBL CHEMBL2107041 |
PasireotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2012
- INN stem
- -tide
- All names
- PASIREOTIDE DIASPARTATE, Pasireotida, Pasireotide (as diaspartate), Pasireotide diaspartate, SOM 230, SOM-230, SOM-230 PAMOATE, SOM230, SOM230 PAMOATE, Signifor, Signifor lar, Signifor lar kit
Sources - ChEMBL CHEMBL3349607 (read 2026-10-02)
- ChEMBL CHEMBL5314380 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL5314382 (read 2026-10-02): salt form, folded into this row
| PASIREOTIDE DIASPARTATE, Pasireotida, Pasireotide (as diaspartate) | Peptide | Approved (2012) | ChEMBL CHEMBL3349607; ChEMBL CHEMBL5314380; ChEMBL CHEMBL5314382 |
PB-718Details- Status
- Status not recorded
- Class
- Peptide
Sources - ClinicalTrials.gov NCT05021666 (read 2026-10-02): trial registration cited on the encyclopedia entry
| — | Peptide | Status not recorded | ClinicalTrials.gov NCT05021666 |
PE-22-28Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 20405001 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| — | Peptide | Status not recorded | PubMed PMID 20405001 |
PeforelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Gnrh iii, Lamprey lh-rh iii, Maprelin xp10, Peforelina, Peforeline
Sources - ChEMBL CHEMBL2108043 (read 2026-10-02)
| Gnrh iii, Lamprey lh-rh iii, Maprelin xp10 | Peptide | Phase 2 | ChEMBL CHEMBL2108043 |
PEG-MGFDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- PEG Mechano Growth Factor, PEGylated mechano-growth factor, Pegylated MGF
Sources - PubMed PMID 16024511 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| PEG Mechano Growth Factor, PEGylated mechano-growth factor, Pegylated MGF | Peptide | Status not recorded | PubMed PMID 16024511 |
PegapamodutideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- peg-; -tide
- All names
- LY-2944876, LY2944876, Pegapamodutida
Sources - ChEMBL CHEMBL3990012 (read 2026-10-02)
| LY-2944876, LY2944876, Pegapamodutida | Peptide conjugate | Phase 2 | ChEMBL CHEMBL3990012 |
PegcetacoplanDetails- Status
- Approved
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2021
- All names
- Empaveli, Syfovre
Sources - openFDA NDA215014 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Empaveli, Syfovre | Peptide conjugate | Approved (2021) | openFDA NDA215014 |
PeginesatideDetails- Status
- Withdrawn
- Class
- Peptide conjugate
- Highest phase
- 4.0
- First approval
- 2012
- INN stem
- peg-; -tide
- All names
- AF 37702 ACETATE, AF-37702, AF-37702 ACETATE, AF37702, AF37702 ACETATE, Hematide, Hematide acetate, Omontys, Omontys preservative free, Peginesatida
Sources - ChEMBL CHEMBL2107866 (read 2026-10-02)
- ChEMBL CHEMBL1963684 (read 2026-10-02): salt form, folded into this row
| AF 37702 ACETATE, AF-37702, AF-37702 ACETATE | Peptide conjugate | Withdrawn | ChEMBL CHEMBL2107866; ChEMBL CHEMBL1963684 |
PegloprastideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- peg-; -tide
- All names
- AVB-620, AVB620
Sources - ChEMBL CHEMBL5095310 (read 2026-10-02)
| AVB-620, AVB620 | Peptide conjugate | Phase 2 | ChEMBL CHEMBL5095310 |
PegloxenatideDetails- Status
- Phase 1
- Class
- Peptide conjugate
- Highest phase
- 1.0
- INN stem
- peg-; -tide
- All names
- PEX-168, PEX168, Peg-40 kd-loxenatide, Pex168
Sources - ChEMBL CHEMBL4802213 (read 2026-10-02)
| PEX-168, PEX168, Peg-40 kd-loxenatide | Peptide conjugate | Phase 1 | ChEMBL CHEMBL4802213 |
PegmispotideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- peg-; -tide
- All names
- BT-051, BT051, Pegmispotida
Sources - ChEMBL CHEMBL5314863 (read 2026-10-02)
| BT-051, BT051, Pegmispotida | Peptide conjugate | Phase 2 | ChEMBL CHEMBL5314863 |
PegsebrenatideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- peg-; -tide
- All names
- NLY-01, NLY01, Nly-01, Nly01, Pegsebrenatida
Sources - ChEMBL CHEMBL4650495 (read 2026-10-02)
| NLY-01, NLY01, Nly-01 | Peptide conjugate | Phase 2 | ChEMBL CHEMBL4650495 |
PegvisomantDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- B2036-PEG, Somavert
Sources - PubMed PMID 10770982 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| B2036-PEG, Somavert | Protein, not a peptide | Approved | PubMed PMID 10770982 |
PemvidutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ALT-801, MD-1373, Pemvidutida, SP-1373
Sources - ChEMBL CHEMBL5095142 (read 2026-10-02)
| ALT-801, MD-1373, Pemvidutida | Peptide | Phase 2 | ChEMBL CHEMBL5095142 |
PENDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9UHG2 (read 2026-10-02): mature peptide 221-242 of ProSAAS
| — | Peptide | Made by the body | UniProt Q9UHG2 |
PendetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Gyk-dtpa, Pendetida
Sources - ChEMBL CHEMBL2108754 (read 2026-10-02)
| Gyk-dtpa, Pendetida | Peptide | Phase 2 | ChEMBL CHEMBL2108754 |
PENK(114-133)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 114-133 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
PENK(143-183)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 143-183 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
PENK(237-258)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 237-258 of Proenkephalin-A
| — | Peptide | Made by the body | UniProt P01210 |
PentagastrinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1974
- All names
- AY-6608, ICI 50,123, ICI-50123, NSC-367746, Pentagastrina, Pentagastrine, Peptavlon
Sources - ChEMBL CHEMBL1328 (read 2026-10-02)
| AY-6608, ICI 50,123, ICI-50123 | Peptide | Approved (1974) | ChEMBL CHEMBL1328 |
Pentapeptide-3Details- Status
- Status not recorded
- Class
- Peptide
- All names
- GPRPA, Gly-Pro-Arg-Pro-Ala-NH2, Pentapeptide-3V, Vialox
Sources - PubMed PMID 9305882 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| GPRPA, Gly-Pro-Arg-Pro-Ala-NH2, Pentapeptide-3V | Peptide | Status not recorded | PubMed PMID 9305882 |
PentetreotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- (-)-pentetoreotide, DTPA-SMS, Pentetoreotide, Pentetreotida, SDZ 215-811, SDZ 215-811S, SDZ-215-811, SDZ-215-811S, SDZ-215811
Sources - ChEMBL CHEMBL2108757 (read 2026-10-02)
| (-)-pentetoreotide, DTPA-SMS, Pentetoreotide | Peptide | Phase 3 | ChEMBL CHEMBL2108757 |
PentigetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Asp-ser-asp-pro-arg, HEP-P, HEPP, Human ige pentapeptide, IGE PENTAPEPTIDE, PENTAPEPTIDE DSDPR, PENTAPEPTIDE-DSDPR, Pentigetida, Pentyde
Sources - ChEMBL CHEMBL2304033 (read 2026-10-02)
| Asp-ser-asp-pro-arg, HEP-P, HEPP | Peptide | Phase 2 | ChEMBL CHEMBL2304033 |
PEPITEMDetails- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 32169847 (read 2026-10-02): earliest PubMed record naming PEPITEM in its title (2020): PEPITEM/Cadherin 15 Axis Inhibits T Lymphocyte Infiltration and Glomerulonephritis in a Mouse Model of Systemic Lupus Er
| — | Peptide | Status not recorded | PubMed PMID 32169847 |
Peptide B27pdDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- Alnedlsswtaadt, Amino acids 125-138 of hla-b, B-27PD, B27PD, B27pd, Optiquel
Sources - ChEMBL CHEMBL4297903 (read 2026-10-02)
| Alnedlsswtaadt, Amino acids 125-138 of hla-b, B-27PD | Peptide | Phase 1 | ChEMBL CHEMBL4297903 |
Peptide TDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL180971 (read 2026-10-02)
| — | Peptide | Phase 2 | ChEMBL CHEMBL180971 |
Peptide YYDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Gt-001, Human peptide yy (3-36), Peptide yy (3-36), Pyy 3-36, Pyy(3-36), Pyy3-36
Sources - ChEMBL CHEMBL4297971 (read 2026-10-02)
- UniProt P10082 (read 2026-10-02): mature peptide 29-64 of Peptide YY
| Gt-001, Human peptide yy (3-36), Peptide yy (3-36) | Peptide | Phase 2 | ChEMBL CHEMBL4297971; UniProt P10082 |
PetrelintideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Petrelintida, ZP-8396, Zp8396
Sources - ChEMBL CHEMBL5314864 (read 2026-10-02)
| Petrelintida, ZP-8396, Zp8396 | Peptide | Phase 2 | ChEMBL CHEMBL5314864 |
PexigananDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Locilex, MSI-78
Sources - PubMed PMID 18990064 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Locilex, MSI-78 | Peptide | Status not recorded | PubMed PMID 18990064 |
PezadeftideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Pezadeftida
Sources - ChEMBL CHEMBL5095144 (read 2026-10-02)
| Pezadeftida | Peptide | Phase 2 | ChEMBL CHEMBL5095144 |
PimelautideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Pimelautida
Sources - ChEMBL CHEMBL3989437 (read 2026-10-02)
| Pimelautida | Peptide | Phase 2 | ChEMBL CHEMBL3989437 |
PinealonDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- EDR tripeptide, Glu-Asp-Arg
Sources - PubMed PMID 21978084 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| EDR tripeptide, Glu-Asp-Arg | Peptide | Status not recorded | PubMed PMID 21978084 |
Pituitary adenylate cyclase-activating polypeptide 27Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P18509 (read 2026-10-02): mature peptide 132-158 of Pituitary adenylate cyclase-activating polypeptide, 2 copies
| — | Peptide | Made by the body | UniProt P18509 |
Pituitary adenylate cyclase-activating polypeptide 38Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P18509 (read 2026-10-02): mature peptide 132-169 of Pituitary adenylate cyclase-activating polypeptide, 2 copies
| — | Peptide | Made by the body | UniProt P18509 |
PlecanatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2017
- INN stem
- -tide
- All names
- Guanilib, Plecanatida, SP-304, SP-304 (SYNERGY), Trulance
Sources - ChEMBL CHEMBL2103867 (read 2026-10-02)
| Guanilib, Plecanatida, SP-304 | Peptide | Approved (2017) | ChEMBL CHEMBL2103867 |
PNC-27Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 20080680 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| — | Peptide | Status not recorded | PubMed PMID 20080680 |
PobrolitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Pobrolitida
Sources - ChEMBL CHEMBL5314865 (read 2026-10-02)
| Pobrolitida | Peptide | Phase 2 | ChEMBL CHEMBL5314865 |
Polymyxin BDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1983
- All names
- Bacitracin Zinc And Polymyxin B Sulfate, Dexasporin, Maxitrol, Neomycin And Polymyxin B Sulfate, Neomycin And Polymyxin B Sulfates And Bacitracin Zinc, Neomycin And Polymyxin B Sulfates And Dexamethasone, Neomycin And Polymyxin B Sulfates And Gramicidin, Neomycin And Polymyxin B Sulfates And Hydrocortisone, Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone, Oticair, Trimethoprim Sulfate And Polymyxin B Sulfate
Sources - openFDA ANDA062423 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Bacitracin Zinc And Polymyxin B Sulfate, Dexasporin, Maxitrol | Peptide | Approved (1983) | openFDA ANDA062423 |
PosatirelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Posatirelina, Posatireline
Sources - ChEMBL CHEMBL2105243 (read 2026-10-02)
| Posatirelina, Posatireline | Peptide | Phase 2 | ChEMBL CHEMBL2105243 |
Potential peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01189 (read 2026-10-02): mature peptide 105-134 of Pro-opiomelanocortin
| — | Peptide | Made by the body | UniProt P01189 |
pr1 Leukemia Peptide VaccineDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Pr1 vac, Proteinase 3 pr1 peptide
Sources - ChEMBL CHEMBL4297811 (read 2026-10-02)
| Pr1 vac, Proteinase 3 pr1 peptide | Peptide | Phase 3 | ChEMBL CHEMBL4297811 |
PramlintideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2005
- INN stem
- -tide
- All names
- AC-0137, AC-137, AC0-137, AC0137, AC137, Pramlintida, Pramlintide acetate anhydrous, Symlin, Symlinpen, Tripro-amylin, Tripro-amylin acetate, Tripro-amylin acetate hydrate
Sources - ChEMBL CHEMBL2103758 (read 2026-10-02)
- ChEMBL CHEMBL3833353 (read 2026-10-02): salt form, folded into this row
| AC-0137, AC-137, AC0-137 | Peptide | Approved (2005) | ChEMBL CHEMBL2103758; ChEMBL CHEMBL3833353 |
PrazarelixDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relix
- All names
- Azaline b, RWJ 47428, RWJ-47428, RWJ47428
Sources - ChEMBL CHEMBL409018 (read 2026-10-02)
- ChEMBL CHEMBL2105773 (read 2026-10-02): salt form, folded into this row
| Azaline b, RWJ 47428, RWJ-47428 | Peptide | Phase 2 | ChEMBL CHEMBL409018; ChEMBL CHEMBL2105773 |
PreptinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01344 (read 2026-10-02): mature peptide 93-126 of Insulin-like growth factor 2
| — | Peptide | Made by the body | UniProt P01344 |
Proadrenomedullin 9-20 terminal peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P35318 (read 2026-10-02): mature peptide 30-41 of Pro-adrenomedullin
| — | Peptide | Made by the body | UniProt P35318 |
Proadrenomedullin N-20 terminal peptideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P35318 (read 2026-10-02): mature peptide 22-41 of Pro-adrenomedullin
| — | Peptide | Made by the body | UniProt P35318 |
proBNP(3-108)Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P16860 (read 2026-10-02): mature peptide 29-134 of Natriuretic peptides B
| — | Protein, not a peptide | Made by the body | UniProt P16860 |
Processed OsteocrinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P61366 (read 2026-10-02): mature peptide 83-132 of Osteocrin
| — | Peptide | Made by the body | UniProt P61366 |
Prolactin-releasing peptide PrRP20Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P81277 (read 2026-10-02): mature peptide 34-53 of Prolactin-releasing peptide
| — | Peptide | Made by the body | UniProt P81277 |
Prolactin-releasing peptide PrRP31Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P81277 (read 2026-10-02): mature peptide 23-53 of Prolactin-releasing peptide
| — | Peptide | Made by the body | UniProt P81277 |
ProstamaxDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- KEDP tetrapeptide, Prostagen, Prostate peptide bioregulator
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KEDP tetrapeptide, Prostagen, Prostate peptide bioregulator | Peptide | Status not recorded | PubMed PMID 19830585 |
ProtirelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1976
- INN stem
- -relin
- All names
- 5-oxo-pro-his-pro-nh2, A-38579, ABBOTT-38579, Lopremone, NSC-760113, Protirelin, synthetic, Protirelina, Protireline, Relefact trh, SYNTHETIC TRH, Thypinone, Thyrel trh, Thyroid releasing hormone, Thyroliberin, Thyrotropin releasing hormone, Thyrotropin-releasing factor, Thyrotropin-releasing hormone, Trh, Trh-cambridge
Sources - ChEMBL CHEMBL1472 (read 2026-10-02)
- UniProt P20396 (read 2026-10-02): mature peptide 84-86 of Pro-thyrotropin-releasing hormone, 6 copies
| 5-oxo-pro-his-pro-nh2, A-38579, ABBOTT-38579 | Peptide | Approved (1976) | ChEMBL CHEMBL1472; UniProt P20396 |
ProxeninDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P53621 (read 2026-10-02): mature peptide 1-35 of Coatomer subunit alpha
| — | Peptide | Made by the body | UniProt P53621 |
PT-141Details- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2019
- INN stem
- -tide
- All names
- Bremelanotida, PT 141, PT-141, PT-141 FREE BASE, Vyleesi, Vyleesi (autoinjector)
Sources - ChEMBL CHEMBL2070241 (read 2026-10-02)
- ChEMBL CHEMBL4297533 (read 2026-10-02): salt form, folded into this row
| Bremelanotida, PT 141, PT-141 | Peptide | Approved (2019) | ChEMBL CHEMBL2070241; ChEMBL CHEMBL4297533 |
PTD-DBMDetails- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 176453931 (read 2026-10-02): PubChem title: Ptd-dbm
| — | Peptide | Status not recorded | PubChem CID 176453931 |
PTHrP[1-36]Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P12272 (read 2026-10-02): mature peptide 37-72 of Parathyroid hormone-related protein
| — | Peptide | Made by the body | UniProt P12272 |
PTHrP[38-94]Details- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P12272 (read 2026-10-02): mature peptide 74-130 of Parathyroid hormone-related protein
| — | Protein, not a peptide | Made by the body | UniProt P12272 |
QRF-amideDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P83859 (read 2026-10-02): mature peptide 91-133 of Orexigenic neuropeptide QRFP
| — | Peptide | Made by the body | UniProt P83859 |
QuazomotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Quazomotida, Wt-1 427 long, Wt1-427 long
Sources - ChEMBL CHEMBL5314767 (read 2026-10-02)
| Quazomotida, Wt-1 427 long, Wt1-427 long | Peptide | Phase 2 | ChEMBL CHEMBL5314767 |
RamorelixDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relix
Sources - ChEMBL CHEMBL3989808 (read 2026-10-02)
| — | Peptide | Phase 2 | ChEMBL CHEMBL3989808 |
RavatirelinDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -relin
Sources - ChEMBL CHEMBL2108306 (read 2026-10-02)
| — | Peptide | Status not recorded | ChEMBL CHEMBL2108306 |
RecanaclotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- IW-9179, Recanaclotida
Sources - ChEMBL CHEMBL3707244 (read 2026-10-02)
| IW-9179, Recanaclotida | Peptide | Phase 2 | ChEMBL CHEMBL3707244 |
RedasemtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- S-005151
Sources - ChEMBL CHEMBL6068588 (read 2026-10-02)
| S-005151 | Peptide | Phase 2 | ChEMBL CHEMBL6068588 |
Regular human insulinDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Humulin R, Humulin R U-500, Myxredlin, Novolin R
Sources - PubMed PMID 25813411 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Humulin R, Humulin R U-500, Myxredlin | Protein, not a peptide | Approved | PubMed PMID 25813411 |
RelamorelinDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -relin
- All names
- BIM-28131, BIM28131, Relamorelina, Relamoreline
Sources - ChEMBL CHEMBL4297525 (read 2026-10-02)
| BIM-28131, BIM28131, Relamorelina | Peptide | Phase 3 | ChEMBL CHEMBL4297525 |
Relaxin A chain (RLN1)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P04808 (read 2026-10-02): mature peptide 163-185 of Prorelaxin H1
| — | Peptide | Made by the body | UniProt P04808 |
Relaxin A chain (RLN2)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P04090 (read 2026-10-02): mature peptide 162-185 of Prorelaxin H2
| — | Peptide | Made by the body | UniProt P04090 |
Relaxin B chain (RLN1)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P04808 (read 2026-10-02): mature peptide 23-53 of Prorelaxin H1
| — | Peptide | Made by the body | UniProt P04808 |
Relaxin B chain (RLN2)Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P04090 (read 2026-10-02): mature peptide 25-53 of Prorelaxin H2
| — | Peptide | Made by the body | UniProt P04090 |
Relaxin-3 A chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8WXF3 (read 2026-10-02): mature peptide 119-142 of Relaxin-3
| — | Peptide | Made by the body | UniProt Q8WXF3 |
Relaxin-3 B chainDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8WXF3 (read 2026-10-02): mature peptide 26-52 of Relaxin-3
| — | Peptide | Made by the body | UniProt Q8WXF3 |
RelugolixDetails- Status
- Approved
- Class
- Small molecule, not a peptide
- Highest phase
- 4.0
- All names
- Orgovyx, Relumina, TAK-385
Sources - PubMed PMID 32469183 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Orgovyx, Relumina, TAK-385 | Small molecule, not a peptide | Approved | PubMed PMID 32469183 |
RetatrutideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- LY-3437943, LY3437943
Sources - ChEMBL CHEMBL5095485 (read 2026-10-02)
| LY-3437943, LY3437943 | Peptide | Phase 3 | ChEMBL CHEMBL5095485 |
RezafunginDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2023
- All names
- Rezzayo
Sources - openFDA NDA217417 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Rezzayo | Peptide | Approved (2023) | openFDA NDA217417 |
RimorphinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01213 (read 2026-10-02): mature peptide 226-238 of Proenkephalin-B
| — | Peptide | Made by the body | UniProt P01213 |
RimtoregtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Rimtoregtida
Sources - ChEMBL CHEMBL5095151 (read 2026-10-02)
| Rimtoregtida | Peptide | Phase 2 | ChEMBL CHEMBL5095151 |
RismorelinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- Rismorelina, Rismoreline
Sources - ChEMBL CHEMBL2108294 (read 2026-10-02)
| Rismorelina, Rismoreline | Peptide | Phase 2 | ChEMBL CHEMBL2108294 |
Rismorelin PorcineDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -relin
- All names
- Rismorelin
Sources - ChEMBL CHEMBL2108761 (read 2026-10-02)
| Rismorelin | Peptide | Status not recorded | ChEMBL CHEMBL2108761 |
RolipoltideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Rolipoltida
Sources - ChEMBL CHEMBL2108284 (read 2026-10-02)
| Rolipoltida | Peptide | Phase 2 | ChEMBL CHEMBL2108284 |
RomiplostimDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- AMG 531, Nplate, TPO mimetic peptibody
Sources - PubMed PMID 18242413 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| AMG 531, Nplate, TPO mimetic peptibody | Protein, not a peptide | Approved | PubMed PMID 18242413 |
RomurtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Nopia, Romurtida
Sources - ChEMBL CHEMBL1908331 (read 2026-10-02)
| Nopia, Romurtida | Peptide | Phase 2 | ChEMBL CHEMBL1908331 |
RotigaptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- GAP (WYETH), Rotigaptida, ZP-123, ZP-123 (ZEALAND)
Sources - ChEMBL CHEMBL450656 (read 2026-10-02)
| GAP (WYETH), Rotigaptida, ZP-123 | Peptide | Phase 2 | ChEMBL CHEMBL450656 |
RovatirelinDetails- Status
- Phase 3
- Class
- Peptidomimetic
- Highest phase
- 3.0
- INN stem
- -relin
- All names
- KPS-0373, Kps-0373, Rovatirelina, Rovatireline, S-0373
Sources - ChEMBL CHEMBL4297622 (read 2026-10-02)
| KPS-0373, Kps-0373, Rovatirelina | Peptidomimetic | Phase 3 | ChEMBL CHEMBL4297622 |
RugecitideDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- LY-3461767, LY3461767, Ly3461767
Sources - ChEMBL CHEMBL6068616 (read 2026-10-02)
| LY-3461767, LY3461767, Ly3461767 | Peptide | Phase 1 | ChEMBL CHEMBL6068616 |
RusalatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -sal-; -tide
- All names
- Chrysalin, Rusalatida, Rusalatide acetate (3:2), TP 508, TP-508, TP-508 ACETATE, TRAP-508, TRAP-508 ACETATE, Tp508
Sources - ChEMBL CHEMBL2111105 (read 2026-10-02)
- ChEMBL CHEMBL2107369 (read 2026-10-02): salt form, folded into this row
| Chrysalin, Rusalatida, Rusalatide acetate (3:2) | Peptide | Phase 2 | ChEMBL CHEMBL2111105; ChEMBL CHEMBL2107369 |
RusfertideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- PTG-300, PTG-300 ACETATE, PTG-300FB, PTG300 ACETATE, Ptg-300
Sources - ChEMBL CHEMBL4650270 (read 2026-10-02)
- ChEMBL CHEMBL4650507 (read 2026-10-02): separate ChEMBL record of the same molecule
| PTG-300, PTG-300 ACETATE, PTG-300FB | Peptide | Phase 3 | ChEMBL CHEMBL4650270; ChEMBL CHEMBL4650507 |
RuxotemitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Kkwwkkw-.beta.-phenyl-fk-nh2, Kkwwkkwdipk-nh2, Ltx 315, Ltx-315, Oncopore, Ruxotemitida
Sources - ChEMBL CHEMBL4297628 (read 2026-10-02)
| Kkwwkkw-.beta.-phenyl-fk-nh2, Kkwwkkwdipk-nh2, Ltx 315 | Peptide | Phase 2 | ChEMBL CHEMBL4297628 |
Salusin-alphaDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8N2E6 (read 2026-10-02): mature peptide 214-241 of Prosalusin
| — | Peptide | Made by the body | UniProt Q8N2E6 |
Salusin-betaDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q8N2E6 (read 2026-10-02): mature peptide 192-211 of Prosalusin
| — | Peptide | Made by the body | UniProt Q8N2E6 |
Satoreotide TetraxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- DOTA-JR-11, Dota satoreotide, Satoreotida tetraxetan, Satoreotide dota
Sources - ChEMBL CHEMBL4297531 (read 2026-10-02)
| DOTA-JR-11, Dota satoreotide, Satoreotida tetraxetan | Peptide | Phase 2 | ChEMBL CHEMBL4297531 |
Satoreotide TrizoxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- JR-11-NODAGA, NODAGA-JR11, OPS-202, Ops202, Satoreotida trizoxetan
Sources - ChEMBL CHEMBL4297532 (read 2026-10-02)
| JR-11-NODAGA, NODAGA-JR11, OPS-202 | Peptide | Phase 2 | ChEMBL CHEMBL4297532 |
SecretinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2004
- All names
- Chirhostim
Sources - openFDA NDA021256 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
- UniProt P09683 (read 2026-10-02): mature peptide 28-54 of Secretin
| Chirhostim | Peptide | Approved (2004) | openFDA NDA021256; UniProt P09683 |
SeglitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- L-363586, MK-678, Seglitida
Sources - ChEMBL CHEMBL311695 (read 2026-10-02)
- ChEMBL CHEMBL2103887 (read 2026-10-02): salt form, folded into this row
| L-363586, MK-678, Seglitida | Peptide | Phase 2 | ChEMBL CHEMBL311695; ChEMBL CHEMBL2103887 |
SelankDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- TP-7, threonyl-lysyl-prolyl-arginyl-prolyl-glycyl-proline
Sources - PubMed PMID 18454096 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| TP-7, threonyl-lysyl-prolyl-arginyl-prolyl-glycyl-proline | Peptide | Status not recorded | PubMed PMID 18454096 |
SelcopintideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Selcopintida
Sources - ChEMBL CHEMBL5095083 (read 2026-10-02)
| Selcopintida | Peptide | Phase 2 | ChEMBL CHEMBL5095083 |
SelepressinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -pressin
- All names
- FE 202158, FE-202158, FE202158, Fe-202158, Selepresina, Selepressine
Sources - ChEMBL CHEMBL1817709 (read 2026-10-02)
| FE 202158, FE-202158, FE202158 | Peptide | Phase 2 | ChEMBL CHEMBL1817709 |
SemaglutideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2017
- INN stem
- -tide
- All names
- NN-9535, NN9535, NNC 0113-0217, NNC-0113-0217, Nn9535, Ozempic, Rybelsus, Semaglutida, Semaglutide component of cagrisema, Semaglutide component of nn1535 icosema, Semaglutide component of nn1535 laisema, Wegovy
Sources - ChEMBL CHEMBL2108724 (read 2026-10-02)
| NN-9535, NN9535, NNC 0113-0217 | Peptide | Approved (2017) | ChEMBL CHEMBL2108724 |
SemaxDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- ACTH(4-7)PGP, methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline
Sources - PubMed PMID 16635254 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| ACTH(4-7)PGP, methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline | Peptide | Status not recorded | PubMed PMID 16635254 |
SemparatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- RO 106-6271/297, RO 70-0001/001, RO-106-6271/297, RO-1066271297, RO-70-0001/001, RO-700001001, RS-66271, RS-66271-297, Semparatida
Sources - ChEMBL CHEMBL2103974 (read 2026-10-02)
- ChEMBL CHEMBL2108879 (read 2026-10-02): separate ChEMBL record of the same molecule
| RO 106-6271/297, RO 70-0001/001, RO-106-6271/297 | Peptide | Phase 2 | ChEMBL CHEMBL2103974; ChEMBL CHEMBL2108879 |
SeractideDetails- Status
- Withdrawn
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1978
- INN stem
- -tide
Sources - ChEMBL CHEMBL1201489 (read 2026-10-02)
| — | Peptide | Withdrawn | ChEMBL CHEMBL1201489 |
SermorelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1990
- INN stem
- -relin
- All names
- Geref, Groliberin, Sermorelina, Sermoreline
Sources - ChEMBL CHEMBL1201490 (read 2026-10-02)
| Geref, Groliberin, Sermorelina | Peptide | Approved (1990) | ChEMBL CHEMBL1201490 |
SetmelanotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2020
- INN stem
- -tide
- All names
- BIM-22493, Imcivree, RM-493, RM-493 ACETATE, Setmelanotida
Sources - ChEMBL CHEMBL3301624 (read 2026-10-02)
- ChEMBL CHEMBL4650273 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL4594386 (read 2026-10-02): separate ChEMBL record of the same molecule
| BIM-22493, Imcivree, RM-493 | Peptide | Approved (2020) | ChEMBL CHEMBL3301624; ChEMBL CHEMBL4650273; ChEMBL CHEMBL4594386 |
SHLP2Details- Status
- Status not recorded
- Class
- Peptide
- All names
- MT-RNR2-derived SHLP2, Small humanin-like peptide 2
Sources - PubMed PMID 27070352 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| MT-RNR2-derived SHLP2, Small humanin-like peptide 2 | Peptide | Status not recorded | PubMed PMID 27070352 |
SHLP6Details- Status
- Status not recorded
- Class
- Peptide
- All names
- MT-RNR2-derived SHLP6, Small humanin-like peptide 6
Sources - PubMed PMID 27070352 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| MT-RNR2-derived SHLP6, Small humanin-like peptide 6 | Peptide | Status not recorded | PubMed PMID 27070352 |
SinapultideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ATI 01, ATI-01, KL-4, KL4, Kl4 peptide, PEPTIDE KL-4, PEPTIDE KL4, RWJ-45652, Sinapultida
Sources - ChEMBL CHEMBL2103901 (read 2026-10-02)
| ATI 01, ATI-01, KL-4 | Peptide | Phase 2 | ChEMBL CHEMBL2103901 |
SLU-PP-332Details- Status
- Status not recorded
- Class
- Small molecule, not a peptide
Sources - PubChem CID 5338394 (read 2026-10-02): PubChem title: Slu-PP-332
| — | Small molecule, not a peptide | Status not recorded | PubChem CID 5338394 |
SolnatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- AP-301, AP301, Ap-301, Ap301, Solnatida
Sources - ChEMBL CHEMBL4297885 (read 2026-10-02)
| AP-301, AP301, Ap-301 | Peptide | Phase 2 | ChEMBL CHEMBL4297885 |
SomapacitanDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- NN8640, Sogroya, somapacitan-beco
Sources - PubMed PMID 36062966 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NN8640, Sogroya, somapacitan-beco | Protein, not a peptide | Approved | PubMed PMID 36062966 |
SomatorelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- INN stem
- -relin; som-
- All names
- Esfarase, Ghrh ferring, Ghrh(1-44) amide, Ghrh(1-44)nh2, Grf 1-44, Somatocrinin, Somatoliberin, Somatoliberin (human), Somatoliberin, human, Somatorelina, Somatoreline, Sr 95228, Sr-95228
Sources - ChEMBL CHEMBL2108862 (read 2026-10-02)
| Esfarase, Ghrh ferring, Ghrh(1-44) amide | Peptide | Approved | ChEMBL CHEMBL2108862 |
SomatostatinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P61278 (read 2026-10-02): mature peptide 103-116 of Somatostatin
| — | Peptide | Made by the body | UniProt P61278 |
Somatostatin-28Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P61278 (read 2026-10-02): mature peptide 89-116 of Somatostatin
| — | Peptide | Made by the body | UniProt P61278 |
SomatrogonDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- CTP-modified hGH, MOD-4023, Ngenla, OPK-88003, somatrogon-ghla
Sources - PubMed PMID 35405011 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| CTP-modified hGH, MOD-4023, Ngenla | Protein, not a peptide | Approved | PubMed PMID 35405011 |
Somatropin (HGH)Details- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Ansomone, Genotropin, HGH, HGH 191AA, Humatrope, Hygetropin, Jintropin, Kigtropin, Norditropin, Omnitrope, Saizen, Serostim, Zomacton, human growth hormone, rhGH
Sources - PubMed PMID 21602453 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Ansomone, Genotropin, HGH | Protein, not a peptide | Approved | PubMed PMID 21602453 |
SonefpeglutideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- -peg-; -tide
- All names
- Sonefpeglutida
Sources - ChEMBL CHEMBL6068175 (read 2026-10-02)
| Sonefpeglutida | Peptide conjugate | Phase 2 | ChEMBL CHEMBL6068175 |
SovateltideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- IRL-1620, Irl-1620, PMZ-1620, SPI 1620, SPI-1620, Sovateltide, Spi 1620, Spi-1620
Sources - ChEMBL CHEMBL3188091 (read 2026-10-02)
| IRL-1620, Irl-1620, PMZ-1620 | Peptide | Phase 3 | ChEMBL CHEMBL3188091 |
Spexin-1Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9BT56 (read 2026-10-02): mature peptide 36-49 of Spexin, 2 copies
| — | Peptide | Made by the body | UniProt Q9BT56 |
Spexin-2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q9BT56 (read 2026-10-02): mature peptide 53-70 of Spexin, 2 copies
| — | Peptide | Made by the body | UniProt Q9BT56 |
SS-31 (Elamipretide)Details- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Bendavia, Elamipretida, MTP 131, MTP-131, MTP131, Nh2-d-arg-dmt-lys-phe-nh2, Ocuvia, RX 31, RX-31, RX31, SS 31, SS-31, SS31, Szeto-schiller peptide
Sources - ChEMBL CHEMBL3833370 (read 2026-10-02)
- ChEMBL CHEMBL4298161 (read 2026-10-02): salt form, folded into this row
| Bendavia, Elamipretida, MTP 131 | Peptide | Phase 3 | ChEMBL CHEMBL3833370; ChEMBL CHEMBL4298161 |
Substance PDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P20366 (read 2026-10-02): mature peptide 58-68 of Protachykinin-1
| — | Peptide | Made by the body | UniProt P20366 |
SucantomotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Sucantomotida
Sources - ChEMBL CHEMBL5314883 (read 2026-10-02)
| Sucantomotida | Peptide | Phase 2 | ChEMBL CHEMBL5314883 |
Sudocetaxel ZendusortideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -taxel; -tide
- All names
- Sudocetaxel zendusortida, TH-1902, TH1902, Th19p01-docetaxel
Sources - ChEMBL CHEMBL5095153 (read 2026-10-02)
| Sudocetaxel zendusortida, TH-1902, TH1902 | Peptide | Phase 2 | ChEMBL CHEMBL5095153 |
SulglicotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Demucine, Gliptide, Sulglicotida
Sources - ChEMBL CHEMBL2108085 (read 2026-10-02)
| Demucine, Gliptide, Sulglicotida | Peptide | Phase 2 | ChEMBL CHEMBL2108085 |
SurvodutideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- BI 456906, BI-456906, BI456906, Survodutida
Sources - ChEMBL CHEMBL5314776 (read 2026-10-02)
| BI 456906, BI-456906, BI456906 | Peptide | Phase 3 | ChEMBL CHEMBL5314776 |
Svn53-67/m57-klh Peptide VaccineDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Survaxm
Sources - ChEMBL CHEMBL4650424 (read 2026-10-02)
| Survaxm | Peptide | Phase 2 | ChEMBL CHEMBL4650424 |
Syn-AkeDetails- Status
- Status not recorded
- Class
- Peptidomimetic
- All names
- Dipeptide Diaminobutyroyl Benzylamide Diacetate, β-Ala-Pro-Dab-NHBn·2AcOH
Sources - PubMed PMID 37349941 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Dipeptide Diaminobutyroyl Benzylamide Diacetate, β-Ala-Pro-Dab-NHBn·2AcOH | Peptidomimetic | Status not recorded | PubMed PMID 37349941 |
SynenkephalinDetails- Status
- Made by the body
- Class
- Protein, not a peptide
Sources - UniProt P01210 (read 2026-10-02): mature peptide 25-97 of Proenkephalin-A
| — | Protein, not a peptide | Made by the body | UniProt P01210 |
Synthetic Peptide Analogue Of Gnrf Conjugated To Diptheria ToxoidDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -tide
- All names
- Improvac, Improvest
Sources - ChEMBL CHEMBL5315094 (read 2026-10-02)
| Improvac, Improvest | Peptide | Status not recorded | ChEMBL CHEMBL5315094 |
TabilautideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Tabilautida
Sources - ChEMBL CHEMBL3989637 (read 2026-10-02)
| Tabilautida | Peptide | Phase 2 | ChEMBL CHEMBL3989637 |
TabimorelinDetails- Status
- Phase 2
- Class
- Small molecule, not a peptide
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- NN-703, NNC-26-0703, Nn703, Tabimorelina, Tabimoreline
Sources - ChEMBL CHEMBL281764 (read 2026-10-02)
| NN-703, NNC-26-0703, Nn703 | Small molecule, not a peptide | Phase 2 | ChEMBL CHEMBL281764 |
TalfirastideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- 5-ile-angiotensin-(1-7), A(1-7), Ang-(1-7), Angiotensin (1-7), Angiotensin 1-7, Angiotensin fragment 1-7, Angiotensin peptide (1-7), Angiotensin-(1-7), Asp-arg-val-tyr-ile-his-pro, Bf-angiotensin 1-7, ETRX-101, Human angiotensin ii (1-7), Marstem, Sh-heptapeptide-13, TXA-127, TXA127, Talfirastida, Txa127, USB-003, USB003
Sources - ChEMBL CHEMBL3545347 (read 2026-10-02)
| 5-ile-angiotensin-(1-7), A(1-7), Ang-(1-7) | Peptide | Phase 2 | ChEMBL CHEMBL3545347 |
Talogreptide MesaroxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- SAR-BBN FREE BASE NON-LABELED, Talogreptida mesaroxetan
Sources - ChEMBL CHEMBL6068177 (read 2026-10-02)
| SAR-BBN FREE BASE NON-LABELED, Talogreptida mesaroxetan | Peptide | Phase 2 | ChEMBL CHEMBL6068177 |
TaltirelinDetails- Status
- Phase 2
- Class
- Peptidomimetic
- Highest phase
- 2.0
- INN stem
- -relin
- All names
- TA-0910, Taltirelina, Taltireline
Sources - ChEMBL CHEMBL2107016 (read 2026-10-02)
| TA-0910, Taltirelina, Taltireline | Peptidomimetic | Phase 2 | ChEMBL CHEMBL2107016 |
TaspoglutideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- BIM-51077, BIM51077, R-1583, R1583, RO-5073031, RO5073031, Taspoglutida
Sources - ChEMBL CHEMBL2107860 (read 2026-10-02)
| BIM-51077, BIM51077, R-1583 | Peptide | Phase 3 | ChEMBL CHEMBL2107860 |
TB-500Details- Status
- Status not recorded
- Class
- Peptide
- All names
- TMSB4X peptide, Thymosin beta-4 fragment, Tβ4 fragment
Sources - PubMed PMID 20536472 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| TMSB4X peptide, Thymosin beta-4 fragment, Tβ4 fragment | Peptide | Status not recorded | PubMed PMID 20536472 |
TecemotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- BLP-25, BLP25, BP-1-148, Blp 25, Blp-25 lipopeptide, Blp25 lipopeptide, EMD 531444, Emepepimut-s, LIPOPEPTIDE BLP-25, Stimuvax, Tecemotida
Sources - ChEMBL CHEMBL3039544 (read 2026-10-02)
| BLP-25, BLP25, BP-1-148 | Peptide | Phase 3 | ChEMBL CHEMBL3039544 |
Technetium (99mtc) ApcitideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1998
- INN stem
- -tide
- All names
- (99MTC)-P246, 99MTC-P246, Acutect, Technetium tc 99m apcitide, Technetium tc-99m apcitide, Tecnecio (99mtc) apcitida, [99MTC]-P246
Sources - ChEMBL CHEMBL1201524 (read 2026-10-02)
| (99MTC)-P246, 99MTC-P246, Acutect | Peptide | Approved (1998) | ChEMBL CHEMBL1201524 |
Technetium (99mtc) EtarfolatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Folatescan, TC-99M EC-20, TC99M-EC20, Technetium tc 99m etarfolatide, Technetium tc 99m pterotetramide, Technetium tc-99m ec20, Technetium tc-99m etarfolatide, Technetium tc-99m pterotetramide, Tecnecio (99mtc) etarfolatida
Sources - ChEMBL CHEMBL3707391 (read 2026-10-02)
| Folatescan, TC-99M EC-20, TC99M-EC20 | Peptide | Phase 2 | ChEMBL CHEMBL3707391 |
Technetium MertiatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1990
- INN stem
- -tide
- All names
- TC-MAG3, TECHNETIUM TC 99M MERTIATIDE, Technescan mag3, Technetium (99mtc) mertiatide, Technetium tc 99m mertiatide, Technetium tc 99m mertiatide kit, Technetium tc-99m mertiatide, Technetium tc-99m mertiatide kit
Sources - ChEMBL CHEMBL2111131 (read 2026-10-02)
- ChEMBL CHEMBL2107488 (read 2026-10-02): salt form, folded into this row
| TC-MAG3, TECHNETIUM TC 99M MERTIATIDE, Technescan mag3 | Peptide | Approved (1990) | ChEMBL CHEMBL2111131; ChEMBL CHEMBL2107488 |
Technetium Tc 99m DepreotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1999
- INN stem
- -tide
- All names
- Neo tect kit, Technetium (99mtc) depreotide
Sources - ChEMBL CHEMBL1201413 (read 2026-10-02)
| Neo tect kit, Technetium (99mtc) depreotide | Peptide | Approved (1999) | ChEMBL CHEMBL1201413 |
Technetium Tc 99m TiatideDetails- Status
- Status not recorded
- Class
- Peptide
- Highest phase
- -1.0
- INN stem
- -tide
- All names
- 99mtc-mag3, Technetium tc 99m mertiatide anion, Technetium tc-99m tiatide (anion), Technetium tc-99m tiatide anion
Sources - ChEMBL CHEMBL2108142 (read 2026-10-02)
| 99mtc-mag3, Technetium tc 99m mertiatide anion, Technetium tc-99m tiatide (anion) | Peptide | Status not recorded | ChEMBL CHEMBL2108142 |
TeduglutideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2012
- INN stem
- -tide
- All names
- ALX 0600, ALX-0600, Gattex, Gattex kit, Revestive, Teduglutida, Teduglutide (rdna origin), Teduglutide recombinant
Sources - ChEMBL CHEMBL2104987 (read 2026-10-02)
| ALX 0600, ALX-0600, Gattex | Peptide | Approved (2012) | ChEMBL CHEMBL2104987 |
TeicoplaninDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- All names
- MDL 507, MDL-507, NSC-759183, Tagocid, Targocid, Targosid, Teichomycin a2, Teicoplanin a2, Teicoplanina, Teicoplanine, Teikoplanin, Ticocin
Sources - ChEMBL CHEMBL4297166 (read 2026-10-02)
| MDL 507, MDL-507, NSC-759183 | Peptide | Phase 3 | ChEMBL CHEMBL4297166 |
TelavancinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2009
- All names
- Vibativ
Sources - openFDA NDA022110 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Vibativ | Peptide | Approved (2009) | openFDA NDA022110 |
TemurtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- RS-37449, Temurtida
Sources - ChEMBL CHEMBL3989635 (read 2026-10-02)
| RS-37449, Temurtida | Peptide | Phase 2 | ChEMBL CHEMBL3989635 |
TeprotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- SO 20881, SO-20881, SQ 20881, SQ-20881, Tepromide, Teprotida
Sources - ChEMBL CHEMBL408983 (read 2026-10-02)
| SO 20881, SO-20881, SQ 20881 | Peptide | Phase 2 | ChEMBL CHEMBL408983 |
TeriparatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1987
- INN stem
- -tide
- All names
- (1-34)-human parathyroid hormone, 1-34-human pth, Ak-159, Ak159, Bonsity, Forsteo, Forteo, HPTH 1-34, HPTH 1-34 (ACETATE SALT), HPTH-1-34, Human parathyroid hormone 1-34, Kauliv, LY 333334, LY-333334, LY333334, Livogiva, Movymia, Parathar, Pth (1-34), Qutavina, Sondelbay, Teriparatida, Teriparatide rdna, Teriparatide recombinant human, Teriparatide sun, Terrosa, ZT-034
Sources - ChEMBL CHEMBL1201549 (read 2026-10-02)
- ChEMBL CHEMBL525610 (read 2026-10-02): separate ChEMBL record of the same molecule
| (1-34)-human parathyroid hormone, 1-34-human pth, Ak-159 | Peptide | Approved (1987) | ChEMBL CHEMBL1201549; ChEMBL CHEMBL525610 |
TerlipressinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2022
- INN stem
- -pressin
- All names
- Glycylpressin, Glypressin, Terlipresina, Terlipressine, Terlivaz, Variquel
Sources - ChEMBL CHEMBL2135460 (read 2026-10-02)
| Glycylpressin, Glypressin, Terlipresina | Peptide | Approved (2022) | ChEMBL CHEMBL2135460 |
TertomotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- GV-1001, GV1001, Gv1001, Htert (534-549), Tertomotida
Sources - ChEMBL CHEMBL2108308 (read 2026-10-02)
| GV-1001, GV1001, Gv1001 | Peptide | Phase 3 | ChEMBL CHEMBL2108308 |
TesamorelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2010
- INN stem
- -relin
- All names
- Egrifta, TH-9507, TH-9507 ACETATE, TH9507, Tesamorelina, Tesamoreline
Sources - ChEMBL CHEMBL1237026 (read 2026-10-02)
- ChEMBL CHEMBL2111290 (read 2026-10-02): salt form, folded into this row
| Egrifta, TH-9507, TH-9507 ACETATE | Peptide | Approved (2010) | ChEMBL CHEMBL1237026; ChEMBL CHEMBL2111290 |
TesofensineDetails- Status
- Status not recorded
- Class
- Small molecule, not a peptide
- All names
- NS2330
Sources - PubMed PMID 17324246 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| NS2330 | Small molecule, not a peptide | Status not recorded | PubMed PMID 17324246 |
TestagenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- KEDG tetrapeptide (Khavinson testis), Testis peptide bioregulator
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KEDG tetrapeptide (Khavinson testis), Testis peptide bioregulator | Peptide | Status not recorded | PubMed PMID 19830585 |
TetracosactideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1970
- INN stem
- -tide
- All names
- Cortrosyn, HOE-254, Tricosactida
Sources - ChEMBL CHEMBL2103923 (read 2026-10-02)
- openFDA NDA016750 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Cortrosyn, HOE-254, Tricosactida | Peptide | Approved (1970) | ChEMBL CHEMBL2103923; openFDA NDA016750 |
Tetrapeptide-21Details- Status
- Status not recorded
- Class
- Peptide
- All names
- GEKG peptide
Sources - PubChem CID 42630677 (read 2026-10-02): PubChem title: GEKG peptide
| GEKG peptide | Peptide | Status not recorded | PubChem CID 42630677 |
TeverelixDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -relix
- All names
- Antarelix, D-23234, EP-24332
Sources - ChEMBL CHEMBL2103945 (read 2026-10-02)
| Antarelix, D-23234, EP-24332 | Peptide | Phase 2 | ChEMBL CHEMBL2103945 |
ThymalinDetails- Status
- Status not recorded
- Class
- Blend or mixture
- All names
- Calf-thymus polypeptide preparation, Thymus peptide complex, Timalin
Sources - PubMed PMID 36169363 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Calf-thymus polypeptide preparation, Thymus peptide complex, Timalin | Blend or mixture | Status not recorded | PubMed PMID 36169363 |
ThymogenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Glu-Trp dipeptide, Glutamyl-tryptophan, Timogen
Sources - PubMed PMID 21957588 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Glu-Trp dipeptide, Glutamyl-tryptophan, Timogen | Peptide | Status not recorded | PubMed PMID 21957588 |
ThymopentinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- TP-5, TP5, Thymopoietin 32-36, Timunox
Sources - PubMed PMID 2185294 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| TP-5, TP5, Thymopoietin 32-36 | Peptide | Status not recorded | PubMed PMID 2185294 |
Thymosin α1Details- Status
- Status not recorded
- Class
- Peptide
- All names
- TA1, Tα1, Zadaxin, thymalfasin
Sources - PubMed PMID 39814420 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| TA1, Tα1, Zadaxin | Peptide | Status not recorded | PubMed PMID 39814420 |
Thymosin β4Details- Status
- Status not recorded
- Class
- Peptide
- All names
- RGN-259, TB4, TMSB4X, Tβ4
Sources - PubMed PMID 12709011 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| RGN-259, TB4, TMSB4X | Peptide | Status not recorded | PubMed PMID 12709011 |
ThymulinDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- FTS, Facteur Thymique Sérique, Serum Thymic Factor
Sources - PubMed PMID 6957870 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| FTS, Facteur Thymique Sérique, Serum Thymic Factor | Peptide | Status not recorded | PubMed PMID 6957870 |
TifuvirtideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -vir-
- All names
- T-1249, T1249, Tifuvirtida
Sources - ChEMBL CHEMBL2108654 (read 2026-10-02)
| T-1249, T1249, Tifuvirtida | Peptide | Phase 2 | ChEMBL CHEMBL2108654 |
TigapotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- PCK-3145, PCK3145, TIGAPOTIDE TRIFLUTATE, Tigapotida, Tigapotide triflutate
Sources - ChEMBL CHEMBL3040192 (read 2026-10-02)
- ChEMBL CHEMBL2369994 (read 2026-10-02): salt form, folded into this row
| PCK-3145, PCK3145, TIGAPOTIDE TRIFLUTATE | Peptide | Phase 2 | ChEMBL CHEMBL3040192; ChEMBL CHEMBL2369994 |
TiplimotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Nbi-5788, Tiplimotida
Sources - ChEMBL CHEMBL2108869 (read 2026-10-02)
| Nbi-5788, Tiplimotida | Peptide | Phase 2 | ChEMBL CHEMBL2108869 |
TirzepatideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2022
- INN stem
- -tide
- All names
- BG-121, LY-3298176, LY3298176, Ly3298176, Mounjaro, Mounjaro (autoinjector), Tirzepatida, Zepbound, Zepbound (autoinjector)
Sources - ChEMBL CHEMBL4297839 (read 2026-10-02)
| BG-121, LY-3298176, LY3298176 | Peptide | Approved (2022) | ChEMBL CHEMBL4297839 |
TosactideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- .alpha.1-28-corticotropin, .alpha.1-28-corticotropin (human), Tosactida
Sources - ChEMBL CHEMBL2103904 (read 2026-10-02)
| .alpha.1-28-corticotropin, .alpha.1-28-corticotropin (human), Tosactida | Peptide | Phase 2 | ChEMBL CHEMBL2103904 |
TozuleristideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- BLZ-100, Tozuleristida
Sources - ChEMBL CHEMBL3990023 (read 2026-10-02)
| BLZ-100, Tozuleristida | Peptide | Phase 2 | ChEMBL CHEMBL3990023 |
TrevogrumabDetails- Status
- Status not recorded
- Class
- Antibody, not a peptide
- All names
- REGN1033, SAR391786
Sources - ClinicalTrials.gov NCT01507402 (read 2026-10-02): trial registration cited on the encyclopedia entry
| REGN1033, SAR391786 | Antibody, not a peptide | Status not recorded | ClinicalTrials.gov NCT01507402 |
TridecactideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- .alpha.-1-13-corticotropin, human, .alpha.1-13-acth, Alpha-1-13-corticotropin, human, Tridecactida
Sources - ChEMBL CHEMBL2108340 (read 2026-10-02)
| .alpha.-1-13-corticotropin, human, .alpha.1-13-acth, Alpha-1-13-corticotropin, human | Peptide | Phase 3 | ChEMBL CHEMBL2108340 |
Trifluoroacetyl Tripeptide-2Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubChem CID 40785040 (read 2026-10-02): PubChem title: Trifluoroacetyl tripeptide-2
| — | Peptide | Status not recorded | PubChem CID 40785040 |
TriletideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Triletida
Sources - ChEMBL CHEMBL2105562 (read 2026-10-02)
| Triletida | Peptide | Phase 2 | ChEMBL CHEMBL2105562 |
Tripeptide-10 CitrullineDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Decorinyl (trade name), Lys-Asp-Ile-Cit-NH2, T10-C
Sources - PubMed PMID 18377618 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Decorinyl (trade name), Lys-Asp-Ile-Cit-NH2, T10-C | Peptide | Status not recorded | PubMed PMID 18377618 |
Tripeptide-29Details- Status
- Status not recorded
- Class
- Peptide
- All names
- Glycyl-prolyl-hydroxyproline
Sources - PubChem CID 11778669 (read 2026-10-02): PubChem title: Glycyl-prolyl-hydroxyproline
| Glycyl-prolyl-hydroxyproline | Peptide | Status not recorded | PubChem CID 11778669 |
TriptorelinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2000
- INN stem
- -relin
- All names
- AY-25650, Arvekap, CL 118,532, CL-118532, Decapeptyl, Decapeptyl sr, Gonapeptyl depot, Ovugel, Salvacyl, Trelstar, Triptodur, Triptodur kit, Triptorelin (as embonate), Triptorelina, Triptoreline, Tryptorelin, WY-42462
Sources - ChEMBL CHEMBL1201334 (read 2026-10-02)
- ChEMBL CHEMBL1200554 (read 2026-10-02): salt form, folded into this row
- ChEMBL CHEMBL5315073 (read 2026-10-02): separate ChEMBL record of the same molecule
| AY-25650, Arvekap, CL 118,532 | Peptide | Approved (2000) | ChEMBL CHEMBL1201334; ChEMBL CHEMBL1200554; ChEMBL CHEMBL5315073 |
TrofinetideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2023
- INN stem
- -tide
- All names
- ACP-2566, Daybue, NNZ-2566, Trofinetida
Sources - ChEMBL CHEMBL197084 (read 2026-10-02)
| ACP-2566, Daybue, NNZ-2566 | Peptide | Approved (2023) | ChEMBL CHEMBL197084 |
Trolamine Polypeptide Oleate CondensateDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1958
- INN stem
- -tide
- All names
- Cerumenex
Sources - ChEMBL CHEMBL1201537 (read 2026-10-02)
| Cerumenex | Peptide | Approved (1958) | ChEMBL CHEMBL1201537 |
Tuberoinfundibular peptide of 39 residuesDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q96A98 (read 2026-10-02): mature peptide 62-100 of Tuberoinfundibular peptide of 39 residues
| — | Peptide | Made by the body | UniProt Q96A98 |
TyrothricinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- All names
- Bactratycin, Coltirot, Dermotricine, Hydrotricine, Martricin, NSC-757363, Solutricine, Tirotricina, Tyri 10, Tyroderm, Tyrosur, Tyrothricine
Sources - ChEMBL CHEMBL577736 (read 2026-10-02)
| Bactratycin, Coltirot, Dermotricine | Peptide | Approved | ChEMBL CHEMBL577736 |
Ucasareotide DasaroxetanDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- Sartate, Ucasareotida dasaroxetan
Sources - ChEMBL CHEMBL5314889 (read 2026-10-02)
| Sartate, Ucasareotida dasaroxetan | Peptide | Phase 2 | ChEMBL CHEMBL5314889 |
UlaritideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- INN 00835, INN-00835, NEMIFITIDE DITRIFLUTATE, Nemifitida, Nemifitide bis(trifluoroacetate), Nemifitide ditriflutate, Ularitida, Urodilatin, Urodilatin ularitide
Sources - ChEMBL CHEMBL2103920 (read 2026-10-02)
- UniProt P01160 (read 2026-10-02): mature peptide 120-151 of Natriuretic peptides A
- ChEMBL CHEMBL2107761 (read 2026-10-02): separate ChEMBL record of the same molecule
- ChEMBL CHEMBL2146091 (read 2026-10-02): salt form, folded into this row
| INN 00835, INN-00835, NEMIFITIDE DITRIFLUTATE | Peptide | Phase 3 | ChEMBL CHEMBL2103920; UniProt P01160; ChEMBL CHEMBL2107761 |
UlimorelinDetails- Status
- Phase 3
- Class
- Peptidomimetic
- Highest phase
- 3.0
- INN stem
- -relin
- All names
- TZP-101, TZP-101 FREE BASE, Ulimorelina, Ulimoreline
Sources - ChEMBL CHEMBL1963249 (read 2026-10-02)
- ChEMBL CHEMBL1923502 (read 2026-10-02): salt form, folded into this row
| TZP-101, TZP-101 FREE BASE, Ulimorelina | Peptidomimetic | Phase 3 | ChEMBL CHEMBL1963249; ChEMBL CHEMBL1923502 |
UrocortinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P55089 (read 2026-10-02): mature peptide 83-122 of Urocortin, 2 copies
| — | Peptide | Made by the body | UniProt P55089 |
UrofollitropinDetails- Status
- Approved
- Class
- Protein, not a peptide
- Highest phase
- 4.0
- All names
- Bravelle, Fertinex, Metrodin HP, highly purified urinary FSH, uFSH
Sources - PubMed PMID 9402268 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Bravelle, Fertinex, Metrodin HP | Protein, not a peptide | Approved | PubMed PMID 9402268 |
UroguanylinDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q16661 (read 2026-10-02): mature peptide 97-112 of Guanylate cyclase activator 2B
| — | Peptide | Made by the body | UniProt Q16661 |
Urotensin-2Details- Status
- Made by the body
- Class
- Peptide
Sources - UniProt O95399 (read 2026-10-02): mature peptide 114-124 of Urotensin-2
| — | Peptide | Made by the body | UniProt O95399 |
Urotensin-2BDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt Q765I0 (read 2026-10-02): mature peptide 112-119 of Urotensin-2B
| — | Peptide | Made by the body | UniProt Q765I0 |
UtreglutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -treg-
- All names
- Utreglutida
Sources - ChEMBL CHEMBL5095156 (read 2026-10-02)
| Utreglutida | Peptide | Phase 2 | ChEMBL CHEMBL5095156 |
VancomycinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2018
- All names
- Firvanq Kit, Tyzavan
Sources - openFDA NDA208910 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Firvanq Kit, Tyzavan | Peptide | Approved (2018) | openFDA NDA208910 |
Vanutide CridificarDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ACC-001, Vanutida cridificar
Sources - ChEMBL CHEMBL2108058 (read 2026-10-02)
| ACC-001, Vanutida cridificar | Peptide | Phase 2 | ChEMBL CHEMBL2108058 |
VapreotideDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- BMY-41606, BMY-41606 ACETATE, DP-05-094, Docrised, Docrised (mexico), Octastatin, Octastatin acetate, RC-160, RC-160 ACETATE, Sanvar, Vapreotida, Vapreotide monoacetate
Sources - ChEMBL CHEMBL3349523 (read 2026-10-02)
- ChEMBL CHEMBL6067976 (read 2026-10-02): salt form, folded into this row
| BMY-41606, BMY-41606 ACETATE, DP-05-094 | Peptide | Phase 3 | ChEMBL CHEMBL3349523; ChEMBL CHEMBL6067976 |
VasopressinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2014
- INN stem
- -pressin
- All names
- Arginine vasopressin, Argipressin or lypressin, Beta-hypophamine, Inyectable de vasopresina, Leiormone, Solute injectable de vasopressine, Vasophysin, Vasopressin In Sodium Chloride 0.9%, Vasopressin component of hbn-1, Vasopressin injection, Vasopressin, unspecified, Vasostrict
Sources - ChEMBL CHEMBL373742 (read 2026-10-02)
- openFDA NDA204485 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Arginine vasopressin, Argipressin or lypressin, Beta-hypophamine | Peptide | Approved (2014) | ChEMBL CHEMBL373742; openFDA NDA204485 |
Vasopressin TannateDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 1982
- INN stem
- -pressin
- All names
- Pitressin tannate
Sources - ChEMBL CHEMBL1201528 (read 2026-10-02)
| Pitressin tannate | Peptide | Approved (1982) | ChEMBL CHEMBL1201528 |
VeldoreotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- COR-005, DG-3173, DG3173, Dg3173, PTR 3173, PTR-3173, Somatoprim, Veldoreotida
Sources - ChEMBL CHEMBL3989911 (read 2026-10-02)
| COR-005, DG-3173, DG3173 | Peptide | Phase 2 | ChEMBL CHEMBL3989911 |
VensemaglutideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Vensemaglutida
Sources - ChEMBL CHEMBL6068314 (read 2026-10-02)
| Vensemaglutida | Peptide | Phase 2 | ChEMBL CHEMBL6068314 |
VentfortDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Vascular peptide bioregulator, Vessel-wall peptide preparation
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Vascular peptide bioregulator, Vessel-wall peptide preparation | Peptide | Status not recorded | PubMed PMID 19830585 |
Vessel dilatorDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P01160 (read 2026-10-02): mature peptide 56-92 of Natriuretic peptides A
| — | Peptide | Made by the body | UniProt P01160 |
VesugenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- KED tripeptide, Lys-Glu-Asp, Vascular tripeptide
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| KED tripeptide, Lys-Glu-Asp, Vascular tripeptide | Peptide | Status not recorded | PubMed PMID 19830585 |
VezocolmitideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Vezocolmitida
Sources - ChEMBL CHEMBL6068188 (read 2026-10-02)
| Vezocolmitida | Peptide | Phase 2 | ChEMBL CHEMBL6068188 |
VicatertideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Vicatertida
Sources - ChEMBL CHEMBL5314893 (read 2026-10-02)
| Vicatertida | Peptide | Phase 2 | ChEMBL CHEMBL5314893 |
VilonDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Lysylglutamic acid
Sources - PubChem CID 7010502 (read 2026-10-02): PubChem title: Lysylglutamic acid
| Lysylglutamic acid | Peptide | Status not recorded | PubChem CID 7010502 |
VIPDetails- Status
- Phase 3
- Class
- Peptide
- Highest phase
- 3.0
- INN stem
- -tide
- All names
- Vasoactive intestinal polypeptide, Vip
Sources - ChEMBL CHEMBL525028 (read 2026-10-02)
- UniProt P01282 (read 2026-10-02): mature peptide 125-152 of VIP peptides
| Vasoactive intestinal polypeptide, Vip | Peptide | Phase 3 | ChEMBL CHEMBL525028; UniProt P01282 |
Vipivotide TetraxetanDetails- Status
- Approved
- Class
- Peptidomimetic
- Highest phase
- 4.0
- First approval
- 2022
- INN stem
- -tide; -xetan
- All names
- 177LU-LABELED PSMA-617, 177Lu-PSMA-617, 177lu-psma-617, DKFZ-PSMA-617, LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN, Lutetium (177lu) vipivotide tetraxetan, Lutetium lu 177 vipivotide tetraxetan, Lutetium lu-177 vipivotide tetraxetan, PSMA-617, PSMA617, Pluvicto, Psma-617 lu-177, Vipivotida tetraxetan, Vipivotide tetraxetan lu-177, Vipivotide tetraxetan lutetium lu-177
Sources - ChEMBL CHEMBL4594280 (read 2026-10-02)
- ChEMBL CHEMBL4594730 (read 2026-10-02): separate ChEMBL record of the same molecule
- ChEMBL CHEMBL4594406 (read 2026-10-02): salt form, folded into this row
| 177LU-LABELED PSMA-617, 177Lu-PSMA-617, 177lu-psma-617 | Peptidomimetic | Approved (2022) | ChEMBL CHEMBL4594280; ChEMBL CHEMBL4594730; ChEMBL CHEMBL4594406 |
Vipivotide Tetraxetan GalliumDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide; -xetan
- All names
- 68ga-psma-617, Psma-617 ga-68, VIPIVOTIDE TETRAXETAN GALLIUM GA-68, Vipivotide tetraxetan gallium ga-68
Sources - ChEMBL CHEMBL4650685 (read 2026-10-02)
- ChEMBL CHEMBL4650357 (read 2026-10-02): salt form, folded into this row
| 68ga-psma-617, Psma-617 ga-68, VIPIVOTIDE TETRAXETAN GALLIUM GA-68 | Peptide | Phase 2 | ChEMBL CHEMBL4650685; ChEMBL CHEMBL4650357 |
VisepegenatideDetails- Status
- Phase 2
- Class
- Peptide conjugate
- Highest phase
- 2.0
- INN stem
- -peg-; -tide
- All names
- Visepegenatida
Sources - ChEMBL CHEMBL5314895 (read 2026-10-02)
| Visepegenatida | Peptide conjugate | Phase 2 | ChEMBL CHEMBL5314895 |
VisolutenDetails- Status
- Status not recorded
- Class
- Peptide
- All names
- Eye peptide preparation, Retinal peptide bioregulator
Sources - PubMed PMID 19830585 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| Eye peptide preparation, Retinal peptide bioregulator | Peptide | Status not recorded | PubMed PMID 19830585 |
VK2735Details- Status
- Status not recorded
- Class
- Peptide
Sources - PubMed PMID 41508550 (read 2026-10-02): first PubMed citation on the encyclopedia entry, verified by citation_verify
| — | Peptide | Status not recorded | PubMed PMID 41508550 |
VoclosporinDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2021
- All names
- Lupkynis
Sources - openFDA NDA213716 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Lupkynis | Peptide | Approved (2021) | openFDA NDA213716 |
VorumotideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- Vorumotida, Wt-1 331 long, Wt1-331 long
Sources - ChEMBL CHEMBL5314789 (read 2026-10-02)
| Vorumotida, Wt-1 331 long, Wt1-331 long | Peptide | Phase 2 | ChEMBL CHEMBL5314789 |
VosoritideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2021
- INN stem
- -tide
- All names
- BMN 111, BMN-111, Bmn 111, Vosoritida, Voxzogo
Sources - ChEMBL CHEMBL3707276 (read 2026-10-02)
| BMN 111, BMN-111, Bmn 111 | Peptide | Approved (2021) | ChEMBL CHEMBL3707276 |
VurolenatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- GLP-1-XTEN, NB-1001, NB1001, NM-002, Vurolenatida
Sources - ChEMBL CHEMBL5095367 (read 2026-10-02)
| GLP-1-XTEN, NB-1001, NB1001 | Peptide | Phase 2 | ChEMBL CHEMBL5095367 |
XelafaslatideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- ONL1204, Onl-1204, Onl1204, Xelafaslatida
Sources - ChEMBL CHEMBL6068318 (read 2026-10-02)
| ONL1204, Onl-1204, Onl1204 | Peptide | Phase 2 | ChEMBL CHEMBL6068318 |
XeninDetails- Status
- Made by the body
- Class
- Peptide
Sources - UniProt P53621 (read 2026-10-02): mature peptide 1-25 of Coatomer subunit alpha
| — | Peptide | Made by the body | UniProt P53621 |
Yttrium Y 90 Capromab PendetideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -mab; -tide
- All names
- 90y-cyt-356, CYT-356-90Y, CYT-356-Y-90, Cyt-356 90y, Oncoltad
Sources - ChEMBL CHEMBL2109552 (read 2026-10-02)
| 90y-cyt-356, CYT-356-90Y, CYT-356-Y-90 | Peptide | Phase 2 | ChEMBL CHEMBL2109552 |
ZelenectideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- BCY-8116, BCY8126, BCY8161, Zelenectida
Sources - ChEMBL CHEMBL5314902 (read 2026-10-02)
| BCY-8116, BCY8126, BCY8161 | Peptide | Phase 2 | ChEMBL CHEMBL5314902 |
Zelenectide PevedotinDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -dotin; -tide
- All names
- BT-8009, BT8009, Bt8009, Zelenectida pevedotina, Zelenectide pavedotin, Zelenectide pevedotine
Sources - ChEMBL CHEMBL5314903 (read 2026-10-02)
| BT-8009, BT8009, Bt8009 | Peptide | Phase 2 | ChEMBL CHEMBL5314903 |
Zelpultide AlfaDetails- Status
- Phase 1
- Class
- Peptide
- Highest phase
- 1.0
- INN stem
- -tide
- All names
- AT-100, AT100, At 100, At-100, Recombinant sp-d
Sources - ChEMBL CHEMBL4650375 (read 2026-10-02)
| AT-100, AT100, At 100 | Peptide | Phase 1 | ChEMBL CHEMBL4650375 |
ZendusortideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
- All names
- TH-19P01, TH19P01, Zendusortida
Sources - ChEMBL CHEMBL5095162 (read 2026-10-02)
| TH-19P01, TH19P01, Zendusortida | Peptide | Phase 2 | ChEMBL CHEMBL5095162 |
ZiconotideDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2004
- INN stem
- -tide
- All names
- .omega.-conotoxin m viia, Prialt, SNX-111, SNX-111 ACETATE, Ziconotida
Sources - ChEMBL CHEMBL1795072 (read 2026-10-02)
- ChEMBL CHEMBL4594214 (read 2026-10-02): separate ChEMBL record of the same molecule
| .omega.-conotoxin m viia, Prialt, SNX-111 | Peptide | Approved (2004) | ChEMBL CHEMBL1795072; ChEMBL CHEMBL4594214 |
ZifogaptideDetails- Status
- Phase 2
- Class
- Peptide
- Highest phase
- 2.0
- INN stem
- -tide
Sources - ChEMBL CHEMBL6068192 (read 2026-10-02)
| — | Peptide | Phase 2 | ChEMBL CHEMBL6068192 |
ZilucoplanDetails- Status
- Approved
- Class
- Peptide
- Highest phase
- 4.0
- First approval
- 2023
- All names
- Zilbrysq
Sources - openFDA NDA216834 (read 2026-10-02): earliest NDA/BLA approval in Drugs@FDA via openFDA
| Zilbrysq | Peptide | Approved (2023) | openFDA NDA216834 |
Zoptarelin DoxorubicinDetails- Status
- Phase 3
- Class
- Peptide conjugate
- Highest phase
- 3.0
- INN stem
- -relin; -rubicin
- All names
- AEZS-108, AN-152, AN-52, Aezs-108, D-81858, ZEN-008, Zoptarelina doxorubicina, Zoptareline doxorubicine
Sources - ChEMBL CHEMBL3544954 (read 2026-10-02)
- ChEMBL CHEMBL3989956 (read 2026-10-02): salt form, folded into this row
| AEZS-108, AN-152, AN-52 | Peptide conjugate | Phase 3 | ChEMBL CHEMBL3544954; ChEMBL CHEMBL3989956 |